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Abstract
METABOLIC ENGINEERING OF SERRATIA MARCESCENS
By Qiang Yan
Virginia Commonwealth University, 2018
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2018
Major Director: Stephen S Fong, Ph.D.
Associate Professor, Chemical and Life Science Engineering

Chitin is the world‟s second most abundant polymer and contains in shrimp/crab
shells as food waste. The potential value of the chitin biomass (e.g. food waste) is
recently considered being ignored by landfill. Chitin can be a potential cheap carbon
source for converting into value-added chemicals by microorganisms. Currently, one
of the hurdles hindering utilizing chitin-based biomass feedstocks is the recalcitrant
nature of chitin to hydrolyze. Wide ranges of chitinase enzymes are found natively in
microorganisms that can potentially be used to effectively hydrolyze chitin to
fermentable sugars. Serratia marcescens is a chitinolytic bacterium that harbors
endogenous chitinase systems. Although S. marcescens chitinases are being
characterized, studies regarding S. marcescens utilizing chitin as a substrate to
produce chemical remain uncharacterized.

With goals of characterzing S. marcescens chitinolytic capabilities and applying S.
marcescens to chemical production from chitin, my dissertation main content includes
9

five chapters: 1) Chapter 1 highlights background information of chitin source, S.
marcescens and potential metabolic engineering targets using chitin as a substrate; 2)
Chapter 2 demonstrates that ChiR is a key regulator in regulating 9 chitinase-related
genes in S. marcescens Db11 and manipulation of chiR can be a useful and efficient
genetic target to enhance chitin utilization; 3) Chapter 3 reports the production of
N-acetylneuraminic acid (Neu5Ac) from chitin by a bottom-up approach of
engineering the nonconventional chitinolytic bacterium, Serratia marcescens,
including native constitutive promoter characterization and transcriptional and
translational pathway balancing; 4) Chapter 4 describes improvement of S.
marcescens chitinolytic capability by an adaptive evolution approach; 5) Chapter 5
elucidates S. marcescens intracellular metabolite profile using a constraint-based
genome-scale metabolic model (iSR929) based on genomic annotation of S.
marcescens Db11. Overall, the dissertation work is the first report of demonstrating
the concept of chitin-based CBP using S. marcescens and the computational model
and genetic molecular tools developed in this dissertation are valuable but not limited
to design-build-test of S. marcescens for contributing to the field of biological science
and metabolic engineering applications.
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Chapter 1 Introduction and Background

1.1 Introduction
Chemicals produced through bioprocesses range from bulk commodity chemicals
such as organic acids and biofuels to high-value specialty chemicals such as
isoprenoid drugs. For specialty chemicals with high monetary value per unit, the
emphasis has been discovery and production feasibility. For other chemicals where
economic pressures constrain industrial scale processes, one area of focus has been on
utilizing cheap, abundant starting materials (Hasunuma et al. 2013; Mosier et al.
2005).

Bio-based degradation of lignocellulosic biomass (cellulose, hemicelluloses and
lignin) was a logical focus of initial research efforts as cellulose is the most abundant
available carbon substrate and potential mechanisms for breaking

down

lignocellulosic material should be identifiable from cellulolytic organisms. As the
world‟s second most abundant carbon substrate, chitin has many similarities
compared to cellulose: highly abundant in nature (1010-1011 tons year-1),
homopolymer of a simple sugar (N-acetylglucosamine), requiring specialized
enzymes for degradation (chitinase). Due to their similarity, implementation of
chitin-based biomass as carbon source for biochemical production can enhance the
nature of the biorefinery industry including broadening the range of practicable
biomass conversion and lowering the environmental impact of our chemical-based
12

industry.

Aiming at developing chemical production bioprocess using chitin as a carbon source,
this chapter mainly focuses on three aspects of background information: 1) chitin
structure and its natural sources, 2) chitinases for degrading chitin into fermentable
sugar, 3) potential chemical targets based on the chitin monomer structure similarities.
1.2 Chitin-based biomass resources
As the world‟s second most abundant polymer, chitin/chitosan occurring as a main
component in seafood wastes (i.e., shrimp, crab, lobster shells) (Yan and Fong 2015).
Annually, such organic marine waste pose a potential issue to the world and society:
disposal has an associated high capital cost (e.g., $150/ton in Australia while dried
shrimp cost $100–120/ton and estimated 1.5 million tons in Southeast Asia alone)
(Dahiya et al. 2006). The potential value of the shell waste for the chemical industry
is being ignored.
1.3 Chitin structure
Chitin,

poly(β-(1→4)-N-acetyl-D-glucosamine(GlcNAc)),

consists

of

N-acetylglucosamine by β-(1→4) glycosidic bond, shown in Figure 1. In nature, there
are two different crystalline forms, α and β. α-chitin is by far the most abundant and
the linear chains of GlcNAc unit are arranged in an antiparallel manner. On the other
hand, β-chitin consists of parallel chains (Rinaudo 2006).

13

Figure 1 Structural of chitin, chitosan, and degradation products with specific
enzymes and reaction.
1.4 Chitinase resources, structures, and categories
1.4.1 Chitinase resources
Chitinases are enzymes that can degrade/break down the long chain chitin into
chitooligosaccharides or the monomer (e.g. N-acetylglucosamine). Chitinases are
encoded in a wide range of organisms including viruses, bacteria, fungi, insects,
14

higher plants, and animals for different purposes such as nutrition, morphogenesis,
and defense against chitin-containing pathogens (Aam et al. 2010; Adrangi and
Faramarzi 2013; Harti et al. 2012).
1.4.2 Chitinase structures
Chitinolytic bacteria generally produce multiple chitinases derived from different
genes. Many chitinolytic bacteria produce only family 18 chitinases, whereas other
bacteria such as the Streptomyces species produce family 19 chitinases in addition to
family 18 chitinases (Dahiya et al. 2006).
1.4.2.1 Catalytic domain
Chitinases catalytic domains have a (β/α)8 TIM-barrel fold with crucial catalytic
residues being located on β-strand number 4 (Vaaje-Kolstad et al. 2013).
High-resolution 3D structures of bacterial chitinases from B. circulans (ChiA1) have
been revealed by X-ray crystallography (Toratani et al. 2006). The catalytic domain of
ChiA1 consists of a deep substrate-binding cleft on the top of its (β/α)8-barrel
structure. A mechanism has been suggested by a hydrophobic stacking interaction
between the aromatic residues in this cleft and bound oligosaccharide (Watanabe et al.
2002; Watanabe et al. 2001).
1.4.2.2 Chitin-binding domain
Chitinases are usually multi-modular. For example, ChiA1 from B. circulans WL-12
contains a C-terminal chitin-binding domain and two fibronectin III-like domains
(FnIII-D-1 and FnIII-D-2) (Watanabe et al. 1990); S. marcescens contains an
N-terminal chitin-binding domain with a fibronectin III domain (ChiA), or a
15

C-terminal chitin-binding domain (ChiB), or a C-terminal FnIII domain coupled with
a downstream chitin-binding domain (ChiC) (Vaaje-Kolstad et al. 2013). The
properties and roles of the chitin-binding domain have been addressed in several
studies but remain partly unresolved. The typical mechanisms of a chitin-binding
domain function to facilitate correct positioning of the catalytic domain, to contribute
to processive action, and to facilitate local decrystallization of the substrate. Several
studies have confirmed that the presence of these domains increases substrate affinity
as well as the efficiency of chitin hydrolysis, especially for more crystalline chitin.

1.4.2.3 Fibronectin III (FnIII) domains

The FnIII domain is one of the most commonly found motifs in animal proteins, and it
has been proposed that bacterial FnIII domains were acquired from animals by
horizontal gene transfer. This domain shares barely detectable sequence identity with
FnIII modules between ChiA from S. marcescens and ChiA1 from B. circulans (Jee et
al. 2002; Watanabe et al. 1994). For example, the FnIII domain from S.
marcescens ChiA consists of aromatic residues that contribute to substrate binding and
substrate hydrolysis (Uchihashi et al. 2001). In contrast to the N-terminal domain of
ChiA from S. marcescens, the structurally characterized FnIII domain of ChiA1 from B.
circulans does not have exposed aromatic residues on its surface (Jee et al. 2002).
Therefore, this domain does not appear to be directly involved in chitin binding.
However, it is proposed that FnIII domains are important for enzyme activity, probably
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by affecting the overall enzyme structure and the spatial localization of the catalytic
domain and the chitin-binding domain.

1.5 A model chitinolytic organism: Serratia marcescens

Many organisms have been isolated and reported with capability of producing/secreting
chitinase. Serratia marcescens is a Gram-negative, chitinolytic bacterium in the
Enterobacteriaceae order. S. marcescens is known as an efficient chitin degrader
(Monreal and Reese 1969; Vaaje-Kolstad et al. 2013). The wild-type Db11 strain of S.
marcescens has 10 chitinase-related genes, of which 5 different chitinases have been
identified, purified and characterized. One of these chitinases is an endo-acting
non-processive chitinase (chiC) (Horn et al. 2006; Suzuki et al. 1999; Synstad et al.
2008); two are processive exochitinases (chiA and chiB) that move along chitin in
opposite directions (e.g. reducing and non-reducing ends) (Brurberg et al. 1995;
Brurberg et al. 1994; Hult et al. 2005; Igarashi et al. 2014); one is a novel surface-active
CBM33-type lytic polysaccharide monooxygenase (cbp21) that introduces chain
breaks by oxidative cleavage (Suzuki et al. 1998; Vaaje-Kolstad et al. 2005;
Vaaje-Kolstad et al. 2010; Watanabe et al. 1997); and one chitobiase (chb) (Kless et al.
1989; Tews et al. 1996) that converts the oligomeric products from the other enzymes
to monomeric N-acetylglucosamine.

1.6 Chitin-based consolidated bioprocessing
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Figure 2 Scheme of consolidated bioprocessing (CBP) from biorenewable feedstock
biomass.
Chitin-based consolidated bioprocessing (CBP) aims at one-step conversion of the
naturally renewable biomass (i.e. shrimp/crab shells) into value-added chemical
without protein purification processes. The CBP approach is mainly motivated by
three benefits (Figure 2). First, it is a sustainable green approach that can
significantly reduce greenhouse gas emissions (e.g. bioprocesses vs chemical
processes). Second, many renewable feedstocks (shrimp/crab shells) are readily
available, inexpensive resources that can lower material costs. Third, CBP is able to
eliminate labor and capital cost of biomass processing by employing a single process
step. Indeed, CBP is widely recognized as the ideal configuration for sustainable,
low-cost hydrolysis and fermentation of cellulosic biomass. In principle, a CBP
strategy can be applied to produce a broad range of chemicals from natural biomass. It
requires degrading recalcitrant biomass substrates into solubilized sugars and
metabolic intervention to direct metabolic flux toward desired products at high yield
and titer (Yan and Fong 2015; Yan and Fong 2017a). With recent advances of
18

synthetic biology and systems biology, development of a non-model organism as a
platform workhorse can be rationally designed and efficiently deployed (Yan and
Fong 2016; Yan and Fong 2017a).
1.7 Potential metabolic engineering targets
Just as cellulose is viewed as a renewable starting carbon source for a variety of
biochemical carbon sources, a variety of potential biochemical products can be made
based on the monomers of chitin degradation, shown in Figure 3.
1.7.1 Glycan biosynthesis
In addition to being a structural component of homogeneous polysaccharides like
chitin, GlcNAc is also a constituent of heterogeneous polysaccharides, such as murein
and hyaluronic acid (also called hyaluronan or hyaluronate, HA). Murein is the basic
component of the bacterial cell wall and consists of crosslinked peptide chains with
repeating GlcNAc and muramic acid residues (Ashry and Aly 2007; Chen et al. 2010).

HA is a linear heteropolysaccharide that is composed of repeating D-glucuronic acid
and GlcNAc residues. HA is a major component of extracellular matrix and is
extensively distributed in connective, epithelial and neutral tissues (Chien and Lee
2007). HA performs numerous roles in cell motility, inflammation and cancer
metastasis (Danishefsky et al. 1969).

Heparin, which is produced by basophils and mast cells, consists of a
variably-sulfated repeating disaccharide unit and acts as an anticoagulant. The major
19

repeating disaccharide unit of keratin sulfate, also called keratosulfate, is composed of
galactose and sulfated GlcNAc. Keratin sulfate is distributed in the cornea, cartilage
and bone and usually acts as a cushion in joints to absorb mechanical shock (Tsai et al.
2001).

Sialyl-lewis is a tetrasaccharide carbohydrate that is usually attached to O-glycans on
the surface of cells. It is known to play a vital role in cell-to-cell recognition processes.
It is also the means by which an egg attracts sperm-first to stick to it, then bond with it
and eventually form a fetus. There are two types of sialyl-lewis, X and A. Sialyl-lewis
X is [NeuAca2-3Galβ1-4(Fuca1-3)GlcNAc]. Defective synthesis of the sialyl-lewis X
antigen results in immunodeficiency (leukocyte adhesion deficiency type 2 (Polley et
al. 1991).
1.7.2 Acetamido sugars
GlcNAc

is

the

precursor

N-acetylgalactosamine,

of

sialic

modified
acid,

acetamido

sugars,

N-acetylmuramic

such

as
acid,

N-acetylmannosaminuronate and several 6-deoxy-2-acetamido sugars, including
bacillosamine and pseudaminic acid, which are core components of bacterial N-linked
and O-linked glycans, respectively (Piacente et al. 2013).

N-acetylneuraminic acid (Neu5Ac) is the most common sialic acid and exists as > 40
structural derivatives in mammalian and avian species. Sialic acids are found at the
end of sugar chains connected to the surfaces of cells and proteins, serving as
20

receptors for influenza viruses mediated endocytosis. The guanidyl derivative of
Neu5Ac, Zanamivir, has been chemically synthesized as novel pharmaceutical agents
to produce neuraminidase inhibitors are used to treat influenza infections.

Because the Neu5Ac content in natural products is too low for the isolation of
Neu5Ac with sufficient recovery and purity, novel processes had to be developed for
the industrial production of this compound (Vimr and Lichtenteiger 2002). Enzymatic
synthesis of Neu5Ac from N-acetylmannosamine (ManNAc) and pyruvate using
Neu5Ac aldolase as a catalyst has been reported (Kang et al. 2012).
1.7.3 Antibiotics biosynthesis
Aminoglycoside antibiotics have been widely used clinically since the first use of
streptomycin as an effective antibiotic in the treatment of tuberculosis. These
antibiotics consist of a central aminocyclitol ring, such as streptamine, streptidine, or
2-deoxystreptamine (2-DOS) (Song et al. 2013).

Neomycin is a 4,5-disubstituted aminoglucoside antibiotic. It is typically used as a
topical preparation, such as Neosporin. Because neomycin is not absorbed from the
gastrointestinal tract and has been used as a preventive measure for hepatic
encephalopathy. By killing bacteria in the intestinal tract, it keeps ammonia levels low
and prevents hepatic encephalopathy, especially prior to GI surgery. The first
glycosylation step of neomycin involved in the formation of pseudodisaccharides is
the addition of N-acetylglucosamine to 2-DOS. NeoM from the neomycin gene cluster
21

was first characterized as the UDP-N-acetylglucosamineglycosyltransferase.

Butirosin is a relatively new aminoglycosidic antibiotic complex active in vitro and in
vivo against various pathogenic gram-positive and gram-negative bacteria. Butirosin
includes two isomers, butirosin A and butirosin B, which differ only in the
configuration at one carbon atom in the pentose moiety.

Figure 3 Potential metabolic targets from N-acetylglucosamine as a carbon source.
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Chapter 2 Study of ChiR function in Serratia marcescens and its application for
improving 2,3-butanediol from crystal chitin

Importance of this part of work:
Since S. marcescens chitinases are highly active, they can be potentially used in the
chemical production industry. In S. marcescens, ChiR is the only chitinase regulatory
protein among 10-chitinase related proteins. Although one study partially reported
that ChiR is essential for chitinase production, it is still unclear how ChiR regulates
the other 9-chitinase genes transcription. Before my dissertation study there was no
studies reporting about S. marcescens producing 2,3-butanediol from chitin.
The conclusions and fundamental results derived from this part of work:
First, a chiR overexpression (chiROE) strain and a chiR deletion (ΔchiR) strain were
generated and characterized in terms of cellular growth, chitinase activity, and total
secreted protein. Compared to the wild-type Db11 strain, the S. marcescens chiROE
strain showed an increase in chitinase activity (2.14- to 6.31-fold increase). Increased
transcriptional expression of chitinase-related genes was measured using real-time
PCR, showing 2.12- to 10.93-fold increases. The S. marcescens ΔchiR strain showed
decreases in chitinase activity (4.5- to 25-fold decrease), confirming ChiR‟s role as a
positive regulator of chitinase expression. Finally, chiR overexpression was
investigated as a means of increasing biochemical production (2,3-butanediol) from
crystal chitin. The chiROE strain produced 1.13 ± 0.08 g/L 2,3-butanediol from 2%
crystal chitin, a 2.83-fold improvement from the wild-type strain, indicating ChiR is
23

an important and useful genetic engineering target for enhancing chitin utilization in S.
marcescens.
2.1 Introduction
S. marcescens is recognized as an efficient and promising native producer of
2,3-butanediol (2,3-BD) (Ji et al. 2011). Recently, a high industry-level titer of
meso-2,3-BD (152.0 g/L) was produced from S. marcescens by a fed-batch
fermentation using sucrose as a substrate (Zhang et al. 2010a; Zhang et al. 2010b). In
S. marcescens, the 2,3-BD synthetic pathway mainly involves three key enzymes,
α-acetolactate

synthase

(ALS),

α-acetolactate

decarboxylase

(ALDC),

and

2,3-butanediol dehydrogenase (BDH) (Zhang et al. 2016). Two molecules of pyruvate
condense to yield one molecule of α-acetolactate and release one molecule of CO2 by
ALS (BudA, SMDB11_2829), then α-acetolactate is decarboxylated into (3R)-acetoin
by ALDC (BudB, SMDB11_2830). Under aerobic conditions, α-acetolactate readily
undergoes non-enzymatic oxidative decarboxylation and forms diacetyl. Finally,
(3R)-acetoin and diacetyl are reduced into 2,3-BD by BDH (SMDB11_1336).

ChiR (SMDB11_2876) has previously been identified as a regulator of several
chitinase genes and is a member of LysR-type transcriptional regulators (LTTRs)
(Suzuki et al. 2001). LTTRs are thought to contact the α-subunit of RNA polymerase
by binding to the characteristic sequence T-N11-A conserved upstream of the regulated
promoter, which is usually an imperfect palindromic sequence (Burn et al. 1989;
Gibson and Silhavy 1999; Maddocks and Oyston 2008). In an initial study of ChiR, S.
24

marcescens mutant strains (N1-N5) were generated by Tn5 insertion mutagenesis and
did not form any clearing zone on YEM agar containing colloidal chitin, while other
extracellular enzymes besides chitinases (e.g. proteases, lipases, nucleases) appeared
to be produced normally, indicating the loss of the ability to form clearing zones on
colloidal chitin is due to defects for chitinase production (Watanabe et al. 1997).
Further genetic analysis of the Tn5 insertion mutants identified disruption of the ChiR
open reading frame (ORF). Furthermore, the authors generated a Tn5 transposon
mutant leading to an inactive chiR gene, and the mutant did not observe any chitinase
activity. In vitro protein binding studies were conducted using gel mobility shift
assays for 4 chitinase genes (chiA, chiB, chiC and cbp21) resulting in the
determination that ChiR specifically binds to the intergenic region between chiR and
cbp21 (Suzuki et al. 2001). Despite these results, several questions remain unclear
related to ChiR function and chitin degradation in S. marcescens: 1) the function and
relationship of ChiR to four potential chitinase-related genes (SMDB11_1083,
SMDB11_1994, SMDB11_4602 and SMDB11_1190) is still unknown; 2) the
transcriptional effects of ChiR on chitinase-related gene expression have not been
studied; 3) the effect of modifying ChiR expression on cellular function and chitin
utilization have not been studied.

In this study, we developed an efficient genetic engineering strategy for genetic
manipulation of S. marcescens with a goal of improving chitinolytic activity based on
ChiR function. Our approach was to construct a S. marcescens chiR deletion strain
25

and a S. marcescens chiR overexpression strain to first explicitly study ChiR function
in terms of growth phenotypes, chitinase activity, and chitinase gene expression. To
evaluate ChiR function on chitin utilization and biochemical production, direct
bioconversion of untreated chitin to 2,3-BD is demonstrated with highest production
titers achieved in a chiR overexpression strain of S. marcescens.
2.2 Materials and methods
2.2.1 Strains and culture conditions
The Serratia marcescens Db11 was purchased from the Caenorhabditis Genetics
Center (Twin City, USA http://www.cbs.umn.edu/CGC) (Flyg et al. 1980). All strains
used in this study can be found with detailed information in Table 1. The S.
marcescens chiROE strain harbors plasmid pQY38 containing pUC19 backbone with
an insertion of chiR gene under PampR promoter and a synthetic ribosome binding site
(RBS). The S. marcescens ΔchiR strain was constructed by replacement of chiR gene
with the nptII gene in its chromosomal DNA. E. coli NEB10β (New England Biolabs,
Ipswich, USA) was used as the host to propagate pUC19 and pUN plasmid, construct
pQY45 plasmid and store plasmids. All E. coli strains were grown in LB or SOC
medium at 37°C and 250 rpm supplemented with 200 mg/L ampicillin or 40 mg/L
kanamycin. In order to monitor growth phenotype changes, all the S. marcescens
strains were grown in M9 medium with 0.1% yeast extract and 2% various carbon
sources (glucose, N-acetylglucosamine, and colloidal chitin) at 30°C and 250 rpm.
Chitinase assay experiments were analyzed by growing S. marcescens strains in LB or
LB with crystal chitin or colloidal chitin.
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Table 1 Strains and plasmids used in this study.
Strain or plasmid

Relevant genotype or description

Source

or

reference(s)
Strains
E. coli NEB10β

Δ(ara-leu) 7697 araD139 (StrR)

New England Biolab

S. marcescens Db11

Wild-type

Caenorhabditis
Genetics Center

S. marcescens chiROE

S. marcescens Db11 harbors plasmid pQY38

This study

S. marcescens ΔchiR

chiR::nptII

This study

pUC19

ampr,

New England Biolab

pQY38

pUC19 vector cloned with chiR gene under the promoter of ampR,

This study

plasmids

r

amp
pUN

nptII gene under promoter of ampR, kanr

This study

pQY45

pUC19 vector cloned with nptII gene under the promoter of ampR

This study

flanking around 1 kb homologous arms at upstream and
downstream, ampr and kanr

2.2.2 Plasmids
Primers and DNA fragments sequence can be found in Table S1 of Supplementary
Materials. For construction chiR overexpression vector, pUC19 backbone was
amplified by PCR using primers pUC19bb-f and pUC19bb-r. The chiR gene insertion
sequence was designed, synthesized and purchased as a double-stranded DNA
fragment

from

IDT

(Coralville,

USA).

A

synthetic

RBS

(5′-TCGGAATTAAAATAAATATTAAGGAAAATATAAAC-3′) was designed at an
arbitrary translation initiation rate (TIR) number of 60,000 using RBS calculator
(https://www.denovodna.com/software). The pQY38 plasmid was assembled from
two above-mentioned DNA fragments using isothermal assembly (Gibson et al. 2009).
For construction of chiR deletion plasmid (pQY45), pUC19 was used as backbone;
the kanamycin resistance marker (nptII) of the pUN plasmid was amplified by PCR
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using primers kanoverlap-f and kanoverlap-r; about 1 kb fragments upstream and
downstream of chiR gene of S. marcescens genome was amplified by PCR using the
two appropriate sets of primers (primer ha1-f/ha1-r and primer ha2-f/ha2-r). The four
DNA fragments were assembled using isothermal assembly reaction, and then pQY45
was generated. Briefly, the isothermal assembly reaction was conducted in total
volume 20 μL with 0.05 pmol pUC19 backbones, 0.05 pmol insertion gblock, and 10
μL Gibson assembly master mix. The reaction was incubated at 50°C for 1 h. After
the reaction, 4 μL of the mixture was transformed into E. coli NEB10β by
electroporation, and the recombinant strains were screened by LB medium agar plate
containing 200 μg/ml ampicillin.
2.2.3 Transformation of S. marcescens and allelic exchange
The method for chromosomal deletion in S. marcescens relies on a successful delivery
of double-stranded DNA in S. marcescens and endogenous recombinases can facilitate
homologous recombination, similar to a previous study (Deng and Fong, 2010). To
delete chiR gene of S. marcescens, the nptII gene with about 1 kb flanking regions
was amplified by PCR from pQY45 plasmid and introduced into S. marcescens by
electroporation. Up to 5 μL of the double-stranded DNA fragment (about 1 μg)
amplified after PCR was added to 50 μL of S. marcescens competent cell and mixed
immediately by tapping the electroporation cuvette (Biorad, USA). The cuvette was
electroporated at 25 kV/cm using gene pulser (Biorad, Hercules, USA). After
electroporation, 1 mL SOC medium was added and the cell recovered by incubating at
30°C for 1 h. The 100 μL of recovered S. marcescens suspension was plated onto LB
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plates supplemented with 320 μg/mL kanamycin and incubated at 30°C for two days.
Kanamycin-resistant candidates were selected. Each candidate genomic DNA was
isolated using a QIAamp® DNA mini kit (QIAGEN, USA) according to the manual
instruction. Colony PCR was performed with primers kan-f and kan-r. The
chromosomal disruption was validated by Sanger sequencing (Eurofins Genomics,
Louisville, USA).

For chiR gene overexpression, pQY38 vector was transformed into S. marcescens by
electroporation. The electroporation procedure was the same as mentioned above and
ampicillin (> 800 μg/mL) resistant colonies were selected. Plasmids of positive
transformants were extracted, and the chiR gene insertion was validated by
sequencing using UNS7-f and UNS5-f primer (Eurofin genomics, Louisville, USA).
2.2.4 Preparation of colloidal chitin
Crystal chitin from shrimp shells was obtained from Sigma-Aldrich (C7170, USA).
Colloidal chitin was prepared using the modified method of Roberts and
Selitrennikoff as follows (Roberts and Selitrennikoff 1988). Initially, 5 g of chitin
from shrimp shells (Sigma, C7170) was added slowly to 90 mL of 37% HCl (w/v).
The mixture was vigorously stirred for 2 h. Then, 500 mL of 95% ethanol was added
to this suspension and centrifuged at 6000 rpm for 20 min at 4ºC. The pellet was
washed with distilled water until chitin achieved a neutral pH and was stored frozen
until use.
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2.2.5 Cell density measurement
The culture density of S. marcescens strains was generally determined by measuring
optical density at 600 nm on a Biomate3 UV/VIS spectrophotometer (Thermo, USA).
The growth of S. marcescens on crystal chitin or colloidal chitin was determined by
measuring cytoplasmic protein content by centrifuging 1 mL culture at 10,000×g for 5
min. Pellets were re-suspended in fresh media and centrifuged at 10,000×g for 5 min
again. Sediments were dissolved and lysis in 200 μL 1×Bugbuster protein extraction
reagent (EMD Millipore, USA). After 20 min incubation, the lysate was centrifuged at
10,000×g for 5 min, and the proteins in the supernatant were measured by the
Bradford protein assay (Bradford 1976). Using a calibration curve to correlate the
overall protein content with dry cell weight (DCW), the measurements were
converted to dry weight; the correlation factor was DCW (g/L) = 1.20 ± 0.03 ×
Protein (g/L)
2.2.6 Chitinase activity assay
Chitinase activity assays were measured according to the manual instruction of a
chitinase assay kit (Sigma-Aldrich, CS0980) (Tronsmo and Harman 1993).
Endochitinase

activity

was

detected

using

0.2

mg/mL

4-Nitrophenyl

β-D-N,N′,N′′-triacetylchitotriose as a substrate; β-N-acetylglucosaminidase activity
was determined using 0.5 mg/mL 4-Nitrophenyl N-acetyl-β-D-glucosaminide as a
substrate; chitobiosidase activity was measured using 1 mg/ml 4-Nitrophenyl
N,N′-diacetyl-β-D-chitobioside as a substrate. Specifically, 1 mL cell culture was
centrifuged at 10,000 × g for 5 min. Each reaction contained 10 μL supernatant
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samples and 90 μL substrate in chitinase assay buffer (Sigma-Aldrich, USA). The
reaction was incubated in a 96-well plate at 37°C for 30 min and was stopped by
adding 200 μL 0.4 M Na2CO3 solution. The adsorption at 405 nm was conducted
immediately to measure the release of 4-Nitrophenol. Chitinase activity was defined
as one unit of activity will release 1.0 μmole of 4-Nitrophenol from the appropriate
substrate per minute at pH 4.8 at 37°C.
2.2.7 RNA preparation and real-time PCR
In order to study transcriptional level changes in the culture of the three S. marcescens
strains after overexpression of chiR gene and after chiR gene deletion, gene
expression was measured using real-time PCR. All the S. marcescens strains were
grown in M9 medium supplemented with 0.1% yeast extract and 2% chitin. All cells
were harvested at the mid-log growth phase (OD600 0.4 around 2.5 h). Primer
sequences for real-time PCR experiments are available in Table S2 of the
Supplementary Material. The expression levels of 10 different chitinase-related genes
were measured along with the level of expression of one housekeeping gene (luxS,
SMDB11_0167) that was used as a control, and all transcript levels were normalized
to the level of this housekeeping gene.
2.2.8 Prediction of chitinase-related gene promoter and its potential binding sites
Prediction of each chitinase-related gene promoter region was conducted based on
each

upstream

intergenic

region

using

online

software

BPROM

(http://www.softberry.com/berry.phtml). The promoter region was predicted based
upon bacterial sigma 70 RNAP recognition sites (Solovyev and Salamov 2011). Each
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potential binding site region was manually found based on a part of palindromic
T-N11-A motif in each gene upstream intergenic region.
2.2.9 2,3-BD fermentation
S. marcescens pre-culture was performed in LB medium at 30°C and 250 rpm for
overnight. Then, 10% (v/v) seed culture was inoculated at 150 mL fermentation
medium with a 250 mL Erlenmeyer flask at 30°C with different initial pH value and
shaking speed. The fermentation medium contains M9 minimum medium with 0.1%
yeast extract and 20 g/L different carbon sources (glucose, N-acetyglucosamine or
crystal chitin). Glucose and N-acetylglucosamine were used to investigate 2,3-BD
production in S. marcescens as two carbon sources. In order to evaluate S. marcescens
production of 2,3-BD from chitin, the fermentation was conducted under M9 medium
with 1% yeast extract, 5 g/L N-acetylglucosamine and 20 g/L crystal chitin at pH 7.5,
100 rpm and 30°C.
2.2.10 Detection of 2,3-BD, sugar and byproducts
Sugar, 2,3-BD and other byproducts were detected using an HPLC system (Dionex
Ultimate3000) equipped with Bio-Rad HPX-87H ion exclusion column. The mobile
phase was 5 mM H2SO4 at the rate of 0.6 mL/min and RI, and UV detectors
(wavelength at 199 nm) were used.
2.3 Results
2.3.1 Construction S. marcescens chiR deletion strain and chiR overexpression
strain
In order to generate a S. marcescens chromosomal chiR deletion strain, a
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PCR-targeted DNA fragment was introduced in S. marcescens competent cells to
replace the chromosomal chiR gene with a kanamycin resistance gene. Native
recombinases in S. marcescens were used to facilitate recombination. To address the
problem of degradation of extracellular DNA by nucleases in S. marcescens (Benedik
and Strych 1998; Friedholff et al. 1994; Miller et al. 1994), long nucleotide regions (>
1 kb) homologous to the target chiR gene were used. About 1000-bp fragments with
homology upstream and downstream of the chiR gene were amplified from the S.
marcescens Db11 genome. The kanamycin resistance gene under PampR promoter was
amplified from pUN plasmid by high-fidelity PCR and used for replacement of the
native gene and selection of transformants. The DNA fragments were assembled with
the pUC19 backbone, generating pQY45 plasmid (Figure S1A), which was
transformed into E. coli NEB10β. To disrupt chiR, the insertion fragment was
amplified by PCR and transformed into S. marcescens. After transformation, cells
were incubated on plates containing 320 μg/mL kanamycin for two days. There were
no colonies found on the wild-type plates, however, 7 colonies were found on the
chiR knockout plates with a transformation efficiency of ~5 transformants/μg DNA.
Subsequently, 2 transformants were selected and grown on kanamycin LB liquid
medium with both remaining resistant for 21 generations of serial passage, indicating
a stable gene insertion/disruption occurred. These chiR deletion strains were
confirmed by both PCR and DNA sequencing. PCR using genomic DNA of S.
marcescens chiR deletion strain yielded a single 0.8-kb band, which corresponds to
the expected size of a DNA fragment containing the nptII gene. In contrast, PCR
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using genomic DNA of S. marcescens Db11 did not show a clear band using the same
pair of primer (Figure S1B). These results indicated that chiR gene was successfully
inactivated and kanamycin-resistance gene was swapped with the chiR region. DNA
sequencing data (primer kan-f and kan-r) also confirmed that chiR gene of S.
marcescens Db11 was successfully deleted.

To create a S. marcescens chiR overexpression strain, a shuttle vector, pQY38, was
constructed by inserting a constitutive ampicillin promoter (PampR) and chiR gene into
the pUC19 plasmid backbone (Figure S1C). After transformation with pQY38
(harbors ampicillin resistance), 105 colonies were found on an ampicillin plate
yielding an efficiency of ~1×105 transformants/μg plasmid DNA. We grew one
transformant on ampicillin for 100 generations by serial passage and it remained
resistant to ampicillin, indicating a stable replication during cell propagation. Overall,
we successfully generated a S. marcescens chiR overexpression strain (designated as S.
marcescens chiROE) and a S. marcescens chiR deletion strain (designated as S.
marcescens ΔchiR).
2.3.2 Growth phenotypes
In order to characterize growth phenotypic changes among the three S. marcescens
strains (wild-type Db11, ΔchiR, and chiROE), cell growth was monitored using the
minimum medium (M9) supplemented with various carbon sources such as
N-acetylglucosamine, glucose, and colloidal chitin. N-acetylglucosamine and glucose
were chosen as a carbon source because S. marcescens exhibits catabolite repression
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on different carbon sources (Monreal and Reese 1969; Watanabe et al. 1997). For cell
culture with N-acetylglucosamine and glucose, the S. marcescens chiROE exhibited a
decreased cell yield, while the S. marcescens ΔchiR had an increased cell yield
compared to S. marcescens Db11 (Figure 4A). For cell growth on colloidal chitin
(Figure 4B), the S. marcescens ΔchiR strain exhibited severely inhibited growth and a
maximum cell lysate protein of 0.21 g/L, while both the S. marcescens Db11 and the S.
marcescens chiROE were able to grow on colloidal chitin with maximum overall cell
lysate protein concentrations of 1.42 g/L and 1.25 g/L, respectively. Colloidal chitin
creates an opaque suspension so protein concentration is used as a proxy for cell
biomass since optical density cannot be used.

Figure 4 Time profile of cell growth of three S. marcescens strains. (A) Optical
density OD600 of S. marcescens Db11 (circle), S. marcescens chiROE (triangle),
and S. marcescens ΔchiR (square) on glucose (glc, filled) and N-acetylglucosamine
(GlcNAc, unfilled) in a flask culture at 30°C for 48 h; (B) Overall protein
concentration of cell lysate of S. marcecens Db11 (filled circle), S. marcescens
chiROE (open circle), and S. marcescens ΔchiR (inverted triangle) using colloidal
chitin as sole carbon in a flask culture at 30°C for 180 h.
2.3.3 Chitinase activity and overall secreted protein changes
In order to determine chitinolytic capability changes among the three S. marcescens
strains, we measured secreted chitinase activity corresponding to the three different
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chitinase

mechanisms:

endochitinase

activity,

chitobiosidase

activity,

and

β-N-acetylglucosaminidase activity. Since S. marcescens chitinases are induced by the
presence of crystal chitin or colloidal chitin, the three S. marcescens strains secreted
chitinase activity was tested under three different culture conditions, plain LB
medium and LB medium supplemented with either colloidal chitin or crystal chitin.
For endochitinase activity, the S. marcescens chiROE strain showed increased activity
compared to the wild-type Db11 strain (1.93-, 1.84-, and 2.23-fold increases when
grown on crystal chitin, colloidal chitin or plain LB, respectively). The S. marcescens
ΔchiR strain showed a significant reduction in endochitinase activity (22.7-, 14.3-, and
10.0-fold reduction on crystal chitin, colloidal chitin, and LB, respectively) compared
to the wild-type Db11 (Figure 5A). For chitobiosidase activity, the S. marcescens
chiROE showed increased activity compared to the S. marcescens Db11 with 1.40-,
1.39-, and 2.14-fold increases on crystal chitin, colloidal chitin or plain LB,
respectively, while the ΔchiR strain exhibited decreased activity by 25.0-, 25.0- and
10.0-fold from the wild-type Db11 for growth on crystal chitin, colloidal chitin, and
LB, respectively (Figure 5B). For β-N-acetylglucosaminidase activity, the chiROE
strain showed increased activity (2.46-, 3.88-, and 6.31-fold increases on crystal chitin,
colloidal chitin, or LB, respectively) compared to the wild-type Db11. The S.
marcescens ΔchiR strain showed decreased β-N-acetylglucosaminidase activity (4.54-,
2.63-, and 3.45-fold decreases on crystal chitin, colloidal chitin, or LB, respectively)
compared to the wild-type Db11 (Figure 5C). In addition, we observed an increase in
the overall amount of secreted protein in the S. marcescens chiROE strain and a
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decrease in overall secreted protein in the S. marcescens ΔchiR strain as compared to
S. marcescens Db11 (Figure 5D). The total secreted protein concentration for the S.
marcescens chiROE strain was 1.46-, 2.03- and 2.41-fold higher than the Db11 strain
for growth on crystal chitin, colloidal chitin, or LB, respectively. Decreases of 5.88-,
3.13-, and 2.38-fold were observed in overall secreted protein under crystal chitin,
colloidal chitin or LB, respectively for the ΔchiR strain when compared to the
wild-type Db11. Overall, the S. marcescens chiROE strain showed increased chitinase
activity while the S. marcescens ΔchiR strain showed decreased chitinase activity
compared to S. marcescens Db11.
2.3.4 Regulation of chitinase gene expression by ChiR
In order to understand the role of ChiR in the regulation of chitinase genes in S.
marcescens, 10 chitinase-related genes (including chiR) were examined by real-time
PCR using the wild-type Db11 strain, the ΔchiR strain, and the chiROE strain (Table
2, Table S5, and Table S6).
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Figure 5 Specific chitinase activity and secreted protein of three S. marcescens
strains: the ΔchiR strain, the wild-type Db11, and the chiROE strain. (A) specific
endochitinase activity (U/g cell). (B) specific chitobiosidase activity (U/g cell). (C)
Specific β-N-acetylglucosaminidase activity (U/g cell). (D) Specific protein
secretion (mg protein/g cell) with chitin (black filled bar), colloidal chitin (unfilled
bar), and plain LB (gray filled bar).
In the chiROE strain, chiR mRNA levels increased 593.59-fold as compared to the
wild-type strain, as expected. Concurrently, the 9 chitinase-related genes showed
significantly increased expression ranging from 2.12- to 10.93-fold increases (Table
2). This result showed that ChiR is an activator by upregulating all chitinase-related
genes in S. marcescens. Five genes (SMDB11_0468: endochitinase, SMDB11_2875:
exochitinase, SMDB11_2877: chitin binding protein, SMDB11_1994: chitinase, and
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SMDB11_4243: exochitinase) showed greater than 5-fold increases in expression
compared to the wild-type Db11. For the ΔchiR strain, chiR mRNA levels were not
detected, as expected, and expression levels of the 9 chitinase-related genes were
significantly decreased by 1.14- to 4.35-fold compared to the S. marcescens Db11
(Table 2). The one gene in the chiR operon (cbp21, SMDB11_2877) exhibited a
4.35-fold decrease in expression compared to the wild-type strain. Overall, these
results demonstrated ChiR is a positive regulator of all chitinase-related genes in S.
marcescens and were consistent with observed changes in chitinase activity conducted
by assays.
Table 2 Chitinase-related gene expression in S. marcescens Db11, chiROE and ΔchiR
by real-time PCR.
Gene
no.

Fold-change
Locus

Db11

chiROE

ΔchiR

binding

1.00±0.10

10.93±0.70

0.54±0.08

binding

1.00±0.15

5.28±0.13

0.87±0.10

None

1.00±0.05

9.32±0.96

0.56±0.16

1 binding site

1.00±0.12

593.59±41.01

0.00±0.00

Chitin binding protein

6

binding

1.00±0.13

9.23±0.78

0.23±0.03

(cbp21)

sites

Gene product

Estimated
binding site

1

SMDB11_4243

Exo-chitinase (chiA)

7
sites

2

SMDB11_2875

Exo-chitinase (chiB)

3
sites

3

SMDB11_0468

Endo-acting
non-processive chitinase
(chiC)

4

SMDB11_2876

LysR-family
transcriptional

regulator

(chiR)
5

SMDB11_2877

6

SMDB11_0477

Chitobiase (chb)

1 binding site

1.00±0.09

3.78±0.19

0.76±0.11

7

SMDB11_1083

Putative

None

1.00±0.08

2.12±0.11

0.88±0.25

binding

1.00±0.09

6.74±0.25

0.82±0.11

chitin-binding

protein
8

SMDB11_1994

Chitinase

2
sites

9

SMDB11_4602

Putative chitobiase

1 binding site

1.00±0.09

3.09±0.24

0.83±0.17

10

SMDB11_1190

N-beta

1 binding site

1.00±0.05

2.36±0.21

0.82±0.12
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acetylhexosaminidase
(NagZ)

2.3.5 Direct 2,3-butanediol production from crystal chitin
An initial baseline of 2,3-butanediol production in the S. marcescens Db11 was
conducted for growth on glucose and N-acetylglucosamine. There was no difference
between cell growth using glucose and N-acetylglucosamine (Figure S2A). The
starting concentration of 20 g/L glucose or 20 g/L N-acetylglucosamine was depleted
by around 30 h (Figure S2B). S. marcescens Db11 was able to produce 3.90 ± 0.03
g/L 2,3-BD from N-acetylglucosamine and 5.16 ± 0.05 g/L 2,3-BD from glucose
(Figure S2C), indicating that N-acetyglucosamine can be used a carbon source by S.
marcescens Db11. There was almost no difference at 2,3-BD production among the
ΔchiR strain (3.82 ± 0.07 g/L), the chiROE strain (3.65 ± 0.05 g/L) and the wild-type
strain (3.90 ± 0.03 g/L) when grown in either 20 g/L N-acetylglucosamine, implying
that ChiR does not affect the 2,3-BD synthetic pathway.

To test the utility of overexpressing ChiR for a chitin-based consolidated bioprocess,
untreated chitin was used as the carbon source for producing 2,3-butanediol using the
wild-type Db11 strain and the chiROE strain. Cell growth, chitinase activity, total
secreted protein and 2,3-BD production were monitored during a 3-day fermentation.
Cell yields for the two strains were comparable at the end of fermentation (the
chiROE strain cell yield of 1.03 ±0.05 g/L and the wild-type Db11 cell yield of 1.22 ±
0.15 g/L) (Figure S3A). However, the chiROE strain showed clear increases in
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endochitinase, chitobiosidase, and β-N-acetylglucosaminidase activity with 3-, 1.75-,
and 3.26-fold increases, respectively, compared to the wild-type Db11 (Figure S3B).
A final 2.93-fold improvement in 2,3-BD titer (1.13 ±0.08 g/L) was achieved in the S.
marcescens chiROE compared to 2,3-BD titer (0.4 ± 0.05 g/L) for the S. marcescens
Db11 (Figure 6), indicating an improvement in utilization chitin as carbon source
after overexpression chiR.

Figure 6 Production of 2,3-BD using the S. marcescens Db11 (filled circle) and the S.
marcescens chiROE strain (unfilled circle) under M9 medium supplemented with 1%
yeast extract and 2% chitin at 30°C and 100 rpm.
2.4 Discussion
Due to the abundance of chitin in nature and its availability as an industrial waste
product, use of chitinases and chitinolytic organisms have the potential to be used for
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consolidated bioprocessing applications for biochemical production such as biofuels
or pharmaceuticals (Aam et al. 2010; Dahiya et al. 2006; Yan and Fong 2015). S.
marcescens has been an interesting organism for studying chitin degradation due to its
native chitinolytic capabilities. Among the 10 chitinase-related genes known in the S.
marcescens Db11, one regulatory protein, ChiR, was previously identified as a
potential positive regulator of chitinase genes (Watanabe et al. 1997; (Suzuki et al.
2001). In this study, we studied ChiR function by the construction of a chiR
overexpression (chiROE) strain and a chiR deletion (ΔchiR) strain. We found that
ChiR significantly improved the expression of chitinolytic enzymes in S. marcescens.
The overexpression strain, chiROE, had increased chitinase activity ranging from
2.14- to 6.13-fold higher than the wild-type Db11 and gene expression of 9
chitinase-related genes also increased 2.12- to 10.93-fold (compared to the wild-type
Db11). Both activity and transcription data implied ChiR can be a promising target for
enhancing chitin utilization. The chiROE strain was then grown on untreated crystal
chitin and produced a maximum titer of 1.13 ± 0.08 g/L of 2,3-butanediol, a 2.93-fold
improvement over the wild-type strain. To our knowledge, this is the first report of
direct bioconversion of 2,3-butanediol from untreated chitin in S. marcescens.

Previous studies using mutagenesis and interaction assays have suggested that ChiR is
a potential positive regulatory protein of chitinases in S. marcescens with proposing a
regulatory cascade where ChiR positioned as an early phase regulator. In our study,
the function of ChiR was tested directly by employing genetic tools to delete and
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overexpress chiR. We reported 9 chitinase-related gene expression level changes in a
chiR overexpression strain and a chiR deletion strain compared to the wild-type strain
and corresponding chitinase activity. The S. marcescens chiROE strain was able to
increase all 10 chitinase-related gene transcription levels. In our study, we found that
4 genes (chiA, chiB, cbp21, and SMDB11_1994) that possess more than 2 binding
sites had more than 5-fold increases in transcription level (Table 2 and Table S3) after
chiR overexpression. It was also found that another 4 genes (chb, SMDB11_1083,
SMDB11_4602, and SMDB11_1190) showed 2.12- to 3.78-fold increased expression
and have less than 2 potential ChiR binding sites. One exception to the ChiR binding
is the chiC gene that had 9.32-fold increased expression but no identifiable ChiR
binding site. These data seem to indicate that ChiR functions in a more direct manner
for regulating chitinase-related gene expression rather triggering a regulatory cascade.
The real-time PCR data also identified a potential novel chitinase SMDB11_1994 that
is annotated to encode a GH18 protein whose role and function is still uncharacterized.
A protein blast showed this protein is 87% similarity to ChiD (PDB: 4NZC) from
Serratia

proteamaculans

that

is

a

chitinase

with

both

hydrolytic

and

transglycosylation functions (Madhuprakash et al. 2013).

The overall physiological effect of manipulating ChiR was considered. The chiROE
strain had lower biomass/cell yields when grown on glucose or N-acetylglucosamine
compared to the wild-type Db11 and the ΔchiR strain. Additionally, the ΔchiR strain
had biomass/cell yields that were increased by 1.30-fold compared to the wild-type
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strain for growth on glucose or N-acetylglucosamine. In the chiROE strain,
endochitinase, chitobiosidase and β-N-acetylglucosaminidase activity per cell were
roughly 2.23-, 2.14-, and 6.31-fold higher, respectively, compared to the wild-type
strain. The chiROE strain also had 2.41-fold higher total secreted protein per cell as
compared to the wild-type strain. This increase in chitinase activity and in secreted
overall protein concentration implies that an increased metabolic burden of producing
chitinases production may decrease the availability of metabolic resources to produce
basic biomass components (Wu et al. 2016); the chiROE strain likely has an increased
metabolic burden (associated with chitinase production) while the ΔchiR strain likely
has a reduced metabolic burden. These results would be consistent with the changes in
biomass/cell yield for the chiROE and ΔchiR strains.

Chitin and colloidal chitin have an induction effect on chitinase production; however,
their regulatory roles are still unclear. We tested S. marcescens Db11 transcriptomics
(unpublished data) when grown at LB, LB plus colloidal chitin and LB plus chitin.
First, we found that chiR gene mRNA level did not change significantly in these three
conditions. Second, transcript levels for most chitinase-related genes showed no
significant difference among the three growth conditions. One exception is that cbp21
mRNA level increased more than 2-fold under LB with chitin/colloidal chitin
compared to that grown under plain LB medium. Furthermore, in terms of overall
protein secretion at the three growth conditions, there was almost no overall secreted
protein changes of the ΔchiR strain, while an ascending trend of secreted overall
44

protein from plain LB, LB plus colloidal chitin, and LB plus chitin were observed in
both the chiROE strain and the wild-type strain (Figure 5D). One explanation
regarding the relationship between the observance of chitinase activities changes and
the measurement of mRNA level changes under three conditions is that chitin or
colloidal chitin may assist in inducing chitinase secretion instead of inducing chitinase
overexpression.

Recently, genetic engineering of regulatory proteins for enhancing cellulase or
chitinase production has been employed with various degrees of success (Aghcheh et
al. 2014; Häkkinen et al. 2014; Portnoy et al. 2011; Wang et al. 2013). For instance,
Deng and Fong demonstrated that CelR is a negative regulator of cellulose production
in Thermobifida fusca and a recombinant CelR deletion strain enabled an
enhancement of specific cellulase activity by 16.70-fold (Deng and Fong 2010).
Multiple regulatory targets were investigated and applied to improve cellulase
production in Trichoderma reesi (Aghcheh et al. 2014; Häkkinen et al. 2014; Portnoy
et al. 2011; Wang et al. 2013). Overexpression of a single regulator gene, deletion of a
single regulator gene or a combinational method can result in increasing cellulase
activity range from 2- to 5-fold, shown in Table S7. A study that investigated tuning
multiple regulator expression levels in Penicillium oxolicum. After overexpression of
clrB and deletion of bgl2 and creA, the cellulase activity increased from 10- to 50-fold
on different substrates (Yao et al. 2015). In our study, we demonstrated that a chiR
overexpression strain was able to increase chitinase activity 2.14- to 6.31-fold
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compared to the wild-type S. marcescens Db11 strain as a direct result of increasing
mRNA levels for 9 chitinase-related genes.

Despite high levels of interest and research effort to developing bioprocesses using
renewable feedstock, very few examples exist that demonstrate direct utilization of
untreated feedstock. In the present study, we report direct bioconversion of untreated
crystal chitin to 2,3-butanediol with a maximum titer of 1.13 ± 0.08 g/L from 3 days
batch fermentation in a ChiR overexpression strain of S. marcescens. Recently,
several attempts have been made to utilize various natural biorenewable resources for
producing 2,3-BD, shown in Table 3. Jiang et al. used diluted sulfide acid to
hydrolyze Jatropha hulls, resulting in a 37.3 g/L of reducing sugar. After 60 h
fermentation, 4.11 g/L 2,3-BD was produced with a yield of 0.11 g/g in a
non-cellulolytic native producer, Klebsiella oxytoca (Jiang et al. 2012). In another
study, Shin introduced a synthetic 2,3-BD pathway and overexpression of a
periplasmic cellodextrinase (Ced3) in E. coli. Fermentation was conducted coupled
with simultaneous saccharification (SSF) and a maximum titer 4.2 g/L 2,3-BD was
obtained after 24 h fermentation with a yield of 0.84 g/g from cellodextrin (Shin et al.
2012). Another novel concept was demonstrated by using a cyanobacterium to
produce 2,3-BD through photosynthetic pathways. In their initial study, a synthetic
2,3-BD synthetic pathway was introduced in Synechococcus elongatus controlled by
an IPTG inducible promoter PLlacO1. As a proof of concept, 0.13 g/L 2,3-BD was
produced from a recombinant S. elongates (Nozzi and Atsumi 2015). A follow-up
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study focused on combinational optimization of sugar/light supplementation and cell
density yielding a maximum titer of 3.0 g/L 2,3-BD after 10 days fermentation
(McEwen et al. 2016). In our initial study, the chiROE strain was able to produce 1.13
± 0.08 g/L 2,3-BD from 2% untreated crystal chitin, indicating a promising CBP
scheme. This is the first study reported the feasibility using chitin as a feedstock for
2,3-BD production in S. marcescens.
Table 3 Microbial production of 2,3-butanediol production from biomass feedstocks.
Substrate

Microorganisms

Titer (g/L)

Yield (g/L)

Time

References

(h)
Light + glucose

Synechococcus elongatus

3.0

n.p.

10 days

(McEwen et al.
2016)

Light

S. elongatus

0.12

n.p.

n.p.

(Nozzi and Atsumi

Lignocellulosic biomass

Klebsiella oxytoca

4.11

0.11

60 h

(Jiang et al. 2012)

E. coli

4.2

0.84

24 h

(Shin et al. 2012)

Crystal chitin

S. marcescens Db11

0.40

0.02

72 h

This study

Crystal chitin

S.marcescens chiROE

1.13

0.06

72 h

This study

2015)

hydrolysate
Lignocellulosic biomass
hydrolysate

Future studies can be made mainly based on two directions. First, this study
demonstrates a proof-of-concept in producing 2,3-BD from chitin, however the
2,3-BD titer remains low, so future work can focus on improvements to increase
2,3-BD titer. For instance, increasing substrate concentration and feeding strategies
can be employed to improve 2,3-BD titer. Combinational approaches of strain
improvements can be made: first, adaptive evolution techniques can be applied to
obtain a genomically stable mutant that is capable of fast decomposition of chitin;
second, metabolic engineering strategies can be made to delete competitive metabolic
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pathways (i.e. acetic acid, ethanol, lactic acid) that drain the metabolic flux away from
2,3-BD. Second, from an industrial application perspective, an efficient and
economical pretreatment process from shrimp/crab shells to crystal chitin needs to be
developed, since purified crystal chitin is not readily available in nature. Chitin can be
extracted directly from shrimp/crab shells after removal of protein, calcium and low
molecular weight compounds by treatment with sodium hydroxide and hydrochloric
acid. The process kinetics of both demineralization and deproteinization have been
previously considered and Percot et al. demonstrated that an optimization of the
pretreatment parameters (e.g. concentration, time, temperature) can yield a low
residual content of calcium (below 0.01%) and a high degree of acetylation (DA)
(almost 95%) (Percot et al. 2003) that is suitable for downstream usage. In another
method, Aye and Stevens investigated extraction of chitin from fresh shrimp shells
through grinding and sieving (Aye and Stevens 2004). These authors demonstrated
that the chitin after the dry screening method is ready to be used as a feedstock for an
animal. These pretreatment methods without additional enzymes can contribute to
developing a chitin biorefinery process from food wastes.
2.5 Conclusion
Microbial utilization of chitin, a potential renewable biomass feedstock, is being
pursued as a means of developing novel consolidated bioprocessing for the
production of chemicals. Serratia marcescens is a gram-negative bacterium that is
known for its chitinolytic capability and as a native 2,3-butanediol producer. In S.
marcescens, ChiR has been suggested to be a positive regulator of chitinase
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production. In this study, we aim to understand the effect of ChiR in regulating nine
chitinase-related genes in S. marcescens Db11 and demonstrate manipulation
of chiR as a useful and efficient genetic target to enhance chitin utilization. First,
a chiRoverexpression (chiROE) strain and a chiR deletion (ΔchiR) strain were
generated and characterized in terms of cellular growth, chitinase activity, and total
secreted protein. Compared to the wild-type Db11 strain, the S. marcescens
chiROE strain showed an increase in chitinase activity (2.14- to 6.31-fold increase).
Increased transcriptional expression of chitinase-related genes was measured using
real-time PCR, showing 2.12- to 10.93-fold increases. The S. marcescens
ΔchiR strain showed decreases in chitinase activity (4.5- to 25-fold decrease),
confirming ChiR‟s role as a positive regulator of chitinase expression.
Finally, chiRoverexpression was investigated as a means of increasing biochemical
production (2,3-butanediol) from crystal chitin. The chiROE strain produced
1.13 ± 0.08 g/L 2,3-butanediol from 2% crystal chitin, a 2.83-fold improvement
from the wild-type strain, indicating ChiR is an important and useful genetic
engineering target for enhancing chitin utilization in S. marcescens.
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Chapter 3 Design and modularized optimization of one-step production of
N-acetylneuraminic acid from chitin in Serratia marcescens

Importance of this part of work:
Since I have successfully developed shuttle vectors for overexpression of genes in S.
marcescens and demonstrated that S. marcescens can directly utilize chitin to produce
chemicals, this part of work is to demonstrate a proof-of-concept of producing novel
chemcials from chitin by introducing exogenous pathway genes in S. marcescens.
Prior to this dissertation work, there is few research reporting about producing
N-acetylneuraminic acid (chemical target) from chitin. Here, I demonstrate an
engineered bioprocess to produce N-acetylneuraminic acid (Neu5Ac) directly from
chitin using the chitinolytic bacterium, Serratia marcescens by selecting and
characterizing promoters, characterization of heterologous enzyme activity, and
optimization of pathway fluxes.
The conclusions and fundamental results derived from this part of work:
By generating RNA-Seq data for S. marcescens growth in different carbon-limited
conditions (glucose, N-acetylglucosamine and glycerol), 12 promoters with varying
strength were identified and characterized to implement for transcriptional control.
Neu5Ac production was initially engineered into S. marcescens through heterologous
expression of N-acetyglucosamine 2-epimerase (slr1975) and N-acetylneuraminic
acid aldolase (nanA). Activity of both genes was characterized in vitro for kinetics and
in vivo expression using promoters identified in this study. Optimization of Neu5Ac
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production was accomplished by balancing pathways fluxes through promoter
swapping and replacing the reversible nanA with the irreversible gene neuB. The
optimized recombinant strain PT5-slr1975-PrplJ-neuB was able to produce 0.48 g/L
Neu5Ac from 20 g/L N-acetylglucosamine, and 0.30 g/L Neu5Ac from 5 g/L crystal
chitin. These results represent the first demonstration of direct conversion of crystal
chitin to N-acetylneuraminic acid and illustrate the potential utility of S. marcescens
as a chitinolytic bioprocess organism.
3.1 Introduction
Metabolic engineering approaches to chemical production from renewable biomass
feedstocks (such as cellulosic biomass) have received tremendous research interest
(Liao et al. 2016; Lynd et al. 2005; Olson et al. 2012). Chitin is the second most
abundant carbon compound on earth that is a homopolymer of N-acetylglucosamine
and can be degraded by chitinases as a potential renewable raw material. The special
property of chitin is that it serves as a source for both carbon and nitrogen (C:N = 8:1),
which is an ideal resource for production of nitrogen-rich chemical compounds (i.e.
N-acetylneuraminic acid, C:N =11:1) (Steiger et al. 2011). Development of chitin as a
potential biomass feedstock can enhance the biorefinery industry by broadening the
range of practicable biomass options and lowering the environmental impact of food
industry waste (Yan and Chen 2015; Yan and Fong 2015). In theory, chitin could be
used in a consolidated bioprocess (CBP) (Lynd et al. 2005) in a similar fashion as
cellulose, however, this has yet to be demonstrated. Two of the main areas hindering
development of a chitinolytic CBP is a lack of genetic engineering tools and limited
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characterization of metabolism in chitinolytic species.

Considering the various aspects of a chitin-based CBP scheme, we sought to develop
the chitinolytic bacterium Serratia marcescens, as a potential platform organism for
N-acetylneuraminic acid (Neu5Ac) production. S. marcescens has been studied and
characterized for its chitinolytic capabilities (Monreal and Reese 1969; Vaaje-Kolstad
et al. 2013; Watanabe et al. 1997) and can exclusively convert chitin into GlcNAc
(Kim et al. 1998). The genome of S. marcescens Db11 has been sequenced (Iguchi et
al. 2014). The main challenge is to engineer a synthetic pathway for Neu5Ac
production in S. marcescens since the wild-type S. marcescens Db11 does not harbor a
natural route and existing genetic engineering tools are limited. Currently only a small
number of well-characterized and tractable S. marcescens promoters are available for
in vivo application. A T5 promoter (Gerc et al. 2012) and a native budAB operon
promoter (Sun et al. 2012b) were investigated either to study a multifunctional
peptide synthetase (T5 promoter) or to facilitate NADH regeneration by
overexpression of an oxidase (budAB promoter). In the previous work, we have
developed an in-frame chromosomal gene deletion method for S. marcescens based
on its native exonucleases and recombinases, and also established a stable shuttle
vector thus expanding the tools available for manipulation of S. marcescens (Yan et al.
2017).

N-acetylneuraminic acid (Neu5Ac) is a ubiquitous sialic acids that carries out various
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biological functions by acting as a receptor for microorganisms, viruses, toxins, and
hormones, by masking receptors and regulation of the immune system (Chen and
Varki 2010; Schauer 2000; Varki 1992). It can be used as a nutraceutical for infant
brain development (Wang 2009), pharmaceutical for preventing influenza virus
infections (Itzstein et al. 1993), and nanocarrier for cancer targeting and therapy
(Bondioli et al. 2011).

Previous metabolic engineering studies for production of Neu5Ac have primarily used
engineered strains of E. coli for the production of Neu5Ac from glucose by
fermentation. Boddy and Lundgren assembled a six-step pathway for Neu5Ac
production from fructose-6-phosphate by overexpressing genes of glucosamine
synthase (glmS), Neu5Ac synthase (neuB), and UDP-GlcNAc 2-epimerase (neuC)
from Neisseria meningitides (Lundgren and Boddy 2007). The nanA and nanT genes
were then knocked out to abolish sialic acid catabolism. In this engineered pathway,
NeuB was responsible for converting N-acetylmannosamine (ManNAc) and
phosphoenolpyruvate (PEP) to Neu5Ac. As a result, 1.5 g/L Neu5Ac was obtained
with glucose as the carbon source in a 98 h fermentation process. In another study,
Kang et al. designed a Neu5Ac synthetic pathway by introducing a GlcNAc
2-epimerase (Slr1975) and glucosamine-6-phosphate acetyltransferase (GNA1) in E.
coli DH5α (Kang et al. 2012). By deleting the feedback inhibition of
glucosamine-6-phosphate synthase (ΔnagAB) to increase the accumulation of GlcNAc
and pyruvate (ΔackAΔpoxBΔldhA) and blocking the catabolism of Neu5Ac (ΔnanT),
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7.85 g/L of Neu5Ac was obtained using glucose as the carbon source in a 96-h
fed-batch fermentation with productivity of 0.08 g/L h. In a follow-up study, Yang et
al. engineered an aptazyme-based biosensor of Neu5Ac to evolve the key enzyme
Neu5Ac synthase (NeuB) (Yang et al. 2017). The modified strain was able to improve
the titer by 34%. Samain et al. overexpressed NeuB and NeuC from Campylobacter
jejuni in a neuA, nanA, nanK and nanT deletion strain of E. coli producing 39 g/L of
Neu5Ac with glycerol as the carbon source (Samain 2008).

Here we investigate developing a chitin-based CBP scheme to utilize chitin-based
feedstock to produce N-acetylneuraminic acid through a single-unit operation
(chitinase production and secretion, hydrolysis of chitin, and fermentation of available
sugars to produce Neu5Ac). The main advantage of this CBP process is to reduce the
substrate cost and simplify the process while still producing a value-added product. A
rough analysis of the economic difference between a glucose-based process and the
CBP is shown as follows. Assuming 1 g chitin can produce 1 g N-acetylglucosamine
(a highest yield reported 0.76 GlcNAc g/g chitin (Husson et al. 2017)), the carbon
cost to produce 1 kg Neu5Ac from dried shrimp shells ($100-120/ton (Yan and Chen
2015)) is around $0.071 based on the theoretical yield of 1.40 g Neu5Ac/g GlcNAc;
while for the glucose process, the carbon cost to produce 1 kg Neu5Ac from the
glucose ($55.5/kg, Sigma) is about $32.27 based on the theoretical yield of 1.72 g
Neu5Ac/g glucose.
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In this study, we applied the recently developed systems for overexpression of genes
in S. marcescens to generate designed strains that directly converts crystal chitin to
Neu5Ac. To identify reliable promoters, we started with characterizing S. marcescens
gene expression levels (RNA-Seq) of the wild-type strain grown on various carbon
sources (glucose, N-acetylglucosamine, and glycerol) and tested the activity of 12
potential constitutive promoters by measuring the mRNA (real-time PCR) and protein
expression levels (fluorescence intensity) of a gfp reporter gene. Subsequently, a
two-step

synthetic

pathway

(N-acetylglucosamine

2-epimerase

and

N-acetylneuraminic aldolase) for Neu5Ac production was introduced in S. marcescens
and the functionality of the pathway enzymes was validated by real-time PCR and
enzymatic activity assays. Improvement of Neu5Ac titer (0.48 g/L Neu5Ac from 20
g/L N-acetylglucosamine) was achieved by tuning mRNA level (promoter swapping)
and by utilizing an irreversible enzyme to replace a reversible enzyme (switch
N-acetylneuraminic aldolase to N-acetylneuraminic acid synthase). Thus, S.
marcescens has been engineered to directly convert untreated chitin to Neu5Ac.
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Figure 7 A scheme of N-acetylneuraminic acid from chitin by Serratia marcescens.
3.2 Materials and methods
3.2.1 Bacterial strains and plasmids
S. marcescens Db11 is the wild-type strain and was purchased from Caenorjabditis
Genetics Center (Twin City, MN https://cbs.umn.edu/cgc) (Flyg et al. 1980). E. coli
NEB10β (New England Biolabs, Ipswich, MA) was used as a host for
pUC19-backbone plasmid construction and propagation. E. coli TOP10 (Thermo
Fisher Scientific, Waltham, MA) was used as a host for pEXP-backbone plasmids
plasmid construction and propagation. Strain and plasmids used in this study are listed
in Table 4.

Table 4 Strains and plasmids used in this study.
Strain name

Genotype

Resources

S. marcescens Db11

Wild-type

Caenorjabditis
Genetics Center

S. marcescens pQY04
S. marcescens pQY05

Db11 strain harbors pUC19 inserted by PT5-GFP, amp

R

Db11 strain harbors pUC19 inserted by PampR-GFP, amp
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R

This study
This study

S. marcescens pQY06

Db11 strain harbors pUC19 inserted by PbudAB-GFP, ampR

This study

S. marcescens pQY19

Db11 strain harbors pUC19 inserted by PompA-GFP, amp

R

This study

S. marcescens pQY20

R

This study

R

This study

S. marcescens pQY21

Db11 strain harbors pUC19 inserted by PrplJ-GFP, amp

Db11 strain harbors pUC19 inserted by PrpsL-GFP, amp

R

This study

R

This study

S. marcescens pQY27

Db11 strain harbors pUC19 inserted by PphlA-GFP, amp

R

This study

S. marcescens pQY23

Db11 strain harbors pUC19 inserted by PcysP-GFP, ampR

This study

S. marcescens pQY22

R

S. marcescens pQY24
S. marcescens pQY25

S. marcescens pQY26

Db11 strain harbors pUC19 inserted by PgpmA-GFP, amp
Db11 strain harbors pUC19 inserted by PmetF-GFP, amp

Db11 strain harbors pUC19 inserted by PrpsG-GFP, amp

This study

Db11 strain harbors pUC19 inserted by PSMDB11_4509-GFP, amp

R

This study
R

S. marcescens pQY28

Db11 strain harbors pUC19 inserted by PcysP-slr1975-PcysP-nanA, amp

S. marcescens pQY29

R

Db11 strain harbors pUC19 inserted by PrplJ-slr1975-PrplJ-nanA, amp

This study
This study

R

This study

Db11 strain harbors pUC19 inserted by PT5-slr1975-PrplJ-nanA, amp

R

This study

S. marcescens pQY37

Db11 strain harbors pUC19 inserted by PrplJ-slr1975-PT5-nanA, amp

R

This study

S. marcescens pQY43

R

S. marcescens pQY30
S. marcescens pQY36

Db11 strain harbors pUC19 inserted by PT5-slr1975-PT5-nanA, amp

Db11 strain harbors pUC19 inserted by PT5-AGE-PrplJ-nanA, amp

This study
R

S. marcescens pQY42

Db11 strain harbors pUC19 inserted by PT5-slr1975-PrplJ-neuB, amp

S. marcescens pQY46

Db11 strain harbors pUC19 inserted by PT5-AGE-PrplJ-neuB, ampR

This study

E. coli NEB10β

Δ(ara-leu) relA1 endA1 (Str )

NEB

E. coli pQY16
E. coli pQY17
E. coli pQY18

This study

R

E. coli NEB10β harbors pUC19 inserted by PT5-GFP, amp

R

E. coli NEB10β harbors pUC19 inserted by PampR-GFP, amp

This study

R

This study

R

This study

R

This study

E. coli NEB10β harbors pUC19 inserted by PbudAB-GFP, amp

E. coli pQY19

E. coli NEB10β harbors pUC19 inserted by PompA-GFP, amp

E. coli pQY20

R

This study

R

This study

E. coli pQY21

E. coli NEB10β harbors pUC19 inserted by PrplJ-GFP, amp

E. coli NEB10β harbors pUC19 inserted by PrpsL-GFP, amp

R

This study

E. coli pQY25

E. coli NEB10β harbors pUC19 inserted by PmetF-GFP, amp

R

This study

E. coli pQY27

E. coli NEB10β harbors pUC19 inserted by PphlA-GFP, ampR

This study

E. coli pQY23

R

This study

E. coli pQY24

E. coli pQY22
E. coli pQY26

E. coli NEB10β harbors pUC19 inserted by PgpmA-GFP, amp

E. coli NEB10β harbors pUC19 inserted by PcysP-GFP, amp

E. coli NEB10β harbors pUC19 inserted by PrpsG-GFP, amp

R

E. coli NEB10β harbors pUC19 inserted by PSMDB11_4509-GFP, amp

This study
R

This study
R

E. coli pQY28

E. coli NEB10β harbors pUC19 inserted by PcysP-slr1975-PcysP-nanA, amp

E. coli pQY29

R

E. coli NEB10β harbors pUC19 inserted by PrplJ-slr1975-PrplJ-nanA, amp

This study
This study

R

This study

E. coli NEB10β harbors pUC19 inserted by PT5-slr1975-PrplJ-nanA, amp

R

This study

E. coli pQY37

E. coli NEB10β harbors pUC19 inserted by PrplJ-slr1975-PT5-nanA, amp

R

This study

E. coli pQY43

E. coli NEB10β harbors pUC19 inserted by PT5-AGE-PrplJ-nanA, amp

R

E. coli pQY42

E. coli NEB10β harbors pUC19 inserted by PT5-slr1975-PrplJ-neuB, ampR

E. coli pQY30
E. coli pQY36

E. coli pQY46
E. coli TOP10

E. coli NEB10β harbors pUC19 inserted by PT5-slr1975-PT5-nanA, amp

E. coli NEB10β harbors pUC19 inserted by PT5-AGE-PrplJ-neuB, amp
recA1 araD139 Δ(ara leu) (StrR) endA1

R

This study
This study
This study
Invitrogen

R

E. coli pQY32

E. coli TOP10 harbors pEXP-5NT PT7-slr1975, amp

E. coli pQY33

R

This study

R

This study

R

This study

E. coli pQY35
E. coli pQY40

E. coli TOP10 harbors pEXP-5NT PT7-nanA, amp
E. coli TOP10 harbors pEXP-5NT PT7-neuB, amp
E. coli TOP10 harbors pEXP-5NT PT7-AGE, amp
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This study

Plasmid

Feature

Resources

pUC19

Used for gene expression in S. marcescens, ampR

NEB

pEXP 5NT/TOPO®

Used for cell-free protein expression, ampR

Invitrogen

All plasmids were constructed by DNA assembly techniques (Gibson et al. 2009). The
vector backbones were PCR-amplified using Q5® Hot Start DNA polymerase (New
England Biolabs, Ipswich, MA). The inserts (promoter sequences and coding
sequences) were chemically synthesized from Integrated Device Technology (San
Jose, CA) and the sequences and primers can be found in Table S8 and Table S9,
respectively. The PCR products were purified by a PCR purification kit (Zymo
Research, Irvine, CA). The vector backbone were mixed with Gibson Assembly®
Master Mix (New England Biolabs, Ipswich, MA) and incubated at 50°C for 1 h.
Subsequently, the assembly mixture was transformed to E. coli NEB10β or TOP10
strain. The presence of correctly cloned insertion was validated by colony PCR and
DNA sequencing (Eurofins Genomics, Louisville, KY).
3.2.2 Chemicals and reagents
All chemicals unless otherwise specified were acquired from Sigma-Aldrich (St.
Louis, MO) or Thermo Scientific (Waltham, MA).
3.2.3 Media and cultivation
All the E. coli strains were grown in LB or SOC media containing appropriate
antibiotics at 37°C on a rotary shaker (250 rpm). Antibiotics were used at the
following concentrations: ampicillin, 200 μg/mL; streptomycin, 40 μg/mL.

All S. marcescens strains were grown in a M9 medium containing 0.1% yeast extract
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and various carbon sources at 30°C on a rotary shaker (200 rpm). Carbon sources
were used at the following concentration: N-acetylglucosamine, 20 g/L; glucose, 20
g/L; glycerol, 20 g/L; chitin, 20 g/L; colloidal chitin, 20 g/L. Antibiotics were used at
the following concentrations: ampicillin, 800 μg/mL. The 20 mL pre-cultures of S.
marcescens strains were grown through overnight in a 125 mL Erlenmeyer flask at
30°C on a rotary shaker (200 rpm). For fermentative production of Neu5Ac, the S.
marcescens preculture was inoculated at 5% in 2 L Erlenmeyer flask and cells were
grown at 30°C on a rotary shaker (200 rpm).

Stock cultures of E. coli and S. marcescens were maintained at -80°C in 26% (v/v)
glycerol.
3.2.4 mRNA sequencing
The total RNA of S. marcescens Db11 was isolated using mid-log phase cell cultures
by QIAGEN RNA protect reagent (Venlo, Netherlands) in combination with the
QIAGEN RNeasy Mini kit (Venlo, Netherlands). The mRNA was isolated, enriched,
and reverse transcribed into cDNA. The resulting cDNA was sequenced by a
pair-ended reads using Illumina Hiseq 2500 (San Diego, CA). An average insert size
of 500 bp was created and draft mRNA-Seq data were generated. CLC Genomics
Workbench version 10 (QIAGEN, Venlo, Netherlands) and FASTQC were applied to
trim reads for quality sequence data. The S. marcescens Db11 genome (GeneBank:
HG326223) was used as a reference. Each mRNA sample was tested with two runs.
The gene expression level was calculated by normalizing each gene‟s reads per
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kilobase per million mapped sequence reads (RPKM) to overall gene numbers,
namely:
Gene expression level =

RPKM value
4831

3.2.5 Measurement of cell density
The measurement of S. marcescens strains culture density was generally quantified at
OD600 using a Biomate3 UV/VIS spectrophotometer (Thermo Fisher Scientific,
Waltham, MA). The growth of S. marcescens strains on crystal chitin and colloidal
chitin was measured by testing cytoplasmic protein content (Yan et al. 2017). The
correlation factor of the overall protein content to the dry cell weight (DCW) was
DCW (g/L) = 1.20 ±0.03 × Protein (g/L).
3.2.6 Quantification of gene transcription using real-time PCR
The expression levels of sfgfp, slr1975, and nanA in the S. marcescens recombinant
strains and the wild-type Db11 strain were measured by real-time PCR. A
housekeeping gene (luxS, SMDB11_0167) was used as a reference gene. Primers used
for real-time PCR can be found in Table S10. The relative mRNA level of the targeted
gene was quantified by normalizing to the reference gene.
3.2.7 Measurement of GFP fluorescence intensity
The GFP fluorescence intensity of the S. marcescens recombinant strain cultures were
measured by flow cytometry. The protocol is according to our previous study with
minor modifications (Yan and Fong 2017b). Briefly, the cell cultures were harvested
at exponential phase (OD600 ≈ 0.4 at 2.5 h) and stored on ice for at least 1 h to cease
cell growth. Cell pellets were then re-suspended with PBS buffer to an optical density
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(OD600 0.1 ~ 0.2) in a 1.5 mL centrifuge tube. The flow cytometry analysis was
performed using BD AccuriTM C6 flow cytometer (San Jose, CA). The fluorescence
intensity of each S. marcescens recombinant strains was normalized to the
fluorescence intensity of the wild-type Db11.
3.2.8 Quantification of Neu5Ac, GlcNAc and by-products
The concentration of GlcNAc, Neu5Ac, and all by-products were analyzed by an
Ultimate 3000 HPLC (Dionex, Sunnyvale, CA), equipped with a Bio-Rad Aminex
HPX-87H column (Hercules, CA), a UV detector (199 nm) (Dionex, Sunnyvale, CA),
and a refractive index detector (Shodex, Japan). The condition was run with 5 mM
H2SO4 at 0.6 mL/min and 55°C.
3.2.9 Measurement of in vitro Neu5Ac production
The in vitro Neu5Ac production by the S. marcescens recombinant strains was
measured by feeding the cell lysates with GlcNAc. In brief, the S. marcescens cell
cultures were harvested by centrifuging at 14,000×g and 4°C for 5 min. The cell
pellets were washed twice by PBS buffer and lysed by 1×Bugbuster (EMD Millipore,
Billerica, MA) for 30 min. The cell lysate was centrifuged at 14,000×g and 4°C for 5
min and the supernatant was ready for in vitro Neu5Ac production assay. For strains
overexpressing NeuB, the assay was performed in a total volume of 200 μL including
12.5 mM GlcNAc, 10 mM PEP, 12.5 mM MnCl2, 100 mM Bicine buffer (pH 8.0), 50
μL cell lysate and 2.5 mM ATP. For strains overexpressing NanA, the assay was
performed in a total volume of 200 μL containing 12.5 mM GlcNAc, 10 mM pyruvate,
12.5 mM MgCl2, 100 mM Tris-HCl buffer (pH 7.5), 50 μL cell lysate and 2.5 mM
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ATP. All the reactions were incubated at 37°C and samples were taken every 2 - 4 h.
3.2.10 Cell-free overexpression and purification of Slr1975, AGE, NanA, and
NeuB
The GlcNAc 2-epimerases (Slr1975 and AGE) and Neu5Ac aldolase/synthase (NanA
and NeuB) were produced using a Cell-Free Protein Expression kit (Thermo Fisher
Scientific, Waltham, MA) and purified in a His-Spin Protein MiniprepTM kit (Zymo
Research, Irvine, CA). The enzymes were purified in homogeneity and analyzed by
protein electrophoresis (Bio-Rad, Hercules, CA). Protein concentration was
determined by Bradford assay (Bio-Rad, Hercules, CA)
3.2.11 N-acetylglucosamine 2-epimerase enzyme assay
The GlcNAc 2-epimerase enzyme assay was carried out by measuring ManNAc
production. The reaction mixture was carried out in a 200 μL volume reaction
containing 12.5 mM GlcNAc, 12.5 mM MnCl2, Tris-HCl buffer (pH 7.5), 50 μL
enzyme and 2.5 mM ATP. The reaction was incubated at 37°C for 2 h. Each reaction
was run at least three times. One unit of the enzyme activity was defined as mM
ManNAc produced per hour.
3.2.12 N-acetylneuraminic acid aldolase/synthase enzyme assay
The forward/reverse reaction of NanA or NeuB was carried out by measuring
Neu5Ac/ManNAc production. The enzyme assay reactions were carried out in a 200
μL volume reaction containing appropriate substrates, 12.5 mM MnCl2, 100 mM
Bicine buffer (pH 8.0) and 50 μL enzyme. For the forward reaction of NanA/NeuB
enzyme assay, the substrates are 12.5 mM ManNAc and 10 mM pyruvate/10 mM PEP,
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respectively; for the reverse reaction of NanA/NeuB enzyme assay, the substrate is
12.5 mM Neu5Ac. Each reaction was run at least three times. One unit of the enzyme
activity was defined as mM Neu5Ac/ManNAc produced per hour.
3.3 Results
To develop and optimize an engineered strain of S. marcescens for production of
Neu5Ac from chitin, we conducted RNA-Seq experiments to identify potential native
constitutive promoters, characterized transcriptional strength of identified promoters,
measured activity of heterologous proteins for Neu5Ac production, implemented and
balanced heterologous expression in S. marcescens, and swapped heterologous
proteins to favor Neu5Ac production.
3.3.1 Characterization of S. marcescens constitutive promoter
In order to identify functional native S. marcescens promoters, we targeted native S.
marcescens promoters based upon a mRNA sequencing (RNA-Seq) of the wild-type S.
marcescens

Db11

strain

using

different

growth

conditions

(glucose,

N-acetylglucosamine, glycerol). The total number of reads for each condition were:
5,986,581 (glucose), 7,820,963 (N-acetylglucosamine) and 19,025,155 (glycerol). The
average coverage per gene (4831 total genes) was about 1239, 1619, and 3938 for
glucose, N-acetylglucosamine and glycerol, respectively, indicating a high depth of
coverage. Since our goal is to drive the exogenous Neu5Ac synthetic pathway gene
expression, we specifically targeted promoter sequences with various strengths (high,
medium, and low) based on the range of RPKM values. Based upon mRNA levels in
all three conditions (looking for constitutive promoters), we selected two genes with
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high expression (ompA and rplJ; RPKM > 1.0), 4 genes with medium expression
(rpsG, rpsL, gpmA, and metF; 0.1 < RPKM < 1.0), and 4 genes with low expression
(cysP, phlA, SMDB11_4509, and budAB; RPKM < 0.1), shown in Figure 8A. In
addition to the 10 potential promoters, two promoters were used as a high strength
positive control (PT5) (Gerc et al. 2012) and a medium strength positive control (PampR)
(Yan et al. 2017) that have been used in previous studies.

The functionality of the 12 promoters was examined by measuring both
transcriptional and translational levels of GFP gene (Figure 8B and Figure S4). The
T5 promoter was designated as high strength promoter, whose RFU (2328.32 ± 76.8)
and GFP mRNA value (515876 ± 23800) were ranked highest. There were 5
promoters (PrplJ, PrpsL, PgpmA, PmetF, and PampR), designated as medium strength
promoters, whose RFU ranged from 83 to 402 and GFP mRNA level ranged from 341
to 43237. There were 3 promoters (PrpsG, PphlA and PcysP), designated as low strength
promoters, with RFU ranged from 2.65 to 4.13 and GFP mRNA level ranged from
8.81 to 21.51. Overall, we obtained a library of constitutive promoters with various
promoter strengths (1 high-strength promoter, 5 medium-strength promoters, and 3
low-strength promoters).
3.3.2 Initial construction of Neu5Ac synthetic pathway
he wild-type S. marcescens Db11 strain does not natively produce Neu5Ac
(confirmed by HPLC). Since S. marcescens Db11 can natively produce
N-acetylglucosamine, only two exogenous pathways are required to produce Neu5Ac
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(Figure 1). Several candidate enzymes have been reported to potentially achieve the
desired two biochemical reactions: 1) AGE from Anabaena sp. CH1 (Lee et al. 2007)
or Slr1975 from Synechocystis sp. PCC6803 (Tabata et al. 2002) were two
well-characterized N-acetylglucosamine 2-epimerases with high reported activity to
convert N-acetylglucosamine (GlcNAc) to N-acetylmannosamine (ManNAc) and 2)
Neu5Ac aldolase NanA from E. coli MG1655 (Mahmoudian et al. 1997) or a Neu5Ac
synthase NeuB from Campylobacter jejuni NCTC11168 (Sundaram et al. 2004) for
conversion of ManNAc to Neu5Ac. Initially the following three recombinant strains
were constructed and tested: PT5-slr1975-PT5-nanA, PrplJ-slr1975-PrplJ-nanA, and
PcysP-slr1975-PcysP-nanA based on promoter strengths (high-high, medium-medium,
low-low), shown in Figure 9A.

Figure 8 Characterization of S. marcescens constitutive promoters. (A) RPKM
values of 10 native genes of S. marcescens Db11; (B) GFP expression level of S.
marcescens constitutive promoters by flow cytometry and quantification of GFP
mRNA level of S. marcescens recombinant strains by real-time PCR.
Real-time PCR was employed to measure the mRNA level of slr1975 and nanA in the
three recombinant strains, shown in Figure 9B. The wild-type Db11 strain was used
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as a negative control where slr1975 and nanA mRNA transcripts were not detected.
Compared to the mRNA level of slr1975 and nanA of the PcysP-slr1975-PcysP-nanA
strain, the PT5-slr1975-PT5-nanA strain showed 29.45- and 28.57-fold increases,
respectively, and the PrplJ-slr1975-PrplJ-nanA strain showed 14.79- and 12.29-fold
increases, respectively.

To test if Slr1975 and NanA were functional and to evaluate their activity, a cell-free
Neu5Ac production assay was conducted by incubating 2.5 g/L GlcNAc with the cell
lysates of the recombinant strains. After 2 h incubation, the PT5-slr1975-PT5-nanA
strain exhibited 154 ± 13.2 mg/L Neu5Ac, the PrplJ-slr1975-PrplJ-nanA strain exhibited
78.9 ±8.76 mg/L Neu5Ac, and the PcysP-slr1975-PcysP-nanA strain showed 34.1 ±2.45
mg/L Neu5Ac (Figure 9C). The in vitro Neu5Ac production titer results were
consistent with the measured mRNA levels where an increase transcription level by
using stronger promoters led to an increase the Neu5Ac production rate.

While using the strong promoter (PT5) to drive expression of both genes led to the
highest Neu5Ac production in vitro, implementation in vivo showed that this design
had a strong negative effect on cell growth where the PT5-slr1975-PT5-nanA strain had
a growth rate of μmax 0.19 ±0.03 /h. This is significantly slower when compared to the
PrplJ-slr1975-PrplJ-nanA strain (μmax 0.53 ± 0.01 /h), the PcysP-slr1975-PcysP-nanA strain
(μmax 0.86 ± 0.02 /h), and the wild-type strain (μmax 0.88 ± 0.01 /h), shown in Figure
9D. One possible explanation is that the high overexpression of the two exogenous
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genes in the S. marcescens PT5-slr1975-PT5-nanA strain adds significant metabolic
burden to the cells, hindering basal metabolic needs that are required to support
growth.
3.3.3 Neu5Ac titer improvement by tuning promoter strength
The combination of cellular growth and product yield affect the overall cellular
productivity, so an iteration on the strain design was conducted to attempt to balance
cell

growth

and

Neu5Ac

titer

by

tuning

promoter

strengths.

The

PT5-slr1975-PrplJ-nanA strain and PrplJ-slr1975-PT5-nanA strain were created by
adapting a high (PT5) and medium strength (PrplJ) promoter combination while
retaining the same coding sequences (slr1975 and nanA genes), shown in Figure 9A.
Compared to the PcysP-slr1975-PcysP-nanA strain, the mRNA levels of slr1975 and
nanA

were

25.76-

and

8.64-fold,

and

10.06-

and

27.31-fold

for

the

PT5-slr1975-PrplJ-nanA strain and PrplJ-slr1975-PT5-nanA strain, respectively, shown in
Figure

9B.

The

in

vitro

Neu5Ac

production

result

showed

that

the

PT5-slr1975-PrplJ-nanA strain increased 1.7-fold Neu5Ac titer compared to the
PT5-slr1975-PT5-nanA strain and had the highest in vitro titer of any of the strains
tested to this point; however, the PrplJ-slr1975-PT5-nanA strain decreased Neu5Ac titer
compared to the PT5-slr1975-PT5-nanA strain (Figure 9C). The growth rate of the
PT5-slr1975-PrplJ-nanA strain and PrplJ-slr1975-PT5-nanA strain were 0.49 ± 0.01 /h
and 0.50 ± 0.02 /h, which was significantly improved from the PT5-slr1975-PT5-nanA
strain (Figure 9D). The PT5-slr1975-PrplJ-nanA strain showed the highest in vitro titer
and reasonable growth rates and thus looked to be the most promising strain at this
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point.

While conducting the in vitro Neu5Ac production assays, several observations were
made related to Neu5Ac production. First, while Neu5Ac was produced within 2 h,
the concentration decreased between 2 h and 4 h and reached a plateau after 8 h. Also,
detectable amounts of GlcNAc and pyruvate were left after 8 h. These observations
were consistent during testing of all the recombinant strains. One possible reason
could be an exhaustion of ATP that hinders conversion of GlcNAc to ManNAc. To
test this possibility, ATP was fed at 2 h after ATP might have been exhausted. This did
lead to an increase in the final Neu5Ac concentration (605.26 ± 38.67 mg/L), shown
in Figure 10B. Since ATP can be regenerated in vivo, we believed that the designs
would have sufficient ATP available once implemented in S. marcescens to maintain
Neu5Ac production. The observation of leftover GlcNAc and pyruvate implied that
the in vitro system was hitting a chemical equilibrium between forward and reverse
reactions since both pathways (slr1975 and nanA genes) were reversible.
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Figure 9 The Neu5Ac production by tuning promoter strength of the pathway genes.
(A) The design strategy of tuning promoter strength to improve Neu5Ac production;
(B) Quantifications of the mRNA levels of slr1975 and nanA of the S. marcescens
recombinant strains by real-time PCR; (C) In vitro production of Neu5Ac by using
the S. marcescens recombinant strain cell lysates after 2 h incubation with 2.5 g/L
GlcNAc; (D) Cell growth rates of the S. marcescens recombinant strains at M9
medium with 20 g/L GlcNAc and 0.1% yeast extract at 30°C and 200 rpm.
3.3.4 Neu5Ac improvement by swapping irreversible enzyme
To further investigate the possible effects of the reversibility of reactions on
productivity and details of enzyme activity, two different GlcNAc 2-epimerases (AGE
from Anabaena sp. CH1 and Slr1975 from Synechocystis sp. PCC6803), a Neu5Ac
aldolase (NanA from E. coli MG1655), and a Neu5Ac synthase (NeuB from
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Campylobacter jejuni NCTC11168) were synthesized, produced and purified using E.
coli.

For the last step in production of Neu5Ac, ManNAc is the precursor compound so in
vitro assays were run to test activity and reversibility by incubating with either
ManNAc or with Neu5Ac as the starting substrate. Assays with NanA produced
Neu5Ac from ManNAc with activity of 31.44 ± 0.48 U/mg·protein and produced
ManNAc from Neu5Ac with activity of 60.08 ± 0.76 U/mg·protein, indicating that
NanA functions in a reversible manner, shown in Figure 10B and Figure S5. Assays
with NeuB produced Neu5Ac from ManNAc with activity of 95.12 ± 1.32
U/mg·protein but no production of ManNAc from Neu5Ac was found, indicating that
NeuB converts ManNAc to Neu5Ac in an irreversible manner. For the forward
reaction (ManNAc to Neu5Ac), the enzyme activity of NeuB is around 3.0-fold
higher than NanA. For the enzyme candidates tested for conversion of GlcNAc to
ManNAc, no significant difference of activity or reversibility were found between
AGE and Slr1975 (data not shown).

Based

upon

this

(PT5-slr1975-PrplJ-nanA,

information,

four

additional

PT5-slr1975-PrplJ-neuB,

recombinant

PT5-AGE-PrplJ-nanA,

strains
and

PT5-AGE-PrplJ-neuB) were designed and built to test the different enzymes in
combination, shown in Figure 10A. After 60 h in vitro reaction with supplemented
sufficient ATP, Neu5Ac production reached a plateau. A maximum titer of 1.5 ± 0.09
g/L Neu5Ac was obtained from the PT5-slr1975-PrplJ-neuB construct, that represents
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approximately a 2.5-fold increase above the previous best results of the
PT5-slr1975-PrplJ-nanA construct, shown in Figure 10C. This result indicated that
Neu5Ac production could be significantly improved after swapping the reversible
enzyme NanA to the irreversible enzyme NeuB. After swapping the first step enzyme
from Slr1975 to AGE, there was no significant Neu5Ac production difference, which
is in consistent with having no appreciable difference in enzymatic activity results.
3.3.5 In vivo Neu5Ac production
All of the S. marcescens recombinant strains and the wild-type strain Db11 were
initially grown on 20 g/L GlcNAc to test for Neu5Ac production to test strain
functionality without the complicating factor of chitinase activity. After 48 h of
growth, GlcNAc was almost depleted for the wild-type strain Db11 and all
recombinant strains except for the PT5-slr1975-PT5-nanA strain (See Figure S6A). The
cell growth and metabolic end-products of all S. marcescens strains were monitored
(See Figure S6B and Table S11). Neither intracellular nor extracellular Neu5Ac was
detected during cell culture of the wild-type Db11 strain as expected for the negative
control. A maximum titer of 0.48 ± 0.06 g/L Neu5Ac was produced by the
PT5-slr1975-PrplJ-neuB strain (Figure 11). Compared to the Neu5Ac titer of the initial
PT5-slr1975-PT5-nanA strain, the Neu5Ac production was significantly improved by
about 11.7-fold after balancing the pathways using promoter swapping and switching
the final reaction step to use a faster, irreversible enzyme (neuB).
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Figure 10 The Neu5Ac production by utilizing different enzyme candidates. (A)
The design strategy of different activity enzymes to improve Neu5Ac production;
(B) Specific enzyme activities of NanA and NeuB by feeding either ManNAc or
Neu5Ac as a substrate; (C) In vitro production of Neu5Ac by using the S.
marcescens recombinant strains cell lysates from 2.5 g/L GlcNAc after 48 h
incubation with supplement of 10 mM ATP at 2 h.
3.3.6 Neu5Ac production directly from chitin
The final component was to test for production of Neu5Ac for growth directly on
chitin. The S. marcescens PT5-slr1975-PrplJ-neuB strain and the wild-type strain were
grown on 5 g/L, 10 g/L and 20 g/L crystal chitin or 5 g/L, 10 g/L and 20 g/L colloidal
chitin. After 1 week culture, the S. marcescens PT5-slr1975-PrplJ-neuB strain produced
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0.32 ±0.02 g/L and 0.30 ±0.05 g/L from 5 g/L crystal chitin and 5 g/L colloidal chitin,
respectively, shown in Table 5 and Figure 12. Overall, our results showed that the
engineered S. marcescens strain was capable of producing Neu5Ac directly from
chitin and the maximum titer is on the same order of magnitude as reported from
glucose as a carbon source in E. coli.

Figure 11 In vivo Neu5Ac production from the S. marcescens recombinant strains at
M9 medium with 20 g/L GlcNAc and 0.1% yeast extract at 30°C and 200 rpm.

Table 5 Neu5Ac production from crystal chitin and colloidal chitin using S.
marcescens PT5-slr1975-PrplJ-neuB and the wild-type Db11 strain after 1-week
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fermentation in a rotator flask.
Substrate

Neu5Ac

Biomass

2,3-BD

Acetic acid

Lactic acid

(g/L)

(g/L)

(g/L)

(g/L)

(g/L)

0.37 ±0.02

0.83 ±0.05

0.20 ±0.09

0.13 ±0.01

0.08 ±0.00

0.33 ±0.05

0.87 ±0.04

0.18 ±0.10

0.11 ±0.01

0.06 ±0.00

-

1.08 ±0.01

0.40 ±0.04

0.26 ±0.03

0.15 ±0.01

-

0.99 ±0.03

0.38 ±0.02

0.23 ±0.02

0.10 ±0.01

0.30 ±0.06

0.80 ±0.04

0.19 ±0.02

0.12 ±0.00

0.06 ±0.00

0.32 ±0.05

0.82 ±0.03

0.16 ±0.02

0.10 ±0.00

0.06 ±0.00

0.32 ±0.05

0.81 ±0.03

0.20 ±0.02

0.11 ±0.00

0.07 ±0.00

0.30 ±0.03

0.82 ±0.05

0.18 ±0.02

0.12 ±0.00

0.06 ±0.00

Strain
S. marcescens

crystal chitin (20

PT5-slr1975-PrplJ-neuB

g/L)
colloidal chitin (20
g/L)
crystal chitin (20
g/L)

S. marcescens Db11
colloidal chtin (20
g/L)
S. marcescens

crystal chitin (10

PT5-slr1975-PrplJ-neuB

g/L)
colloidal chitin (10
g/L)

S. marcescens

crystal chitin (5

PT5-slr1975-PrplJ-neuB

g/L)
colloidal chitin (5
g/L)
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Figure 12 N-Acetylneuraminic acid production and cell growth under 5 g/L crystal
chitin M9 medium.
3.4 Discussion
When considering the application of bioprocessing for industrial-scale production of
chemicals, a diversity of issues are involved. A large and growing body of work
utilizes the main workhorse microorganisms (Escherichia coli, Saccharomyces
cerevisiae, Bacillus subtilis) for many applications, but it is becoming necessary to
develop additional platform organisms that can utilize specialized cellular activities or
functions that are not found in the established workhorse organisms. In this study, we
have focused on the chitinolytic organism, Serratia marcescens, to demonstrate its
potential utility as a platform strain for chitin-based CBP applications. Overall, we
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have engineered S. marcescens to directly convert crystal chitin to N-acetylneuraminic
acid. Native constitutive promoters for S. marcescens were identified and tested (1
high-strength promoter, 5 medium-strength promoters, and 3 low-strength promoters)
that were used for this study and can help future engineering of S. marcescens. Here,
the promoters were applied for Neu5Ac production in S. marcescens by
overexpressing two exogenous genes. Tuning the mRNA levels of the pathway genes
resulted in an 11.56-fold Neu5Ac titer increase that balanced pathways flux and
growth considerations. Furthermore, pulling the reaction equilibrium toward Neu5Ac
by use of a fast, irreversible enzyme further increased Neu5Ac titer 1.72-fold. Finally,
the optimized strain (PT5-slr1975-PrplJ-neuB) was able to produce 0.48 ± 0.06 g/L
Neu5Ac from 20 g/L GlcNAc and 0.32 ± 0.05 g/L Neu5Ac was produced from 5 g/L
crystal chitin.

Heterologous expression of genes and tuning gene expression levels in S. marcescens
is limited due to the lack of a well-characterized promoter library and additional
genetic tools. Use of RNA-Seq data from various growth conditions (substrates,
temperature, culture time) can provide useful information to identify native
constitutive promoters and it has been applied to balancing pathways to improve
production titers and to activating cryptic pathways to produce novel chemicals (Li et
al. 2015; Luo et al. 2015; Sun et al. 2012a). It has been found that the wild-type S.
marcescens has mechanisms for catabolite repression by various carbon sources
(Monreal and Reese 1969). To account for catabolite repression, we generated
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RNA-Seq data for growth on glucose, N-acetylglucosamine, and glycerol. Promoters
associated with 10 genes were targeted based upon the RNA-Seq data due to the
similarity on the expression level at the three substrates. To build a promoter library,
two non-native promoters (PT5 and PampR) were also considered and overall, 12
promoters were characterized (transcriptional and translational levels) resulting in a
verified promoter collection containing 1 high-strength promoter, 5 medium-strength
promoters and 3 low-strength promoters. Previous studies have used PbudAB as the
primary native promoter in S. marcescens. It should be noted that the PrplJ promoter
had a 210.7-fold increase in transcription over the PbudAB promoter and is thus the
highest reported native S. marcescens promoter to date.

Promoter engineering as a strategy to improve chemical production by relieving
metabolic burden (Wu et al. 2016), minimizing unnecessary mRNA (Blazeck et al.
2012; Jones et al. 2015), and pulling more metabolic flux toward target chemicals
(Ma et al. 2011; Nowroozi et al. 2014; Pitera et al. 2007; Xu et al. 2011), has been
implemented in many applications (Alper et al. 2005). In this study, we found that
balancing the promoter strengths of the pathway genes can improve Neu5Ac
production (11-fold) for two reasons: 1) It can increase cell growth by minimizing
unnecessary mRNA production and reducing metabolic burden (cell growth rate
increased 2.5-fold) and 2) It can help balance pathway fluxes to pathways in series
when there an inbalance in enzyme activity. In S. marcescens, after GlcNAc is
transported into the cell, there is an interconversion reaction between GlcNAc-6P and
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GlcNAc. The GlcNAc is either used in glycolysis as glucosamine 6-phosphate
(GlcN-6P) for cell growth or flows to the Neu5Ac synthetic pathway by converting
GlcNAc to ManNAc. Future work to enhance flux to the first-step reaction can
reinforce the flux toward the intermediate ManNAc formation and favor accumulation
of Neu5Ac.

Targeting specific enzyme activity to improve microbial biochemical production by
switching a more efficient enzyme at a key-step reaction has been demonstrated in
other studies (Bormann et al. 2014; Shen et al. 2011; Yan and Fong 2017a). For the
case of Neu5Ac synthesis, the bioprocess involving the reversible enzyme, Neu5Ac
aldolase (NanA), usually requires feeding of high concentration of GlcNAc (~ 200
g/L) with a large amount of residual GlcNAc (Kang et al. 2012; Lin et al. 2013; Tao et
al. 2011) to skew the chemical equilibrium. The last step of Neu5Ac formation was
also reported as a bottleneck step of the bioconversion process due to the lower
activity of the aldolase (NanA 0.57 ± 0.09 U/mg protein) than the activity of
epimerase (AGE 37.1 ± 3.6 U/mg protein) (Lin et al. 2013). Yang et al. investigated
the Neu5Ac production by engineered E. coli from the glucose pathways and found
that Neu5Ac titer can be improved by 1.33-fold after swapping NeuB to NanA (Yang
et al. 2017). In this study, we found that NeuB is more efficient and superior than
NanA at both reaction mechanism (irreversible versus reversible) and activity (95.12
± 1.32 U/mg·protein versus 31.44 ± 0.48 U/mg·protein) for Neu5Ac synthesis. The
PT5-slr1975-PrplJ-neuB strain produced 1.58-fold more Neu5Ac in vivo compared to
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the PT5-slr1975-PrplJ-nanA strain. Future experiments on protein engineering of the
NeuB could be conducted to investigate NeuB‟s effect on improving Neu5Ac
production on a molecular basis.

The engineered S. marcescens PT5-slr1975-PrplJ-neuB from this work can produce
Neu5Ac from GlcNAc, colloidal chitin, and crystal chitin. The Neu5Ac maximum
titers achieved by our designed strain was 0.48 g/L from GlcNAc. 0.33 g/L from
colloidal chitin, and 0.37 g/L from crystal chitin. The Neu5Ac titer achieved by our
designed strain is on the same order of magnitude as the highest reported from E. coli
using fermentation approaches (1.62 g/L from 30 g/L glucose) (Kang et al. 2012). The
Neu5Ac titer obtained by our designed strain (0.37 g/L from crystal chitin) is the
highest reported so far (Steiger et al. 2011).
3.4 Conclusion
In this study, we demonstrated the direct conversion of untreated chitin to
N-acetylneuraminic acid (Neu5Ac) using an engineered chitinolytic bacterium,
Serratia marcescens. To add to the genetic tools and facilitate engineering of S.
marcescens, we used RNASeq data to identify and characterize a set of native
constitutive promoters. Production of Neu5Ac was evaluated by functional
transcription

and

N-acetylglucosamine

protein

activities

2-epimerase

after

(Slr1975)

heterologous

and

Neu5Ac

expression
aldolase

of

(NanA).

Subsequently, Neu5Ac production titers were improved 11.56- fold by promoter
engineering to minimize unnecessary mRNA production and to pull carbon flux
79

toward ManNAc accumulation.

Further optimization was achieved (1.56-fold

increase) by adapting an irreversible Neu5Ac synthase (NeuB) to push the reaction
equilibrium toward Neu5Ac. The optimized recombinant strain PT5-slr1975-PrplJ-neuB
was able to produce 0.48 g/L Neu5Ac from 20 g/L N-acetylglucosamine and 0.32 g/L
Neu5Ac from 5 g/L crystal chitin. This is the first study to report de novo production
of Neu5Ac from chitin in S. marcescens.
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Chapter 4 Adaptive evolution S. marcescens to increase chitin utilization
efficiency and genome resequencing platform reveals insightful mechanism

Importance of this part of work:
I have demonstrated production of 2,3-butanediol and N-acetylneuraminic acid from
chitin using S. marcescens. One of the challenges when considering S. marcescens as
a workhorse for consolidated bioprocessing is that degradation of recalcitrant chitin is
a long process. Laboratory adaptive evolution has been proved to be a powerful tool
for improving organisms‟ substrate utilization. The fact that S. marcescens can grow
on chitin makes it an ideal candidate to conduct adaptive evolution experiments. Since
chitinolytic organism are not fully characterized and identified, to the best of my
knowledge, this is the first of study to conduct adaptive evolution research using
chitin as a substrate.
The conclusions and fundamental results derived from this part of work:
I conducted serial passage of Serratia marcescens in colloidal chitin M9 medium for
four months, propagating 288 generation, yielding an evolved strain S. marcescens
EPS. Physiological changes including increased chitinase activities, decreased
secreted proteins, increased cell yield on chitin, and metabolic end-products changes
from the wild-type strain to the EPS strain were observed. Cellular morphological
characterization showed the EPS strain exhibits a large cell size (length and height).
The EPS strain was capable of producing 1.41 g/L 2,3-butanediol from 2% crystal
chitin, a 3.7-fold increase compared to that of the wild-type strain. In addition, the
molar ratio of 2,3-butanediol to byproducts is improved from the wild-type strain
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(2.5:2.5:1) to the EPS strain (4.8:2.7:1). Key mutations occurred in two gene products
(SMDB11_2700 and SMDB11_1516) that encode a LysR-family regulator and a
fimbrial adhensin may be accounting for the increased chitinase activities and
overproduction of 2,3-butanediol.
4.1 Introduction
Chitin is the second most common organic compound on earth and can be potentially
used as an inexpensive and renewable raw material for many applications (Yan and
Chen 2015; Yan and Fong 2015). One of potentially interesting schemes to utilize
chitin for biochemical production is using chitinolytic organisms to perform one-step
conversion, known as consolidated bioprocessing (CBP) (Yan and Fong 2017a). To
more fully utilize chitin, efforts are being made to identify, characterize, and utilize
chitinolytic organisms. Collectively, chitinolytic microorganisms are a small fraction
of overall known species with different species found in many different branches of
life such as Serratia marcescens (Vaaje-Kolstad et al. 2013), Bacillus circulans (Jee et
al. 2002), and Acinetibacter parvus (Kim et al. 2017). While generally poorly
characterized, chitinolytic microbes possess great physiological and biochemical
diversity making them interesting organisms to study from both a basic and applied
perspective. Serratia marcescens is a particularly interesting chitinolytic bacterium
that has been well-studied and more efficient at producing chitinases than most other
chitinolytic bacteria.

One of the main challenges to utilizing chitin is that chitin degradation/hydrolysis is a
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slow and difficult process. The roles, activity, and regulatory mechanisms controlling
expression of different chitinases are all being studied with a goal of being able to
understand and increase the rate of chitin hydrolysis (Vaaje-Kolstad et al. 2013; Yan et
al. 2017). Another potential approach to increase the rate of chitin hydrolysis is to
conduct adaptive evolution experiments with a chitinolytic organism. By serial
passage of a microorganism growing in one constant substrate medium, a mutated
daughter cell whose growth outpaces other cells can eventually take over the whole
population by its own daughter cells. Laboratory adaptive evolution has been applied
to many cellulolytic microorganisms as a means for inducing systemic changes to
improve cell growth on cellulosic materials (Deng and Fong 2011a; Lin et al. 2016;
Patyshakuliyeva et al. 2016). In cases where selection is based upon growth rate that
is related to increased consumption of the limiting substrate, thus, laboratory
evolution may be a means for increasing the rate of chitin hydrolysis in a chitinolytic
organism.

In this study, our goal is to improve S. marcescens chitin utilization efficiency by
propagating S. marcescens Db11 in a minimum M9 medium containing colloidal
chitin as a sole carbon source. After 4-month laboratory adaptive evolution
experiments, an end-point evolved strain was isolated with clear cellular physiological
changes including increase of chitinase activities and cell growth, decrease of overall
secreted proteins, and changes of secreted end-point metabolites and cellular
morphology. Whole genome sequencing of the evolved strains was performed to seek
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single nucleotide variations (SNVs) and identified key mutations in a regulator gene
upstream region and a fimbrial adhensin gene. In addition, the evolved strain was
capable of improving 2,3-butanediol production by 3.7-fold from 2% crystal chitin
compared to that of the wild-type strain.
4.2 Materials and Methods
4.2.1 Adaptive evolution of S. marcescens
Starting with the wild-type strain of S. marcescens Db11, whose genome has recently
been sequenced (Iguchi et al. 2014), laboratory evolution experiments were conducted
for growth in M9 medium with 2% colloidal chitin as a sole carbon source for four
months. The S. marcescens strains were serial passage into the fresh medium while
cells remained in exponential growth. The phenotypes (cell growth, chitinase activity
and overall secreted proteins) were measured every five days and the amount of
dilution at each passage was adjusted daily to account for changes in growth rate.
After around four months of cell propagation, the cell growth and chitinase activity
were stable and the laboratory evolution experiment was stopped. The end-point
strains were propagated for nearly 287 generations and the middle-point strains were
propagated for nearly 143 generations. For subsequent testing, isogenic colonies were
selected by diluting S. marcescens on agar plates containing M9 medium with 2%
colloidal chitin and picking single colonies for culturing.
4.2.2 Growing S. marcescens with glucose, N-acetylglucosamine and colloidal
chitin
S. marcescens strains preculture were grown in LB medium at 30°C and 220 rpm for
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overnight. The preculture was harvested and washed three times using purified water.
Then, 2.5% (v/v) inoculation was added in a 50 mL Erlenmeyer flask containing 35
mL M9 medium with 10 g/L glucose, 10 g/L N-acetylglucosamine, or 20 g/L colloidal
chitin. The S. marcescens strains were incubated at 30°C and 100 rpm for 48 h or 7
days, respectively. The cell growth were monitored either by testing OD600 every 4
hours when grown in glucose or N-acetylglucosamine M9 medium or by measuring
overall cell lysates protein concentration every 24 hours when grown in colloidal
chitin M9 medium.
4.2.3 Cell density measurement
The optical density (OD) was measured as absorbance at 600 nm every 4 h for S.
marcescens growing on glucose and N-acetylglucosamine M9 medium. Due to the
physiology of colloidal chitin (milk white turbid liquid), the cytoplasmic protein
content of S. marcescens strains when grown in colloidal chitin medium was tested
according to the protocol described in our previous publication (Yan et al. 2017). In
brief, 1 mL cell culture was centrifuged at 10,000×g for 5 min. The cell pellets were
re-suspended in fresh media and repeated centrifugation at 10,000×g for 5 min. The
samples were resuspended in 100 μL 1X Bugbuster (EMD Millipore, Billerica, MA)
and lysed by incubating at room temperature for 30 min. Cell wall debris were
removed by centrifuging at 10,000×g for 5 min and the supernatant was used to
measure cytoplasmic protein concentration by the Bradford protein assay (Bio-Rad,
Hercules, CA). The dry cell weight (DCW) is proportionally related to the overall
protein content according to a correlation factor equation: DCW (g/L) = 1.20 ± 0.03 ×
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Protein (g/L)).
4.2.4 Secreted end-products measurement
1 mL cell culture was harvested and centrifuged at 10,000×g for 5 min. The
supernatant was filtered using a 0.22 μm filter and subsequently, the samples were
ready for HPLC measurements. Metabolic end-products were quantified using an
Ultimate3000 HPLC system (Dionex, Sunnyvale, CA), equipped with a Bio-Rad
HPX-87H ion exclusion column (Hercules, CA) and a refractive index detector
(Shodex, Japen). The condition was run with 5 mM H2SO4 at 0.6 mL/min and 55°C.
4.2.5 Chitinase activity assay
Three substrates were used to measure the chitinase activities according to different
enzyme

acting

mechanisms.

For

instance,

0.2

mg/mL

4-Nitrophenyl

β-D-N,N′,N′′-triacetylchitotriose was used to detect endochitinase activity; 0.5 mg/mL
4-Nitrophenyl N,N′-diacetyl-β-D-chitobioside was used to determined chitobiosidase
activity; 1 mg/mL 4-Nitrophenyl N-acetyl-β-D-glucosaminide was used to test
β-N-acetyl-glucosaminidase activity. Briefly, 1 mL cell culture was centrifuged at
10,000×g for 5 min. Each reaction contained 10 μL supernatant samples and 90 μL
substrate dissolved in assay buffer (Sigma-Aldrich, St. Louis, MO). The reaction was
incubated in a 96-well plate at 37°C for 30 min and was terminated by adding 200 μL
0.4 M sodium carbonate solutions. The absorbance at 405 nm was measured
immediately using a microplate reader (VERSAmax, San Jose, CA). Chitinase
activity was defined as one unit of activity will release 1.0 μmole of 4-Nitrophenol
from appropriate per minute at pH 4.8 at 37°C.
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4.2.6 Cell morphological characterization
All S. marcescens strains cell morphology was conducted and characterized using
Atom Force Microscope (AFM). In brief, S. marcescens strains were streaked from
freezer stocks on agar plates containing M9 medium with 2% colloidal chitin and
were incubated at 30°C for 1 week. After 1 week culture, S. marcescens colonies grew
saturated on the agar plates and formed clear zone around them. A single isogenic
colony was picked up and diluted in a 1.5 mL centrifuge tube containing 1 mL DI
H2O. One drop of the cell resuspension solution was placed on the surface of a sample
plate. When the samples were dried at room temperature, they were readily visualized
and characterized by an AFM. Detailed procedures of AFM characterization were
according to a previous publication by a research group at VCU (Wang et al. 2015).
4.2.7 Whole genome resequencing
Genomic DNA was isolated using the DNeasy Blood & Tissue kit (Qiagen, USA)
according to the manufacturer‟s instructions. All the genomic sequencing libraries
were prepared according to the manufacturer‟s instructions. We sequenced the isolates
from S. marcescens MPS and EPS using sequencer and then these two isolates were
also sequenced by Illumina Hiseq3000. In all cases we generated pair-end reads.
4.2.8 Single nucleotide variations (SNVs) detection from sequence data
Sequencing reads obtained using the Roche 454 FLX platform were analyzed by
manufacturer-supplied software and processed by a Technology Center for Genomics
and Bioinformatics at University of California at Los Angelas. Illumina reads were
mapped directly to the S. marcescens reference sequence using a somatic mutation
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calling program. During the alignment of the Illumina data, sequence fragments were
called to a unique genome position and only fragments with a perfect sequence match
or a single base mismatch were used. In general, there was an average coverage of 50
for each gene. The reference genome sequence of S. marcecens Db11 is HG326223.
4.2.9 2,3-butanediol fermentation
S. marcescens pre-culture was performed in LB medium at 30°C and 220 rpm for
overnight. 10% (v/v) seed culture was inoculated for 2,3-butanediol fermentation. S.
marcescens 2,3-butanediol fermentations were conducted in 250-mL Erlenmeyer flask
containing 150 mL M9 minimum medium with 1% yeast extract, 5 g/L
N-acetylglucosamine, and 20 g/L crystal chitin at initial pH 7.5, 30°C and 100 rpm.
4.3 Results and Discussion
4.3.1 Adaptive evolution of S. marcescems
After around four-month serial passage of cells at exponential phage into fresh M9
colloidal chitin medium, the end-point strain, designated as S. marcescens EPS, was
propagated for ~287 generations while the middle-point strain, designated as S.
marcescens MPS was propagated for ~143 generations. By monitoring the overall
population phenotypes, we observed the changes of cell yields, chitinase activities and
overall secreted proteins tend to be steady (Figure 13A, 13B and 13C). Compared to
the parental strain, after 287 generations propagation, the end-point populations
showed a trend of increased chitinase activities (β-N-acetylglucosaminidase,

from

4.259×10-3 to 0.10 U/mL; endochitinase, from 4.77×10-4 to 0.0031 U/mL;
chitobiosidase from 0.0116 to 0.057 U/mL); a trend of decreased overall secreted
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protein (from 71.36 mg/L to 51.63 mg/L); and a trend of increased overall cell yield
(from 6.06 g/L to 7.26 g/L periplasmic protein). Both increases of chitinase activities
and cell yields indicate a potential improvement of S. marcescens chitin utilization
capability.
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Figure 13 Physilogical changes after serial passage of S. marcescens in 2% colloidal
chitin M9 medium. (A) Chitinase activities (U/mL): β-N-acetylglucosaminidase
(black square), chitobiosidae (red circle), endochitinase (blue triangle); (B) Overall
secreted proteins (mg/L); (C) Overall intracellular protein concentration.
4.3.2 Growth changes
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Next, we isolated the evolved middle-point strain (MPS) and end-point strain (EPS)
by diluting on colloidal chitin agar plates. Ten colonies for 143 and 287 generation
populations were picked and tested for chitinase activities, cell growth and secreted
overall protein (data not shown). The chitinase activities were consistent to the mixed
population trend. Thus, we isolated two isogenic strains: a S. marcescens MPS and a S.
marcescens EPS. The two strains in combination with the wild-type Db11 strain were
used to conduct physiological characterization.

Compared to cell growth of wild-type Db11 strain grown in glucose medium, the S.
marcescens MPS and S. marcescens EPS showed slightly decreased cell yields (Fig.
14A). Compared to cell growth of wild-type strain grown in N-acetylglucosamine
medium, the S. marcescens MPS and the S. marcescens EPS growth did not change
apparently. Compared to the cell yield (2.52 g/L) of wild-type strain grown in
colloidal chitin medium, the S. marcescens MPS and S. marcescens EPS exhibited an
increased overall cell yield (3.69 g/L and 3.89 g/L, respectively) (Fig. 14B). The
increase of overall cell yields from wild-type strain to S. marcescens MPS and EPS
are consistent to the overall population trend.
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Figure 14 Time course of cell growth in M9 medium of different carbon souces at
220 rm and 30°C. (A) 10 g/L glucose and 10 g/L N-acetylglucosamine, (B) 2%
colloidal chitin.
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4.3.3 Chitinase activity and metabolic end-products changes
Compare to the chitinase activities of the wild-type strain, the S. marcescens EPS and
the S. marcescens MPS chitinase activities were significantly increased compared to
the wild-type strain (Fig. 15A). For instance, the endochtinase activity of the S.
marcescens EPS (0.00197 U/mL) and the S. marcescens MPS (0.001518 U/mL)
increased 2- and 1.5-fold, respectively. The chitobiosidase activity of the S.
marcescens EPS (0.0634 U/mL) and the S. marcescens MPS (0.0304 U/mL) increased
3.9- and 1.9-fold, respectively. The β-N-acetylglucosaminidase activity of the S.
marcescens EPS (0.132 U/mL) and the S. marcescens MPS (0.032 U/mL) increased
7.73- and 1.88-fold, respectively. Compared to the overall secreted proteins (94.81
mg/L) of the wild-type strain, the S. marcescens EPS (48.18 mg/L) and the S.
marcescens MPS (62.0 mg/L) secreted overall protein was decreased 1.96- and
1.53-folds, respectively (Fig. 15B).

In addition, the main secreted metabolic end-products of the S. marcescens strains
were measured when grown in M9 N-acetylglucosamine medium. The S. marcescens
EPS completely consumed the initial 10 g/L N-acetylglucosamine after 24 h; the S.
marcescens MPS consumed 8.51 g/L N-acetylglucosamine after 24 h; and the
wild-type strain consumed 6.24 g/L N-acetylglucosamine after 24 h. Therefore, the S.
marcescens EPS exhibited more actively at uptaking N-acetylglucosamine than the S.
marcescens MPS and Db11. Compared to the secreted metabolic end-products of the
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wild-type strain, S. marcescens EPS produced 1.93-fold increased 2,3-butanediol,
1.84-fold increased lactic acid, and 1.46-fold increased acetic acid (Fig. 15C). The
overall increased metabolic end-products from the wild-type strain to the MPS and
EPS strain is the consequence of improvement of N-acetylglucosamine uptake rates
while no apparent differences of cell biomass formation among the three strains were
observed. In addition, the molar end-production ratio of S. marcescens EPS
(2,3-butanediol:acetic acid:lactic acid =5:3.3:1) is slightly higher than that of the
wild-type strain (2,3-butanediol:acetic acid: lactic acid =4.5:3.8:1). The increased
molar ratio of 2,3-butanediol:acetic acid:lactic acid from the EPS strain to the
wild-type strain can be due to balance intracellular acidic conditions caused by
production of acetic acid and lactic acid since S. marcescens prefers to produce
2,3-butanediol under an acidic condition (Ji et al. 2011).
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Figure 15 Characterization of phenotypical changes of the evolved strains and
parental strain. (A) Chitinase activity, (B) overall secreted protein, (C) end-point
metabolites.
4.3.4 Cell morphological changes
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All S. marcescens strains were imaged by AFM and the detailed procedures can be
found in the Materials and methods. Under a scope of 50 μm image, compared to S.
marcescens Db11 cellular length and height, there is a generally increase trend of
cellular length and height for S. marcescens MPS and EPS strains, shown in Fig. 16A,
16C, and 16E. Under a scope of 3.0 μm image where single cells were targeted and
centered, the trend of increase at cellular length and height become clear ranging from
S. marcescens Db11 to S. marcescen MPS and S. marcescen EPS (shown in Fig. 16B,
16D, and 16E). On average, S. marcescens EPS strains have a cellular length of 2.19
± 0.19 μm and height of 331 ± 30 nm; S. marcescens MPS strains have a cellular
length of 1.33 ± 0.08 μm and height of 197 ± 20 nm; S. marcescens Db11 strains have
a cellular length of 1.31 ± 0.21 μm and height of 206 ± 34 nm. Overall, the end-point
evolved strains exhibited larger cellular sizes (length and height) than the wild-type
strains. There are two possible reasons that are responsible for the increased cellular
sizes after evolutionary experiments: 1) it might be due to an increased secretion of
more surrounded polysaccharides since Serratia sp. are known to form biofilms
during cell growth; 2) it might be due to the increase of metabolic capabilities where
facilitate nutrients and metabolites mass transformation by increasing outer or inner
membrane areas. Since the evolution experiment was conducted by serial passage of S.
marcescens under chitin as the sole carbon conditions, it may not be surprising that
cells evolved to maximize the cellular membrane to uptake and secrete nutrients and
metabolites

to

survive

under
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the

harsh

conditions.

Figure 16 Cellular morphological characterization of S. marcescens strains by AFM.
(A, C, and E) Image of S. marcescens Db11, MPS and EPS under scope of 50 μm; (B,
D, and F) single cell image of S. marcescens Db11, MPS, and EPS under scope of 3
μm.
4.3.5 2,3-butanediol production from chitin
In order to evaluate the S. marcescens EPS 2,3-butanediol production capability from
crystal chitin, the S. marcescens EPS and Db11 were cultured in 2% crystal chitin
medium for 1-week. Compared to S. marcescens Db11 fermentation, the S.
marcescens EPS shows higher cell yields (1.34 g/L vs 1.13 g/L) (Figure 17A),
specific endochitinase activity (8.31 U/g cell vs 5.42 U/g), specific chitobiosidase
activity (85.4 U/g cell vs 47.3 U/g cell), and specific β-N-acetylglucosaminidase
(103.48 U/g cell vs 35.23 U/g) (Figure 17B). The growth and chitinase activity
phenotypic differences are consistent to the above-mentioned physiological
characterization results. After 72 h incubation, the S. marcescens EPS was able to
produce 1.41 g/L 2,3-butanediol from 20 g/L crystal chitin, 3.7-fold improvement
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compared to that of S. marcescens Db11 (0.38 g/L), shown in Figure 17C.
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Figure 17 Cell growth (A), chitinase activities (B), production of 2,3-BD (C) using
the S. marcescens Db11 (black color) and the S. marcescens EPS strain (blue color)
under M9 medium supplemented with 1% yeast extract and 2% chitin at 30°C and
100 rpm.
The S. marcescens EPS showed generally better growth on chitin than the wild-type
strain and is able to produce 1.41 g/L 2,3-butanediol from 20 g/L crystal chitin due to
more efficiently utilizing chitin as a substrate. Compared to a previous report of
2,3-butanediol titer (1.13 g/L) from a S. marcescens chiR overexpression strain
(chiROE) (Yan et al. 2017), S. marcescens EPS is able to produce 2,3-butanediol titer
25% higher. In addition, the molar ration of 2,3-butanediol:acetic acid:lactic acid of S.
marcescens EPS (4.8:2.7:1) is higher than the S. marcescens chiROE strain (3:2.8:1)
because propagating cells under chitin medium is advantageous to provide selected
pressure for cells to induce better phenotypes, namely growth and metabolic changes.
4.3.6 Whole genome sequencing of the evolved strains
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Whole genome sequencing of the S. marcescens MPS and EPS genomes were
conducted and single nucleotide variations of the evolved strains compared to the
wild-type strain were listed in Table 6. Three SNVs were identified in S. marcescens
MPS genome and eight SNVs were identified in S. marcescens EPS genome
compared to the reference genome. The three SNVs of S. marcescens MPS are
transport proteins. The SNVs of S. marcescens EPS contain transport proteins, global
regulatory proteins, and pathway proteins. Two key mutations of the S. marcescens
EPS were identified to be responsible for the physiological changes: 1) one mutation
occurred at upstream of SMDB11_2700 gene, encoding a LysR-family regulatory
protein; 2) one mutation occurred in the coding sequence of SMDB11_1055,
encoding a fimbrial adhensin.

SMDB11_1055 locates downstream of a chaperone-usher fimbriae operon
(SMDB11_1052, encoding a putative fimbrial protein; SMDB11_1053, encoding a
putative fimbrial chaperone; SMDB11_1054, putative fimbrial usher protein; and
SMDB11_1055, a putative fimbrial adhensin). Through running protein sequence
analysis against other organisms, SMDB11_1055 sequence is highly conserved
among Serratia sp. and under the family of Enterobacteriaceae. Although the
functionality of SMDB11_1055 has yet been characterized, it is generally believed
that a chaperone-usher fibriae forms an outer membrane pore and secretes adhensin
protein (i.e. SMDB11_1055) as a tip for reaching out and targeting substrates. The
mutation of the putative fimbrial adhensin (SMDB11_1055) may affect S. marcescens
100

swarming motility phenotype and potentially increase the possibility of accessing to
the substrate. In other studies, S. marcescens fimbrial proteins have been
demonstrated essential for swarming motility toward its substrates. For instance,
overexpression flagellum dependent genes (i.e. FlhD, encoding the flagellar
expression master operon, and FliA, encoding an alternative sigma factor during
flagellar assembly) can facilitate greatly S. marcescens swarming and swimming to
kill against some fungal hyphae (Hover et al. 2016).

Table 6 Single nucleotide variations (SNVs) of the evolved strains compared to the
wild-type strain after whole genome sequencing.
Position

Mutation

Gene

Annotations

1121161

A→C

SMDB11_1055

Putative fimbrial adhensin

3667780

A→T

SMDB11_3454

unknown

1579431

C→T

SMDB11_1516

rnfC, electron transport complex protein

1121161

A→C

SMDB11_1055

Putative fimbrial adhensin

1579431

C→T

SMDB11_1516

rnfC, electron transport complex protein

1579454

C→G

SMDB11_1516

rnfC, electron transport complex protein

2713402

A→G

SMDB11_2558

fruA, fused fructose-specific PTS enzymes: IIB

S. marcescens MPS

S. marcescens EPS

component/IIC component
2861957

C→A

SMDB11_2700

Upstream of SMDB11_2700

2861957

C→A

SMDB11_2700

Upstream of SMDB11_2702

3667780

A→T

SMDB11_3454

Unknown

4366216

A→G

SMDB11_4092

glnA, glutamine synthetase

SMDB11_2700 encodes a LysR-family transcription regulator. Protein sequence
similarity analysis of SMDB11_2700 showed that it is 67% indentify compared to a
Yersinia pseudotuberculosis LysR-type transcription regulator RovM (Quade et al.
2011), , which controls gene transcription by attaching and changing DNA structures.
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The LysR family regulatory protein functions in variety of categories such as a local
regulator (i.e. chitinase secretion) and as a global regulator (i.e. quorum sensing)
(Maddocks and Oyston 2008). In terms of the phenotypic changes and genome
sequencing results, it is likely that SMDB11_2700 serves as a global regulatory
protein and the mutation occurred in the upstream region of the global regulatory
protein (SMDB11_2700) may affect a cascade effect of regulation in S. marcescens.
In

addition,

Serratia

sp.

quorum

sensing

systems

have

been

reported

directly/indirectly controlling various phenotypes including sliding/swarming motility,
production of chitinase, and butanediol fermentation (Van Houdt et al. 2007).

The mutation of SMDB11_2700 may also be responsible for 2,3-butanediol
overproduction. In general, the overproduction of 2,3-butanediol can be a result of
neutralize the acidic environment caused by the acidic end-products (e.g. acetic acid,
lactic acid and succinic acid). In both Serratia marcescens MG1 and Serratia
plymuthica RVH1, inactivation of the acylated homoserine lactones (AHL) synthase
encoding gene leads to a reduced production of 2,3-butanediol and to a continued
production of acidic end-products at the end of the exponential and throughout the
stationary growth phase, which in turn leads to early growth arrest in the presence of
fermentable sugars (Johansen et al. 1975; Magee and Kosarie 1987). Thus,
SMDB11_2700 may play a key role in quorum sensing systems in Serratia
marcescens Db11 that the mutation at the promoter region of SMDB11_2700 may
account for increased chitinase activities and overproduction of 2,3-butanediol.
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4.4 Conclusion
The newly evolved strain S. marcescens EPS exhibits increased chitinase activities,
decreased secreted proteins, increased cell yield on chitin, and metabolic end-products
changes compared to the wild-type strain. The EPS strain was capable of producing
1.41 g/L 2,3-butanediol from 2% crystal chitin, a 3.7-fold improvement compared to
that of the wild-type strain. In addition, the molar ratio of 2,3-butanediol to
byproducts is improved from the wild-type strain (2.5:2.5:1) to the EPS strain
(4.8:2.7:1). Key mutations occurred in two gene products (SMDB11_2700 and
SMDB11_1516) that encode a LysR-family regulator and a fimbrial adhensin may be
accounting for the increased chitinase activities and overproduction of 2,3-butanediol.
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Chapter 5 Metabolite profile of a chitinolytic bacterium Serratia marcescens
using a transcriptomics-based genome-scale metabolic model

Importance of this part of work:
Since metabolic network of S. marcescens is complex and undertermined,
genome-based constraint metabolic model is a powerful tool to understand metabolic
profile of S. marcescens in a systematic manner. After construction of a computational
model of S. marcescens, it can be readily deployed for predicting genetic targets to
improve chemical production. Prior to my dissertation, no genome-scale metabolic
model of S. marcescens is developed and intracellular metabolic profile remains
uncharacterized.
The conclusions and fundamental results derived from this part of work:
We constructed a constraint-based genome-scale metabolic model (iSR929) including
929 genes, 1185 reactions and 1164 metabolites based on genomic annotation of S.
marcescens Db11. The model performed reasonably comparing simulated cell growth
and metabolites secretion with experimental acquisition, and 138 essential genes were
predicted. The model iSR929 was curated by integrating mRNA-seq data of S.
marcescens growth at three carbon sources (glucose, N-acetylglucosamine, and
glycerol). Major metabolic differences of utilizing the three carbon sources rely on the
utilization of citric acid cycle. Under growth of N-acetylglucosamine, S. marcescens
exhibits high activity of pentose phosphate pathway and nucleotide synthesis but low
activity

of

citric

acid

cycle.

Three

target

chemicals

(2,3-butanediol,

N-acetylneuraminic acid, and n-butanol) can be implemented for metabolic
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engineering applications by S. marcescens and their pathway gene activities were
given.
5.1 Introduction
With recent advances in genomics, omics, and bioprospecting, the breadth of novel
and interesting biochemistry continues to explore. In terms of the large amount of data
and resources available, one current challenge is to conduct elaborate analysis to
translate raw data into knowledge that provides functional insight. Genome-scale
metabolic modeling (GSMM) facilitates metabolic analysis and dovetails well with
genomic and biochemical information. While GSMM have advantages of being easily
accessible and providing gene-protein-reaction level specificity, there are still a
number of limitations (Yan and Fong 2017a). For instance, because metabolic
networks are underdetermined, there exist alternative flux states with different
pathway usage that produce indistinguishable cellular phenotypes. This is an
underlying problem with GSMM that impacts multiple portfolios of these models
including the initial reconstruction (association of specific reactions with annotated
genes) and running simulation predictions (presence of alternate optimal solutions). In
this study, we consider the metabolically under-characterized chitinolytic bacterium,
Serratia marcescens, and utilize mRNA-seq data to run computational simulation to
gain a better understanding of its metabolic network.

S. marcescens is unique among enteric bacteria in many aspects. It secretes
extracellular DNase, gelatinase, lipase, several proteases, a red pigment (prodigiosin),
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chitinases and a chitin binding protein. It is believed to be one of the most efficient
chitin-degrading bacteria in the environment (Monreal and Reese 1969; Vaaje-Kolstad
et al. 2013). S. marcescens Db11 contains ten chitinase-related proteins (Yan et al.
2017). Numerous studies recently have investigated on various facets of the S.
marcescens chitinolytic mechanisms (Hamilton et al. 2014; Kim et al. 1998; Mekasha
et al. 2017; Vaikuntapu et al. 2016). Due to the high efficiency of processing chitin
materials, several individual S. marcescens chitinase genes have been cloned into
those model bacterial species (e.g. Escherichia coli) (Brurberg et al. 1995; Suzuki et
al. 2002; Tuveng et al. 2017). The cloned enzymes were isolated in good
concentrations but failed to show similar level of chitinolytic activity as is found in S.
marcescens. This may be due to the complexity of chitin degradation systems that are
not defined by a few genes but is an interwined network of various enzymes
(Hamilton et al. 2014; Suzuki et al. 2016; Suzuki et al. 2001; Yan et al. 2017). Hence,
it is suggested that the best way to fully utilize the chitinolytic capabilities of S.
marcescens may be developing S. marcescens rather than moving its chitinases into
other systems by heterologous expression.

The ability to produce chemicals of industrial importance using inexpensive
chitinolytic biomass has been a recent focus (Dahiya et al. 2006; Yan and Chen 2015;
Yan and Fong 2015). Microbial conversion of chitin waste into value-added chemicals,
known as consolidated bioprocessing (CBP), can help solve potentially social
problems and make economic benifits. For S. marcescens Db11, the sequencing of its
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genome in 2014 sets up a milestone towards understanding this industrially applicable
microbe (Iguchi et al. 2014). It also showed success towards utilization of crystal
chitin material (Yan et al. 2017). The initial developments in the characterization of S.
marcescens are listed in Table 7. This is a promising development toward making use
of the chitinolytic capabilities of this microbe to reduce the complex multi-step
bioprocess to CBP.
Table 7 Significant milestone for S. marcescens research and characterization.
Year

Development

Group

Citation

1980

Genus Constructed

FlyG and Xanthopoulos

(Flyg

et

al. 1980)
1991-1999

Physical Characterization

Brurberg et al.; Suzuki et

(Brurberg

al.

et

al.

1995;
Watanabe
et

al.

1997)
1998

Shrimp/crab

chitin

degradation

study

to

produce

Kim et al.

N-acetylglucosamine
2014

(Kim

et

al. 1998)

Genome sequenced

Hayashi et al.

(Iguchi et
al. 2014)

2017

Development of genetic modification method

Yan and Fong

(Yan

et

al. 2017)

With the availability of genomic sequences, it has become possible to use genome
annotation and biochemical information to reconstruct cellular metabolic networks.
Whole genome sequence and annotation of S. marcescens Db11 (Iguchi et al. 2014)
was used to build GSMMs. The reaction database used for drafting the model includes
but is not limited to sources such as KEGG (Kanehisa and Goto 2000), BiGG
(Schellenberger et al. 2010), rBioNet (Thorleifsson and Thiele 2011), UniProt
(Consortium 2008) and MBRole (Chagoyen and Pazos 2011).
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The process of compiling biochemical reactions leads to the formulation of a draft
model of S. marcescens, however, at this stage the represented metabolic network
inevitably is incomplete and has numerous metabolic gaps. Thus, any initial model
that is generated undergoes a gap-filling step. For our models, gap-filling was initially
performed using a computational gap-filling algorithm (Brooks et al. 2012; Gowen
and Fong 2010; Roberts et al. 2010; Vanee et al. 2014; Vanee et al. 2010). After
gap-filling, simulations can be run by specifying input constraints such as substrate
uptake rate, metabolites production rate, or oxygen uptake rate.

Once the model provides a framework to understand the cellular process, it can be
used to find target for focused metabolic engineering to yield products of
biotechnological value (Roberts et al. 2010). The most widely-used algorithms for
design and simulation of genome-scale constraint-based metabolic models such as
OptKnock (Burgard et al. 2003), OptForce (Ranganathan et al. 2010), EMiLio (Yang
et al. 2011) are based on flux distribution and flow through chemically balanced
reactions (FBA). FBA uses linear programming to optimize the objective function as
follows:
Maximize: Z
Subject to: Sv = 0,
ai ≤ vi ≤ bi for all reactions i,
where, Z is the flux through objective function (biomass production and production
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optimization), S: stoichiometry of the reactions represented as matrix, v is reaction
flux vector, ai and bi are the constraints placed on the flux vi of the reaction i (Palsson
2015).

Even after compiling biochemical information and gap-filling a model, there often are
discrepancies between the computational model results and in vivo states due to
difficulty in identifying using only computational approaches. A second step of model
curation can be done by integrating high-throughput omics data with the framework
of a computational model to realize “content in context” (Palsson 2015). The
high-throughput omics data can be obtained by multi-scale high-throughput
sequencing techniques such as transcriptomics, proteomics and metabolomics. This
step reconciles computational predictions with experimental data and thereby helps
enhance the characterization of the metabolic activity.

A variety of applications using incorporating omics data with the framework of
GSMM have been reported for many prokaryotic microbes to more closely match
cellular processes (Gowen and Fong 2010; Vanee et al. 2017; Vanee et al. 2014). Once
the model closely resembles a biological system, it can be optimized for defined
objective function. This objective function may range from production of biomass to
production of a chemical target. Following the in silico optimization of yields the
computational design may eventually be replicated for applications in industry,
therapeutics or health-related predictions.
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In this study, we aim at understanding metabolite profile of S. marcescens Db11 and
its chitinolytic regulation systems. Therefore, a genome-scale metabolic model,
iSR929, consisting of 1185 reactions, 1164 metabolites and 929 genes was
constructed. The constructed model was analyzed for 1) accuracy compared to
experimental results; 2) prediction of essential genes; 3) metabolic differences under
different carbon growth. We also proposed three potential chemical compounds for
metabolic engineering implementation.
5.2 Materials and Methods
5.2.1 Microbial growth
The Serratia marcescens Db11 was purchased from the Caenorhabditis Genetics
Center (Twin City, USA http://www.cbs.umn.edu/CGC) (Flyg et al. 1980). The S.
marcescens strain was grown in a M9 medium or LB medium containing various
carbon sources. Carbon sources in the M9 medium were used at the following
concentration: glucose, 5 g/L; N-acetylglucosamine, 5 g/L; glycerol 5%. S.
marcescens pre-culture was performed in LB medium at 30°C and 250 rpm for
overnight. Then, 2.5% seed culture was inoculated at 50 mL M9 minimum medium
with a 250 mL Erlenmeyer flask at 30°C, initial pH 7.5, and 220 rpm. Stock cultures
of S. marcescens were maintained at -80°C in a 26% (v/v) glycerol.
5.2.2 Construction of the model iSR929
The core of the stoichiometric metabolic model is a list of metabolic reactions
occurring in S. marcescens, compiled based on evidence from genome annotations
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and experimental observations. An initial list of biochemical reactions was assembled
based on predicted enzymatic functions in the genomic annotations available from
IMG, UniProt, and KEGG (Consortium 2008; Kanehisa and Goto 2000; Markowitz et
al. 2008). Specifically, Enzyme Commission (EC) numbers of annotated S.
marcescens genes were used to select reactions from a set of database reactions.
5.2.3 Linear programming for flux balance analysis
In-house python scripts were used to run the FBA simulations using the linear
programming algorithm as shown in the introduction.
5.2.4 Objective function of FBA: biomass equation
The draft model aims at the growth optimization and the best estimates used in
metabolic modeling scenario are biomass equation, which was designed by slightly
manipulating the biomass equations from closely related species and available
published information about S. marcescens growth conditions (Yan et al. 2017). The
box below shows the biomass equation used for the simulation of all the version of
the model.
5.2.5 Biomass Equation:
0.05 5mthf + 5.0E-5 accoa + 0.488 ala_L + 0.0010 amp + 0.281 arg_L + 0.229
asn_L + 0.229 asp_L + 45.7318 atp + 1.29E-4 clpn_SM + 6.0E-6 coa + 0.126 ctp +
0.087 cys_L + 0.0247 datp + 0.0254 dctp + 0.0254 dgtp + 0.0247 dttp + 1.0E-5 fad +
0.25 gln_L + 0.25 glu_L + 0.582 gly + 0.154 glycogen + 0.203 gtp + 45.5608 h2o +
0.09 his_L + 0.276 ile_L + 0.428 leu_L + 0.0084 lps_SM + 0.326 lys_L + 0.146
met_L + 0.00215 nad + 5.0E-5 nadh + 1.3E-4 nadp + 4.0E-4 nadph + 0.001935
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pe_SM + 0.0276 peptido_SM + 4.64E-4 pg_SM + 0.176 phe_L + 0.21 pro_L +
5.2E-5 ps_SM + 0.035 ptrc + 0.205 ser_L + 0.0070 spmd + 3.0E-6 succoa + 0.241
thr_L + 0.054 trp_L + 0.131 tyr_L + 0.0030 udpg + 0.136 utp + 0.402 val_L -->
45.5608 adp + 45.56035 h + 45.5628 pi + 0.7302 ppi
5.2.6 Gap analysis
The draft model consists of the list of reactions however there are patches in the
network that obstruct continuous flow of the flux through the pathway. These links
are filled in by using the reaction databank and suggesting the list of reactions
required to complete the network. FBA-GAP is used to suggest the connection
nodes/reactions that are missing. The use and application of this framework have been
described in past by Roberts et al., Vanee et al., and Gowen and Fong (Gowen and
Fong 2010; Roberts et al. 2010; Vanee et al. 2014). FBA-GAP takes a draft model and
biomass reaction and uses distances in the reaction network and mathematical
optimization to produce a list of metabolites that are necessary for biomass production
but cannot be produced or consumed by the cell. Reactions producing and consuming
this list of metabolites are obtained from a reference database. These potentially
gap-filling reactions were manually checked for relevant evidence such an associated
protein/enzyme characterized or gene annotations. On detecting the specific evidence,
these reaction additions to the model were accepted. The process is repeated until a
positive biomass flux value is obtained.
5.2.7 Essentiality
Constraint-based models can be analyzed by FBA to make comprehensive in silico
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gene essentiality predictions (Oh et al. 2007). For each gene in the model, that gene is
assumed to be deleted or nonfunctional. Then, using the GPR relationships, the effect
of the in silico gene knockout on reaction activities is assessed. If the gene is crucial
to the activity of a reaction in the model, then that reaction is constrained to have zero
flux to simulate the effect of the gene deletion. Finally, the model with new constraint
is analyzed by FBA, maximizing the growth objective for batch growth on glucose. If
the maximum flux on the biomass reaction is zero, then the deleted gene is predicted
to be essential. If the maximum flux on the biomass reaction is greater than zero, the
deleted gene is predicted to be nonessential. All constraints are reset to their default
values, and the process is repeated for the next gene in the model.
5.2.8 mRNA sequencing
The total RNA of S. marcescens Db11 was isolated using mid-log phase cell cultures
by QIAGEN (Venlo, Netherlands) RNA protect reagent in combination with the
QIAGEN (Venlo, Netherlands) RNeasy Mini kit. The mRNA was isolated, enriched,
and reverse transcribed into cDNA. The resulting cDNA was sequenced by a
pair-ended reads using Illumina Hiseq 2500 (San Diego, CA). An average insert size
of 500 bp was created and draft mRNA-Seq data were generated. CLC Genomics
Workbench version 10 (QIAGEN, Venlo, Netherlands) and FASTQC were applied to
trim reads for quality sequence data. The S. marcescens Db11 genome (GeneBank:
HG326223) was used as a reference. Each mRNA sample was tested with two runs.
The gene expression level was calculated by normalizing each gene‟s reads per
kilobase per million mapped sequence reads (RPKM) to overall gene numbers.
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5.2.9 Measurement of cell density
The measurement of S. marcescens strains culture density was generally quantified at
OD600 using a Biomate3 UV/VIS spectrophotometer (Thermo Fisher Scientific,
Waltham, MA). The growth of S. marcescens strains on crystal chitin and colloidal
chitin was measured by testing cytoplasmic protein content (Yan et al. 2017). The
concentration factor of the overall protein content to the dry cell weight (DCW) was
DCW (g/L) = 1.20 ±0.03 × protein (g/L).
5.2.10 Quantification of secreted metabolites
The concentration of N-acetylglucosamine, glucose, glycerol and all by-products
(acetic acid, succinic acid, 2,3-butanediol, and ethanol) were analyzed by an Ultimate
3000 HPLC (Dionex, Sunnyvale, CA), equipped with a Bio-Rad Aminex HPX-87H
column (Hercules, CA), a UV detector (199 nm) (Dionex, Sunnyvale, CA), and a
refractive index detector (Shodex, Japan). The condition was run with 5 mM H2SO4
at 0.6 mL/min and 55°C.
5.2.11 Integration of gene expression data with genome-scale reconstruction
The integration of mRNA-seq data with the iSR929 model was analyzed using the
method described by (Shlomi et al. 2008), in which the Boolean mapping from genes
to reactions in iSR929 was used to translate gene expression data into predicted
reaction activity states. Based on the relative gene expression levels calculated from
RNAseq data, gene expression states were determined according to the following
rules:
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gene state =

-1

g=0

0

0<g≤γ

1

γ<g

Where g is the normalized expression level as determined by RNAseq (e.g. RPKM)
and γ is the threshold above which a gene is called „on‟. The resulting gene states
were then mapped using the gene-protein-reaction (GPR) relationships in iSR929 to
generate lists of reactions predicted to be high or low, as determined by a flux with an
absolute value higher than a given reaction threshold epsilon (ε). MILP was then used
as in to find a network flux state that maximizes agreement with the expression based
reaction activities, where a reaction was confirmed to be on when its flux was greater
than or equal to a given reaction threshold ε (Shlomi et al. 2008). This method is
distinct from traditional FBA because it is able to predict flux state for the network
independent of a biomass objective function, which may be valuable in cases where
cells may not have been evolved towards a maximum growth rate and, therefore, are
not operating optimally.
5.2.12 Determination of intracellular citric acid and isocitric acid concentration
Intracellular levels of citric acid and isocitric acid were evaluated using a citrate assay
kit (Sigma-Aldrich, St. Louis, MO) and an isocitric acid kit (BioVision, Milpitas, CA),
respectively. In brief, S. marcescens cells growth were ceased at 2.5 h (OD600 about
0.4) and were collected by centrifuging at 4°C, 15,000 rpm, and 10 min. Citric acid
and isocitric acid assays were conducted according to the manual‟s instruction. 10 μL
supernatant samples were added in a total volume of 100μL reaction. Citric acid and
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isocitric acid concentrations were determined at 570 nm and 450 nm by a VERSAmax
microplate reader (Molecular Devices, Sunnyvale, CA), respectively.
5.3 Results and discussion
5.3.1 Construction of S. marcescens GSMM
Based upon genomic and available physiological evidence, a genome-scale
constraint-based metabolic model for S. marcescens, hereafter denoted iSR929, was
constructed. iSR929 contains 1185 reactions representing the function of 929 genes
and 1164 metabolites (see Table 8). Among the 1100 gene associated reactions of the
total 1185 reactions, there are 795 reactions that are associated with only one reaction
and there are 305 reactions associated with more than one enzyme, meaning either
isozymes or enzyme complexes. Of the 1164 metabolites, 1099 metabolites are
intracellular, 43 metabolites are extracellular, and 22 metabolites are boundary.
Furthermore, we added chitobiose degradation reactions to the model based upon the
annotation and experimental evidence (EC 3.2.1.52, SMDB11_0477, SMDB11_1190
SMDB11_1542 and SMDB11_4602).
Table 8 Overview of genome-scale constraint-based model of S. marcescens iSR929.
Serratia marcescens
Genome size
ORFs
Included genes
Reactions associated with only 1 gene
Reactions associated with more than 1 gene
Reactions with gene associated
Intracellular metabolites
Extracellular metabolites
Boundary metabolites

5.11 Mb
4832
929
795
305
1185
1099
43
22
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The breakdown of iSR929 by functional categories is represented in Figure 18. The
amino acid metabolism forms the largest of these, with 253 reactions. Experimentally,
S. marcescens appears to have the capacity to synthesize all 20 amino acids (Yan et al.
2017), and iSR929 reflects this. Other large groups of reactions include subsystems
related to carbohydrate metabolism (glycolysis, pentose phosphate pathway, pyruvate
metabolism, and citric acid cycle), cofactor and vitamin metabolism (nicotinate and
nicotinamide metabolism, folate biosynthesis, and prophyrin and chlorophyll
metabolism) and nucleotide metabolism (including reactions related to purine and
pyrimidine synthesis). The model also includes reactions relating to the synthesis of
lipids, including fatty acid, glyceropospholipid, and glycerolipid metabolism.

Figure 16 Reactions by functional category with number of reactions in model iSR929.

To test the predictions of the iSR929 model, we simulated growth of S. marcescens by
applying FBA, assuming minimal media conditions with one of three possible carbon
sources (glucose, N-acetylglucosamine, or glycerol). We then compared model
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predictions to experimentally observed growth rates and fermentation product
secretion profiles of S. marcescens grown in batch culture. In addition to the carbon
source, the in silico minimal medium used for simulations contained water (H2O),
ammonia (NH4), sulfate (SO4), phosphate (pi), calcium (Ca2), ferrous iron (Fe3),
hydrogen sulfide (H2S), potassium (K), magnesium (Mg2), pantothenate (pnto-r), and
nicotinate D-ribonucleotide (nmn). In each of the three simulation conditions (glucose,
N-acetylglucosamine, and glycerol), we applied progressively more experimentally
determined constraints associated with by-product secretion rates to determine how
closely the computational results could match the experimental results given the
possibility of alternate optimal solutions. Figure 19 shows the simulation results for
each growth condition when exchange rates for the carbon sources, acetic acid, and
succinic acid were constrained to match experimental observations.
5.3.2 Computational prediction of gene knockout targets
We conducted comprehensive in silico single gene deletions with iSR929, using
glucose as a carbon source and the other minimal media components (as described
above), and constraining glucose uptake to its experimentally observed value for
batch growth (10.53 mmol/gDW/h). Gene essentiality results are shown in Figure 18.
In the case of growth on glucose, we found that 138 (14.9%) of S. marcescens genes
included in iSR929 were predicted to be essential. We also examined which
subsystems of iSR929 contained the highest percentage of essential reactions
(„vulnerable subsystems‟). Among the most vulnerable subsystems are the amino acid
metabolism, nucleotide metabolism, lipid metabolism, and metabolism of cofactors
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and vitamins.
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Figure 17 Comparison of model predictions to experimental values. S. marcescens iSR929
was used to simulate growth in multiple conditions. Actual and predicted flux rates are
shown and predicted fermentation product production rates are shown as ranges as
determined by flux variability analysis. For each simulation, the boundary fluxes for growth
rate, GlcNAc uptake rate, growth rate and glycerol uptake rate were constrained to match the
measured fluxes during (A) glucose, (B) N-acetylglucosamine, (C) glycerol conditions,
respectively.
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5.3.3 mRNA sequencing of S. marcescens under growth of different carbon
sources
mRNA samples of S. marcescens Db11 were prepared from cell growth on six
conditions: M9 medium with glucose, N-acetylglucosamine, or glycerol, plain LB
medium, LB medium with crystal chitin or colloidal chitin. The reason for choosing
these conditions are: 1) there is a general catabolite repression when S. marcecens
growing in glucose or N-acetyglucosamine; 2) the three carbon sources can help
identify S. marcescens active metabolic fluxes and metabolic differences. Overall, the
average coverage per gene (4831 genes) of each sample‟s mRNA-seq implies a
high-depth-coverage (generally 250).
5.3.4 Integration of mRNA-seq data into the GSMM
The integration of mRNA-seq data of S. marcescens at M9 medium with glucose,
N-acetylglucosamine, and glycerol was deployed in the iSR929 based on the mixed
integer linear programming algorithm approach (Shlomi et al. 2008). In order to setup
a cutoff value of gamma, we initially categorized gene expression level into 58 cutoffs
based on an exponential of 1.2, and a distribution of gene numbers against each gene
expression level range was then plotted, a representative figure of M9 glucose
condition was shown in Figure S7. The lower bound is 3.00, which precludes around
10% of the total number of genomic genes across all the conditions, and the upper
bound is 850.56, which circled around 5% of the total number of genomic genes
across all the conditions, shown in Table S12.
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The model of S. marcescens was then run a simulation by integrating the
transcriptomics data using a linear programming under the three conditions separately,
where a reaction flux is 1000 if the corresponding gene‟s RPKM is over 850.56 and a
reaction flux is 0 if the gene‟s RPKM is less than 3.00. A summary of the active
metabolic reactions under three carbon sources were categorized in different
metabolic pathway modules (Table 9). When growing at glucose condition, there are
150 active reactions. Among these 150 reactions, the majority is in carbohydrate
metabolism (42), amino acid metabolism (38), lipid metabolism (12), cofactor
metabolism

(12),

and

nucleic

acid

metabolism

(6).

When

growing

at

N-acetylglucosamine condition, there are 132 active reactions. Among these 132
active reactions, the majority is in carbohydrate metabolism (39), amino acid
metabolism (28), lipid metabolism (6), cofactor metabolism (9), and nucleic acid
metabolism (10). When growing at glycerol condition, there are 146 active reactions.
Among these 146 active reactions, the majority is in carbohydrate metabolism (44),
amino acid metabolism (41), lipid metabolism (6), cofactor metabolism (8), and
nucleic acid metabolism (7).

Table 9 Numbers of active metabolic reactions in iSR929 by running simulation
based on the transcriptomic data.
glucose

N-acetylglucosamine

glycerol

Butanoate metabolism

4

4

2

Citrate cycle (TCA cycle)

13

0

10

Glycolysis / Gluconeogenesis

7

10

9

Glyoxylate and dicarboxylate metabolism

3

2

1

Pentose and glucuronate interconversions

0

2

2

Pentose phosphate pathway

6

14

11

Carbohydrate metabolism
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Propanoate metabolism

1

0

1

Pyruvate metabolism

6

5

6

Amino sugar and nucleotide sugar metabolism

2

2

2

Alanine, aspartate and glutamate metabolism

4

3

5

Arginine and proline metabolism

9

10

23

beta-Alanine metabolism

0

0

2

Glutathione metabolism

2

2

0

Taurine and hypotaurine metabolism

2

2

2

Valine, leucine and isoleucine biosynthesis

5

2

2

Glycine, serine and threonine metabolism

16

9

7

Purine metabolism

6

1

6

Pyrimidine metabolism

0

9

1

Fatty acid degradation

2

0

0

Glycerophospholipid metabolism

8

4

4

alpha-Linolenic acid metabolism

2

2

2

Oxidative phosphorylation

3

3

4

Nitrogen metabolism

0

0

1

Pantothenate and CoA biosynthesis

3

1

0

Riboflavin metabolism

2

2

2

One carbon pool by folate

6

6

6

Monobactam biosynthesis

2

2

2

Streptomycin biosynthesis

2

2

2

Benzoate degradation

1

0

0

Nitrotoluene degradation

2

2

2

Transportation

31

31

29

Total

150

132

146

Amino acid metabolism

Nucleic acid metabolism

Lipid metabolism

Energy metabolism

Metabolism of cofactors and vitamins

Biosynthesis of other secondary metabolites

Xenobiotics metabolism

The main active pathways for the metabolism of glucose as a sole carbon source were
shown in Figure 20A. The glucose trespasses the cell membrane and flows through
glycolysis and pentose phosphate pathway to yield pyruvate. Then, the main flux goes
to citrate cycle, butanonate metabolism (yielding 2,3-butanediol), amino acid
synthesis, lipoylprotein synthesis, and pyruvate metabolism (yielding ethanol, formate,
lactate, and acetate).
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The main active pathway for the metabolism of N-acetylglucosamine as a sole carbon
source was shown in Figure 20B. For the metabolism of N-acetylglucosamine, the
carbon source was hypothesized first to be phosphorylated by a membrane type II
phosphotransferase (SMDB11_0473). The SMDB11_0473 gene expression level
under N-acetylglucosamine condition (RPKM 967.20) was 12.09- and 5.13-fold than
those under glucose (RPKM 80.23) and glycerol (RPKM 188.36) conditions,
respectively. The carbon flows through glycolysis metabolism from fructose-6P to
regenerate glucose-6P. The glucose-6P flows to the pentose phosphate pathway to
yield pyruvate. Then, the majority carbon was distributed into purine and pyrimidine
metabolism, butanonate metabolism (secreted 2,3-butanediol as an end-product),
pyruvate metabolism (yielding ethanol, formate, lactate, and acetate as end-products),
amino acid synthesis, and lipoylprotein synthesis.

The main active pathways for the metabolism of glycerol as a sole carbon source were
shown in Figure 20C. Glycerol metabolism is thought to convert to pyruvate by three
steps: a membrane facilitator protein (SMDB11_4021), an ATP-dependent glycerol
kinase (SMDB11_4022), and a glycerol-3-phosphate dehydrogenase (SMDB11_3886)
(Murarka et al. 2008). The SMDB11_4021 expression level of glycerol condition
(RPKM 1772.81) is 89.5- and 70.8-fold higher than those of glucose and
N-acetylglucosamine condition. The SMDB11_4022 expression level of glycerol
condition (RPKM 4535.25) is 76.6- and 63.6-fold higher than those of glucose
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(RPKM 59.20) and N-acetylglucosamine (RPKM 71.28) condition. The gene
expression level of SMDB11_3886 of glycerol condition (RPKM 1683.89) is 59.9and 54.7-fold higher than those of glucose (RPKM 28.10) and N-acetylglucosamine
(RPKM 30.78) condition. The main active flux goes to glycolysis, pentose phosphate
pathway, amino acid synthesis, and pyruvate metabolism.
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Figure 18 Summary of active pathways after running Ruppin algorithm using model
iSR929 at each growth conditions. (A) M9 glucose; (B) M9 N-acetylglucosamine; (C)
M9 glycerol. The most active metabolism pathways were marked in red.
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5.3.5

S.

marcescens

exhibits

lower

activity

in

TCA

cycle

under

N-acetylglucosamine as a sole carbon source
According to the model prediction, the main metabolic differences among the three
carbon sources imply the utilization of TCA cycles. When glucose is the sole carbon
source, the citrate cycle is fully active; under glycerol condition, the citrate cycle is
partially active (R00361_smac, R01082_smac, R02164_smac, R00405_smac,
R02570_smac, and R00621_smac); while under N-acetylglucosamine condition, the
TCA cycle is not active. Intracellular citric acid and isocitric acid level can be
indicators of activities of the TCA cycles and have been examined before. The fact
that intracellular citric acid and isocitric acid concentration under growth of
N-acetylglucosamine were lower than those under growth of glucose and glycerol
supports the model prediction results (Figure 21A and Figure 21B). When
N-acetylglucosamine is the sole carbon source, S. marcescens tends to utilize
intermediates (e.g. oxaloacetate, fumarate, and 2-oxoglutarate) as precursors for
amino acids synthesis. At the meantime, the majority carbon source flows for
synthesis of nucleotides (e.g. purine and pyrimidine) from the ribose-5P generated
from the pentose phosphate pathways since N-acetylglucosamine is an ideal carbon
source for amino-sugar and nucleotides synthesis (e.g. C:N ratio 8:1).
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Figure 19 Intracellular citric acid (A) and isocitric acid (B) concentrations of S.
marcescens Db11 grown at glucose, N-acetylglucsamine, and glycerol.
5.3.6 Insights of metabolic engineering application of S. marcescens from the
model iSR929
Recently, developing the chitinolytic bacterium, S. marcescens as a workhorse to
directly utilize chitin as carbon source to produce value-added chemicals is an
interesting topic. The process includes directly degrading of chitin yielding
fermentable

sugar

(N-acetylglucosamine),

subsequently

conversion

of

N-acetylglucosamine producing target chemicals. Based on the aforementioned
experimental observation and computational simulation results, we target three
chemical compounds (2,3-butanediol, n-butanol, and N-acetylneuraminic acid) and
illustrate possible routes for deploying the pathway implementation.

S. marcescens Db11 is a native 2,3-butanediol producer. Direct production of
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2,3-butanediol from crystal chitin by S. marcescens Db11 have been experimentally
validated and the model iSR929 reflected it across all conditions (Yan et al. 2017).
The proposed pathways of 2,3-butanediol and the corresponding annotated genes
were shown in Figure 22A. Unlike other reported S. marcescens 2,3-butanediol
producers (Bai et al. 2015; Zhang et al. 2016), S. marcescens Db11 harbors only two
2,3-butanediol dehydrogenases (meso and (2S,3S)) and relatively small amount of
(2S,3S)-2,3-butanediol

dehydrogenase

was

expressed

compared

to

the

meso-2,3-butanediol dehydrogenase, indicating meso-2,3-butanediol is the major
product.

The second target of interest is a biofuel chemical, n-butanol. The iSR929
incorporates most of the reactions present in the butanoate metabolism. Besides the
2,3-butanediol synthetic pathway, two active reactions (R01171 and R01975) were
found under glucose conditions and one active reactions (R01171) was observed
under glycerol conditions. One consideration of the computational simulation is that
butanoate is a product of a secondary pathway and S. marcescens may not
overproduce this pathway associated genes. Thus, it is not necessarily surprising that
growth simulations with no genetic designs incorporated may not show flux through
secondary pathways. The proposed n-butanol synthetic pathway and their gene
expression levels in S. marcescens Db11 were listed in Figure 22B. The annotated
pathway toward n-butanol is partially completed but missing the last step enzyme (EC
1.2.1.10 alcohol dehydrogenase). A bifunctional alcohol dehydrogenase (AdhE2) from
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Clostridium acetobutylicum is reported with highest activity of alcohol production
(Deng and Fong 2011b) and can be an appropriate enzyme candidate for heterologous
expression in S. marcescens. Furthermore, from the mRNA level of the n-butanol
pathway genes, it is also unclear that the pathway is readily active when
overexpression of adhE2 gene in S. marcescens. For instance, the first step enzyme
(SMDB11_4664 acetoacetate-CoA transferase) mRNA level is relative low and
up-regulation of this gene mRNA level may also be needed.

The third chemical target of interest is N-acetylneuraminic acid. The S. marcescens
Db11 doesn‟t harbor an endogenous pathway for N-acetylneuraminic acid synthesis.
Compared

to

the

glucose-based

N-acetylneuraminic

acid

synthesis,

N-acetylglucsaomine/chitin as a carbon sources are advantageous: 1) it requires only
two steps for N-acetylneuraminic acid synthesis from N-acetylglucosamine compared
to glucose; 2) no additional nitrogen source is needed (Steiger et al. 2011; Yan and
Fong 2015). The growth of S. marcescens under N-acetylglucosamine condition
showed that the first-step enzyme (SMDB11_0473) of N-acetylglucosamine uptake is
highly active (RPKM 967.20). The SMDB11_0473 (N-acetylglucosamine transferase)
is a reversible N-acetylglucosamine transferase that can generate intracellular
N-acetylglucosamine

(Kang

et

al.

2012),

shown

in

Figure

22C.

The

N-acetylglucosamine can be further converted to N-acetylneuraminic acid by
additional two steps (N-acetylmannosamine 2-epimerase and N-acetylneuraminic acid
synthase) (Kang et al. 2012). Further overproduction of N-acetylneuraminic acid may
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require carefully balance the heterogeous pathways since heterologous expression
may generate metabolic burden.

Figure 20 Proposed pathways for potential chemicals of interest production as metabolic
engineering targets by S. marcescens and their corresponding gene expression values
obtained from mRNA-Seq data
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5.4 Conclusion
In this study, we constructed a S. marcescens genome-scale metabolic model iSR929.
The model contains 929 genes, 1185 reactions and 1164 metabolites. The iSR929
model is able to provide reasonable predictions that match with experimental
acquisition. Integrating transcriptomics data of different carbon sources (e.g. glucose,
N-acetylglucosamine and glycerol) to the model reveals major metabolic difference is
the utilization of TCA cycles. Three biochemicals (2,3-butanediol, n-butanol, and
N-acetylneuraminic acid) were proposed as promising metabolic engineering
implementation targets and pathway activities were given. Overall, our results show
metabolite profile of S. marcescens and the model iSR929 can be applied to
identifying genetic targets for chemical overproduction.
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Chapter 6 Conclusion

6.1 Summary
Serratia marcescens is a chitinolytic bacterium. Its most important characteristics
were able to produce kinds of enzymes especially chitinases. The chitinases of S.
marcescens were identified to have broad manners of acting on crystalline chitin. The
highly efficient chitinases can be used in various industries especially the chemical
production industry, because chitinases can degrade chitin to sugars which are used by
other microorganism to produce chemicals. Although there are some other bacteria
which are able to produce chitinases, S. marcescens is much easier to be cultured and
cheaper in the industry. Thus, the study of S. marcescens is of great importance. My
dissertation work aims at characterizing a S. marcescens strain and developing it as a
platform strain for chemical production from chitin.

Although S. marcescens chitinases have been characterized, the S. marcescens
chitinolytic regulatory mechanisms remain unclear. ChiR is the only regulator protein
that is believed to be essential for chitinase production, however, prior to this
dissertation, its functionality of regulating chitinases is still not known. By generating
a ChiR deletion strain and a ChiR overexpression strain allows me to characterize S.
marcescens physiological changes of cell growth, chitinase production and activities.
My results showed that ChiR is a positive regulator in controlling all chitinase
transcription in S. marcescens. The chiROE strain produced 1.13 ± 0.08 g/L
2,3-butanediol from 2% crystal chitin, a 2.83-fold improvement from the wild-type
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strain, indicating ChiR is an important and useful genetic engineering target for
enhancing chitin utilization in S. marcescens.

Since I have demonstrated S. marcescens can grow on chitin and produce
2,3-butanediol from crystal chitin, I further exploit possibilities of producing novel
chemicals (e.g. N-acetylneuraminic acid) using S. marcescens. Chitin may be an ideal
substrate for producing N-acetylneuraminic acid since no additional nitrogen source is
needed. Prior to this study, production of N-acetylneuraminic acid in S. marcescens
has not been reported yet. In order to introduce an exogenous pathway for production
of

N-acetylneuraminic

acid

from

N-acetylglucosamine,

we

systematically

characterized S. marcescens promoters and heterologously overexpression an
N-acetylglucosamine 2-epimerase and N-acetylneuraminic acid synthase. After
transcriptional and translational balancing the pathways, the optimized recombinant
strain PT5-slr1975-PrplJ-neuB was able to produce 0.48 g/L Neu5Ac from 20 g/L
N-acetylglucosamine, and 0.30 g/L Neu5Ac from 5 g/L crystal chitin. These results
represent the first demonstration of direct conversion of untreated chitin biomass to
N-acetylneuraminic acid and illustrate the potential utility of S. marcescens as a
chitinolytic bioprocess organism.

The capability of S. marcescens growing on chitin allows me to further improve S.
marcescens growth phenotype on chitin as a substrate since the first step of chitin
degradation is usually the rate-limiting step. Therefore, I conducted serial passage of
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Serratia marcescens grown in colloidal chitin medium for 4 months, propagating 288
generation. The newly evolved strain S. marcescens EPS exhibits increased chitinase
activities, decreased secreted proteins, increased cell yield on chitin, and metabolic
end-products changes compared to the wild-type strain. The EPS strain was capable
of increasing 2,3-butanediol production from 2% crystal chitin, a 3.7-fold
improvement compared to that of the wild-type strain. In addition, the molar ratio of
2,3-butanediol to byproducts is improved from the wild-type strain (2.5:2.5:1) to the
EPS strain (4.8:2.7:1). Key mutations occurred in two gene products (SMDB11_2700
and SMDB11_1516) that encode a LysR-family regulator and a fimbrial adhensin
may be accounting for the increased chitinase activities and overproduction of
2,3-butanediol. To the best of my knowledge, this is the part of dissertation work is
the frst adaptive evolution study using chitin as a substrate.

In previous parts of my dissertation, I have mainly focused on experimental
implementation of S. marcescens. Computational tool is a powerful tool for
mimicking the complexity of metabolic networks since the intraceullar fluxes are
always undertermined. Before my dissertation study, there is no GSMM construction
of S. marcescens and its metabolic profile remains uncharacterized. In this part of
dissertation, a constraint-based genome-scale metabolic model (iSR929) including
929 genes, 1185 reactions and 1164 metabolites based on genomic annotation of S.
marcescens Db11 was constructed. The model performed reasonably comparing
simulated cell growth and metabolites secretion with experimental acquisition, and
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138 essential genes were predicted. I have learned from the model prediction guided
by mRNA-seq data that major metabolic usage differences are the utilization of citric
acid cycle when GlcNAc is a substrate compared to glycerol or glucose as a substrate.
On the contrary, S. marcescens exhibits high activity of pentose phosphate pathway
and nucleotide synthesis but low activity of citric acid cycle when GlcNAc is the
substrate. In addition, I have demonstrated that three target chemicals (2,3-butanediol,
N-acetylneuraminic acid, and n-butanol) can be implemented for metabolic
engineering applications by S. marcescens by giving their pathway gene activities.
6.2 Future work
Although a lot of work has been done in S. marcescens which has been described in
this dissertation, there are still some work in S. marcescens that can be done in the
future. First of all, the transcriptomics and metabolimics of the evolved S. marcescens
EPS and MPS strains are needed to be tested and with these data, the systems level
mechanisms could be discovered and so that the better way to increase chitinase
production and 2,3-butanediol production could be discovered. Second, transforming
the optimized constructs PT5-slr1975-PrplJ-neuB into the evolved strain may be helpful
to increase Neu5Ac titer from chitin. Third, the constructed genome-scale metabolic
model may be used to predict some genetic targets to simulate Neu5Ac production by
implementing Neu5Ac production as an objective function. At the meantime,
experimental implementation can be employed and the design-build-test cycle can be
conducted to improve Neu5Ac titer.
6.3 Commercial feasibility
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During my research, it was found that the chitinase production in S. marcescens is
very powerful and the chitinase activity keeps highly active. Because S. marcescens is
a Gram-negative bacterium and can use crystal chitin to grow, the cultivation of S.
marcescens on the industrial level is relatively lower than those model organisms (e.g.
Escherichia coli and Sacchamyces cerevisiae). Due to the special properties tested in
the dissertation, S. marcescens could be used in the industry to produce chitinases in
large scale. In order to produce a large-scale chitinases, we probably need to obtain
some data of the cell physology and chitinase acitivity from bioreactors (i.e. 5 liter),
then transform the information and fermentation parameters into even large scale (i.e.
100 liter). To the fact that S. marcescen is a native 2,3-butanediol producer, it may be
particular of interest for the 2,3-butanediol chemical industry. Besides the
experimental demonstrations of chemicals (e.g. Neu5Ac and 2,3-BD), n-butanol can
be another target for experimental implementation. My work provided deep insight,
valuable knowledge and useful tools that should be able to help a potential chitin
degradation, chitinase production, or even chitin-based CBP industry.
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Appendix A Tables
Table S1 Primers used in this study
Primers

DNA sequences (5′-3′)

pUC19bb-f

CCTCGTCTCAACCAAAGCAATCAACCCATCAACCACCTGGGGCGTAAT
CATGGTCATAGC

pUC19bb-r

CGAGTAGTTCAGTAGCGGAAATGTCAGAGCCAGCGTCTTGACTGGCC
GTCGTTTTACAA

UNS7-f

CAAGACGCTGGCTCTGA

UNS5-f

GAGCCAACTCCCTTTACAAC

ha1-f

CAAGACGCTGGCTCTGACATTTCCGCTACTGAACTACTCGGATTATTT
GCTCAGGTTGAC

ha1-r

AATGACACTAAATTCCCAAGG

ha2-f

GGAATAGAGACGAAGGGAC

ha2-r

GAGCCAACTCCCTTTACAACCTCACTCAAGTCCGTTAGAGTTTCTTCCT
GTCACGCTATT

kanoverlap-f

CGATTTTTGTGCGCCACCACCTTGGGAATTTAGTGTCATTTTTCTTATTTT
ATTTTAAAGAGGAATTTGTAACAAGGGGTGTTATGAGCC

Kanoverlap-r

GCCGAATGCTGCGGGGTTTTCATTGAGTTAACCGTTTGATTTTCGCGTC
CCTTCGTCTCTATTCCATTAGAAAAACTCATCGAGCATCAA

kan-f

ATGAGCCATATTCAACGGG

kan-r

TTA GAA AAACTCATCGAGCATC

a

underline in red is overlap.

Table S2 Real-time PCR primers used in this study
gene

Forward primers (5’-3’)

Reverse primer (5‟-3‟)

luxS

CCCTGAGCTGAACGAGTACC

ATCCAGAATGTGCTTGGCGA

chiA

CATTTGGCGCCGTTGAAAGA

GGTGAAATTGCGCCCGTAAA

chiB

GAAAGGGCTGTTCGTCACCT

AGATGCCAGAACATCACGCC

chiC

AGCAAGGCCAGTTCACCAAT

GGATGCCCTGGCCTTTCATA

chiR

GCGACACGCATAGCACAAAG

ATCATCGCCATCGGCCAAAT

cbp21

TTCGAACTGGATCAGCAAACG

GCGGTCAGCTTCCAGGTAAA

chb

TCGATAGCGTCAACGACTGG

GTCCGGGTTCACCTCGTAAG

SMDB11_1083

AACATGCGTCAACCAAACCG

GCCACCAGACCATTCCAGAC

SMDB11_1994

AACGTCAAAAGCCCACAGGA

CGTTGAATCGTACAGGTTGGC

SMDB11_4602

CAGGACGGCTATCAGGGCAT

CGGCAGAATTTCATTGCGGT

SMDB11_1190

GCTACGAGCTGGATGCAGAA

TCGTGGAAGTTGCGGGTAAA
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Table S3 Potential binding sites of 10 chitinase-related genes in S. marcescens predicted using a conserved LTTR family motif
Gene ID

Upstream sequence

SMDB11_4243

accattcgaaaaacctgctttttaaagcaggttttttttcgcccgtagtttatgaggatgagtacctccgcaggaggttcgagcctcgcgaagcgagacaacgttgctttagcaacggcccgcagggcgcgcatcaaagatg
cgcgtaatcctctctcgccgaccaccattcgaaaaacctgctttttaaagcaggttttttttcgcctgcagtttatgaggatgagtacctccttcgctacgaccggcttcgctttatggcgtgcctcaatctgccgtcctcgtgaaat
atatttatcctttacgcttaattaattcacattccttattcccattaggttcttattttcatgtttaaataaattcatgcttgccaaataaaacccgattgatagcgctcttgttttcacgttttttttacctatagtctaaatggacaacgcggg
aactcttattcccgtcgcgtgggaaataccgtgattatttattaacgttaatcttcgtggattattgcggaattttttcgcttcggcaatgcgtagcgacgattaactcttttatgtttatcctctcggaataaaggaatcagttATG

SMDB11_2875

tagctcatctccttttttatttttaattaaatgccaatcacggccggtgggacatcggatattcagaatctaattaaggatgctattacaaagcaaatgaataaatacagcccctatggtcgaattcattcatgctgagcgctggcac
aactcatcagcgccaatttgtgcagcagtgaataaaaattcattgtcattgtgatttatttcgacttttgttttcactaaaaataaacattaatggcaacgggaaatatttccccatcataaaaacatccactctggagaaatgccAT
G

SMDB11_0468

atgcggccatggcggccgcccggccgccattatttccttctccctcagcgtcagtttgaatttaattcgttcatggcagcaaaaggtttcagcctgcctgcattaaaaatcctcattataactttacgccccgccaatagctgatat
tgccggcgagcggaaaacccttaccccttatcaatgaggctaccATG

SMDB11_2876

taagtcactcctgactgaaataatgttgtaagttgagcgtatttcaccgacaaaatgagagagtaataacgcaattggaaataacccttcttgtcggcttgttttatttttatcattctggtcatgcgatagagcggaatgttttaacg
gctattaacgaaaattattatgatgacgatctttgatcgttaggctgaatttatttaactgtcgctgtgtaaaagtagggcgctatgatgaattttatatcaggtcgtgatgaatagtatttaagatagcgctctcatttatgaagtatatt
gcttgttgctatgagtacccttgttcgatttgatcgatttttgtgcgccaccaccttgggaatttagtgtcatttttcttattttattttaaagaggaatttgtATG

SMDB11_2877

tacaaattcctctttaaaataaaataagaaaaatgacactaaattcccaaggtggtggcgcacaaaaatcgatcaaatcgaacaagggtactcatagcaacaagcaatatacttcataaatgagagcgctatcttaaatactatt
catcacgacctgatataaaattcatcatagcgccctacttttacacagcgacagttaaataaattcagcctaacgatcaaagatcgtcatcataataattttcgttaatagccgttaaaacattccgctctatcgcatgaccagaat
gataaaaataaaacaagccgacaagaagggttatttccaattgcgttattactctctcattttgtcggtgaaatacgctcaacttacaacattatttcagtcaggagtgacttATG

SMDB11_0477

cacccagtatgacaaccacaccaacatcccgagctggggcggcggttacggcaacatcttccaggacgagaaagacgtcaagttcatggtcatcgcgccattcaccatcttctgatgcgttccccggcctcgccgccgg
ggcagttaagggaattcaacgatgaaaaaaatcatgctgatgttggcggccgctgcggccctgagcgcctgcgcgcaacccaccgcgccgccggaagacgccaagttgaagcaggcttacagcgcctgcatcaacac
tgccgaaggctcgccggagcgtctgcagccctgtaaggcggtgctgaacgtgctgaaacaagagaagcagcaccagcagttcgccgcgcaggaaacggtgcgggtgatggattatcagaactgcattatggcggtgc
acagcggtaacggtcaggcttacgacgccaagtgcggcaagctgtggcaagaaattcgcgataacaataattaagaaggataagaagATG

SMDB11_1083

atccctcttaagcccaccgttttcgggcgcgctctgcggttgccggtctgcggcagagcgtgccttgcgttttattgccatctcagtgtgagctgctacgattttagctgacgtttttatgccacccgggtcaccggccttgcgc
atattcttcatctcagccagaagaggggcagctATG

SMDB11_1994

aatccgctcgggcgccaccggcgccctctctgcgcggcggcgaaattatcgacgctgctcacaataccgcctttcttcttccccaacggcttgtgaccggcaggcgcttttgctgttatgactgcgacgcttttggcgtcaat
cggttatacgcatccggggcccactgagcccggctttattgtgcccgcccctggcggtacggtcggccttgccgaccacaaggagactgacATG

SMDB11_4602

acccgttcgccccctccggccgggagggggcaactgtgatcccgtccgctttttcaccgcaacggttggacatctgttctgtgctgagtctttatctacagcgttggctgtttttattgatttttttcctctgaggaatttccgAT
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G
SMDB11_1190

cggttggatctgcggcggcagttccgccgctactggcagcagctggatacgcggcgtttaactcctggctggctgcgcctgcaacatcactttttgcaaaacacgccaccctcaccgctgaagctggcgccgctgcacat
ggacatccatccgggcaatttgctcgcgaccggcgaggggctgcggctgatcgactgggagtatgccgccgacggcgatgtggcgttggatatcgccgcgctgtttcgcggcaacggctgggcggcggaggcgcag
cagcgctttttgcagcactacgcgcgccagggctatcacgacgtcgcccggctgcaggcgcaggtgcagcgctggctgccgtgggtggattatctgatgctgctgtggtttgaagtgcgctggcagcagagcggcgac
gccgaatttttgcgctggggcgcggcgctgcgccggcgattctgtttatcatcatccgaattctgaacgaacaataatgaagtgagATG

Green highlight is predicted promoter -35 box, yellow highlight was predicted promoter -10 box; Conserved RBS motif was highlighted in blue;
each chitinase-related gene start codon (ATG) was marked in bold capital; potential binding sites were either highlighted in grey or marked by
underline.
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Table S4 Production of 2,3-BD and byproducts after 72 h fermentation from 2%
chitin using S. marcescens Db11 and chiROE.
S. marcescens Db11

S. marcescens chiROE

Biomass (g/L)

1.08 ±0.11

0.90 ±0.13

2,3-BD (g/L)

0.4 ±0.04

1.13 ±0.08

Acetic acid (g/L)

0.26 ±0.03

0.71 ±0.04

Lactic acid (g/L)

0.15 ±0.01

0.38 ±0.03

Ethanol (g/L)

0.03 ±0.00

0.08 ±0.03

Succinic acid (g/L)

0.17 ±0.02

0.40 ±0.03

Table S5 Ct & Data Analysis for Serratia marcescens Gene Expression
Gene

luxS

chiA

chiB

chiC

chiR

cbp21

wild-type

chiROE

ΔchiR

Rep1

20.26

20.97

19.64

Rep2

20.39

21.02

19.43

Rep3

20.34

20.97

19.46

Ave

20.33

20.99

19.51

Stdv

0.07

0.03

0.11

CV%

0.32%

0.14%

0.58%

Rep1

26.72

24

26.89

Rep2

26.87

24.02

26.84

Rep3

26.97

24.16

27.06

Ave

26.85

24.06

26.93

Stdv

0.13

0.09

0.12

CV%

0.47%

0.36%

0.43%

Rep1

27.77

26.16

28.45

Rep2

27.79

26.13

28.47

Rep3

28.13

26.17

28.73

Ave

27.90

26.15

28.55

Stdv

0.20

0.02

0.16

CV%

0.73%

0.08%

0.55%

Rep1

26.26

23.73

26.47

Rep2

26.32

23.87

26.45

Rep3

26.29

23.58

25.98

Ave

26.29

23.73

26.30

Stdv

0.03

0.15

0.28

CV%

0.11%

0.61%

1.05%

Rep1

28.53

20.03

38.19

Rep2

28.37

20.02

38.12

Rep3

28.68

19.86

38.17

Ave

28.53

19.97

38.16

Stdv

0.16

0.10

0.04

CV%

0.54%

0.48%

0.09%

Rep1

26.73

24.43

28.18
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chb

SMDB11_1083

SMDB11_1994

SMDB11_4602

SMDB11_1190

Rep2

27.07

24.22

28.2

Rep3

26.92

24.42

28.25

Ave

26.91

24.36

28.21

Stdv

0.17

0.12

0.04

CV%

0.63%

0.49%

0.13%

Rep1

25.91

24.81

25.62

Rep2

26.13

24.74

25.47

Rep3

25.97

24.68

25.65

Ave

26.00

24.74

25.58

Stdv

0.11

0.07

0.10

CV%

0.44%

0.26%

0.38%

Rep1

23.94

23.6

23.39

Rep2

23.88

23.51

23.55

Rep3

24.05

23.47

23.02

Ave

23.96

23.53

23.32

Stdv

0.09

0.07

0.27

CV%

0.36%

0.28%

1.17%

Rep1

25.55

23.3

24.87

Rep2

25.36

23.38

24.82

Rep3

25.36

23.3

24.98

Ave

25.42

23.33

24.89

Stdv

0.11

0.05

0.08

CV%

0.43%

0.20%

0.33%

Rep1

22.9

22.15

22.35

Rep2

23.12

21.93

22.38

Rep3

23.02

22.05

22.68

Ave

23.01

22.04

22.47

Stdv

0.11

0.11

0.18

CV%

0.48%

0.50%

0.81%

Rep1

21.79

21.16

21.12

Rep2

21.77

21.07

21.32

Rep3

21.74

21.32

21.24

Ave

21.77

21.18

21.23

Stdv

0.03

0.13

0.10

CV%

0.12%

0.60%

0.47%

157

Table S6 Data Analysis for S. marcescens chitinase gene of interest (GOI) expression level using LuxS as control
Δ Δ Ct

Δ Δ Ct, STDV

6.52

0.00

0.14

1.00

0.14

0.03

3.07

-3.45

0.09

10.93

0.09

0.11

7.42

0.90

0.17

0.54

0.08

20.33

0.07

7.57

0.00

0.21

1.00

0.21

0.02

20.99

0.03

5.17

-2.40

0.04

5.28

0.04

28.55

0.16

19.51

0.11

9.04

-0.93

0.20

0.87

0.10

wild-type

26.29

0.03

20.33

0.07

5.96

0.00

0.07

1.00

0.07

chiROE

23.73

0.15

20.99

0.03

2.74

-3.22

0.15

9.32

0.15

ΔchiR

26.30

0.28

19.51

0.11

6.79

0.83

0.30

0.56

0.16

wild-type

28.53

0.16

20.33

0.07

8.20

0.00

0.17

1.00

0.17

chiROE

19.97

0.10

20.99

0.03

-1.02

-9.21

0.10

593.59

0.10

GOI

Sample

GOI, Ave Ct

chiA

wild-type

26.85

0.13

20.33

0.07

chiROE

24.06

0.09

20.99

ΔchiR

26.93

0.12

19.51

wild-type

27.90

0.20

chiROE

26.15

ΔchiR

chiB

chiC

chiR

cbp21

chb

SMDB11_1083

SMDB11_1994

SMDB11_4602

GOI, STDV

luxS, Ave Ct

Δ Ct, GOI-luxS

luxS, STDV

Fold Change,AVG

Fold change, STDV

ΔchiR

38.16

0.04

19.51

0.11

18.65

10.45

0.12

0.00

0.00

wild-type

26.91

0.17

20.33

0.07

6.58

0.00

0.18

1.00

0.18

chiROE

24.36

0.12

20.99

0.03

3.37

-3.21

0.12

9.23

0.12

ΔchiR

28.21

0.04

19.51

0.11

8.70

2.12

0.12

0.23

0.03

wild-type

26.00

0.11

20.33

0.07

5.67

0.00

0.13

1.00

0.13

chiROE

24.74

0.07

20.99

0.03

3.76

-1.92

0.07

3.78

0.07

ΔchiR

25.58

0.10

19.51

0.11

6.07

0.40

0.15

0.76

0.11

wild-type

23.96

0.09

20.33

0.07

3.63

0

0.11

1.00

0.11

chiROE

23.53

0.07

20.99

0.03

2.54

-1.09

0.07

2.12

0.07

ΔchiR

23.32

0.27

19.51

0.11

3.81

0.18

0.29

0.88

0.25

wild-type

25.42

0.11

20.33

0.07

5.09

0.00

0.13

1.00

0.13

chiROE

23.33

0.05

20.99

0.03

2.34

-2.75

0.05

6.74

0.05

ΔchiR

24.89

0.08

19.51

0.11

5.38

0.29

0.14

0.82

0.11

wild-type

23.01

0.11

20.33

0.07

2.68

0.00

0.13

1.00

0.13

chiROE

22.04

0.11

20.99

0.03

1.06

-1.63

0.11

3.09

0.11

158

SMDB11_1190

ΔchiR

22.47

0.18

19.51

0.11

2.96

0.28

0.21

0.83

0.17

wild-type

21.77

0.03

20.33

0.07

1.44

0.00

0.07

1.00

0.07

chiROE

21.18

0.13

20.99

0.03

0.20

-1.24

0.13

2.36

0.13

ΔchiR

21.23

0.10

19.51

0.11

1.72

0.28

0.15

0.82

0.12

Table S7 Genetic engineering by regulatory protein as a strategy for increasing feedstock biomass utilization.
Regulatory protein

Microorganisms

ClrB, Bgl2, and CreA

Penicilliumoxalicum

CelR

Thermobifida fusca

Xyr1 and Ace1

Trichoderma reesi

VEL1

Trichoderma reesi

Ace3

Strategies

Significance

References

Cellulase activity increased from 10- to 50-fold

(Yao et al. 2015)

Cellulase activity increased 16.69-fold

(Deng and Fong 2010)

Cellulose activity increased 2- to 4-fold

(Wang et al. 2013)

Overexpression VEL1

Cellulase activity increased around 4-fold

(Aghcheh et al. 2014)

Trichoderma reesi

Overexpression Ace3

Cellulase activity increased 3- to 5-fold

(Häkkinen et al. 2014)

XYR1, ACE2, and ACE1

Trichoderma reesi

Overexpression XYR1, ACE1 and ACE2

Cellulase production rate increased around 4.5-fold

(Portnoy et al. 2011)

ChiR

S. marcescens

Overexpression chiR

Chitinase activity increased from 2.14 to 6.31-fold

This study

Overexpression clrB
Deletion bgl2 and creA
Deletion celR
Overexpression xyr1
Downregulation ace1
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Table S8 Gene and promoter sequences used in this study.
Gene

Sequences
5‟-ATGATTGCCCATCGCCGTCAGGAGTTAGCCCAGCAATATTACCAGGCTTTACACCAGGACGTATTGCCCTTTTGGGAAAAATATTCCCTCGATCGCCAGGGGGGCGGTTACTTTAC
CTGCTTAGACCGTAAAGGCCAGGTTTTTGACACAGATAAATTCATTTGGTTACAAAACCGTCAGGTATGGCAGTTTGCCGTTTTCTACAACCGTTTGGAACCAAAACCCCAATGGTT
AGAAATTGCCCGCCATGGTGCTGATTTTTTAGCTCGCCACGGCCGAGATCAAGACGGTAATTGGTATTTTGCTTTGGATCAGGAAGGCAAACCCCTGCGTCAACCCTATAACGTTTT
TTCCGATTGCTTCGCCGCCATGGCCTTTAGTCAATATGCCTTAGCCAGTGGGGCGCAGGAAGCTAAAGCCATTGCCCTGCAGGCCTACAATAACGTCCTACGCCGTCAGCACAATCC
CAAAGGTCAATACGAGAAGTCCTATCCAGGTACTAGACCCCTCAAATCCCTGGCGGTGCCGATGATTTTAGCCAACCTCACCCTGGAGATGGAATGGTTATTACCGCCTACTACCGT

slr1975

GGAAGAGGTGTTGGCCCAAACCGTCAGAGAAGTGATGACGGATTTCCTCGACCCAGAAATAGGATTAATGCGGGAAGCGGTGACCCCCACAGGAGAATTTGTTGATAGTTTTGAA
GGGCGGTTGCTCAACCCAGGACACGGCATTGAAGCCATGTGGTTCATGATGGACATTGCCCAACGCTCCGGCGATCGCCAGTTACAGGAGCAAGCCATTGCAGTGGTGTTGAACA
CCCTGGAATATGCCTGGGATGAAGAATTTGGTGGCATATTTTATTTCCTTGATCGCCAGGGCCACCCTCCCCAACAACTGGAATGGGACCAAAAGCTCTGGTGGGTACATTTGGAAA
CCCTGGTTGCCCTAGCCAAGGGCCACCAAGCCACTGGCCAAGAAAAATGTTGGCAATGGTTTGAGCGGGTCCATGATTACGCCTGGAGTCATTTCGCCGATCCTGAGTATGGGGAA
TGGTTTGGCTACCTGAATCGCCGGGGAGAGGTGTTACTCAACCTAAAAGGGGGGAAATGGAAAGGGTGCTTCCACGTGCCCCGAGCTCTGTGGCTCTGTGCGGAAACTCTCCAAC
TTCCGGTTAGTTAA-3‟
5‟-ATGGGTAAGAACCTCCAAGCCCTGGCGCAATTGTATAAGAATGCTTTGCTGAACGATGTATTGCCGTTCTGGGAAAACCACTCACTTGACTCTGAGGGAGGCTATTTCACCTGTT
TGGATCGCCAAGGCAAGGTCTACGATACGGACAAATTCATCTGGCTGCAAAATCGGCAAGTCTGGACTTTTTCAATGCTCTGCAACCAACTTGAAAAACGTGAAAATTGGTTGAA
AATAGCCCGGAATGGGGCTAAATTCTTGGCGCAACATGGTCGTGATGACGAAGGAAATTGGTATTTTGCCTTGACTCGGGGTGGCGAGCCGTTGGTCCAGCCATATAATATATTCAG
CGATTGTTTCGCGGCCATGGCCTTCAGCCAATACGCTCTGGCCAGTGGGGAGGAATGGGCCAAGGATGTTGCTATGCAAGCCTATAATAACGTTCTGCGTCGGAAAGACAATCCTA
AGGGGAAGTACACGAAAACCTACCCTGGTACGCGCCCGATGAAGGCCCTGGCAGTCCCCATGATCCTTGCAAATCTCACGCTTGAAATGGAGTGGCTTTTGCCGCAAGAGACGCT

AGE

GGAAAATGTCCTTGCTGCAACGGTGCAAGAGGTTATGGGGGATTTCCTGGACCAGGAGCAGGGTCTTATGTATGAGAATGTAGCGCCAGACGGATCGCACATAGATTGTTTTGAAG
GACGGCTGATAAATCCGGGACACGGAATCGAAGCCATGTGGTTTATCATGGACATCGCCCGGCGGAAGAATGATTCCAAGACTATAAATCAAGCGGTCGATGTTGTACTCAATATCT
TGAACTTCGCATGGGATAATGAATATGGGGGTCTGTATTACTTCATGGATGCAGCCGGGCATCCTCCGCAACAGTTGGAGTGGGACCAGAAATTGTGGTGGGTCCACCTCGAATCCC
TCGTCGCCCTGGCCATGGGATACCGTCTGACTGGTCGGGACGCCTGTTGGGCCTGGTACCAGAAAATGCATGATTACAGTTGGCAACATTTTGCAGACCCCGAATACGGTGAATGG
TTCGGCTACTTGAATCGCCGGGGTGAGGTCCTGCTTAATTTGAAAGGAGGAAAGTGGAAAGGTTGTTTTCACGTTCCTCGGGCGATGTATTTGTGCTGGCAGCAATTTGAGGCTCT
GAGCTAA-3‟

nanA

5‟-ATGGCAACGAATTTACGTGGCGTAATGGCTGCACTCCTGACTCCTTTTGACCAACAACAAGCACTGGATAAAGCGAGTCTGCGTCGCCTGGTTCAGTTCAATATTCAGCAGGGC
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ATCGACGGTTTATACGTGGGTGGTTCGACCGGCGAGGCCTTTGTACAAAGCCTTTCCGAGCGTGAACAGGTACTGGAAATCGTCGCCGAAGAGGCGAAAGGTAAGATTAAACTCA
TCGCCCACGTCGGTTGCGTCAGCACCGCCGAAAGCCAACAACTTGCGGCATCGGCTAAACGTTATGGCTTCGATGCCGTCTCCGCCGTCACGCCGTTCTACTATCCTTTCAGCTTTG
AAGAACACTGCGATCACTATCGGGCAATTATTGATTCGGCGGATGGTTTGCCGATGGTGGTGTACAACATTCCAGCCCTGAGTGGGGTAAAACTGACCCTGGATCAGATCAACACA
CTTGTTACATTGCCTGGCGTAGGTGCGCTGAAACAGACCTCTGGCGATCTCTATCAGATGGAGCAGATCCGTCGTGAACATCCTGATCTTGTGCTCTATAACGGTTACGACGAAATC
TTCGCCTCTGGTCTGCTGGCGGGCGCTGATGGTGGTATCGGCAGTACCTACAACATCATGGGCTGGCGCTATCAGGGGATCGTTAAGGCGCTGAAAGAAGGCGATATCCAGACCGC
GCAGAAACTGCAAACTGAATGCAATAAAGTCATTGATTTACTGATCAAAACGGGCGTATTCCGCGGCCTGAAAACTGTCCTCCATTATATGGATGTCGTTTCTGTGCCGCTGTGCCG
CAAACCGTTTGGACCGGTAGATGAAAAATATCTGCCAGAACTGAAGGCGCTGGCCCAGCAGTTGATGCAAGAGCGCGGGTGA-3‟
5‟-ATGCAAATAAAAATCGACAAGCTTACCATCTCGCAGAAGAACCCACTTATAATCCCTGAGATCGGAATAAACCATAATGGCAGCCTCGAGATCGCGAAACTTATGGTTGACGCGG
CGAAACGGGCGGGGGCAAAGATTATTAAACACCAAACTCACATAGTCGAAGACGAAATGAGCCAGGAGGCTAAGAACGTGATCCCCGGCAATGCTAATATTAGTATCTATGAGATC
ATGGAACAGTGCGCCCTGAACTATAAGGACGAGCTTGCTCTGAAAGAATACGTTGAAAAGCAAGGACTTGTATATCTGTCAACCCCGTTTTCTCGTGCGGCTGCGAACCGTCTGGA
GGATATGGGGGTTTCGGCATATAAAATCGGTAGCGGCGAGTGCAATAATTACCCCCTTATCAAGCACATAGCCCAGTTTAAAAAACCAATGATCATAAGTACTGGGATGAATTCTATC

neuB

GAAAGTATAAAACCAACCGTCAAAATTCTTCGGGACTATGAAATACCATTTGTCTTGCTGCACACTACCAACTTGTATCCGACCCCATCACATCTCGTGCGTTTGCAGGCAATGCTG
GAACTTTACAAGGAGTTTAACTGTCTTTACGGACTCTCTGATCACACGACTAATAATCTTGCTTGTATTGGCGCCATCGCCTTGGGAGCTTCTGTGCTGGAGCGTCATTTCACTGACA
CGATGGACCGTAAAGGCCCCGACATTGTCTGCAGTATGGATGAGTCAACCTTGAAGGACCTTATAAATCAAACCCAGGAGATGGTGCTCCTGCGCGGAGATAACAATAAAAACCCG
CTCAAGGAAGAACAAGTTACTATCGACTTCGCCTTCGCCTCCGTAGTGTCGATCAAGGATATAAAAAAGGGGGAGATTCTGAGTATGGATAACATCTGGGTGAAGCGCCCGTCAAA
AGGTGGTATCAGCGCGAAGGACTTTGAGGCCATCCTTGGGAAACGGGCCAAGAAGGACATAAAAAACAATATACAACTGACATGGGATGACTTTGAGTAA-3‟

PT5

5‟-TGTGGAATTGTGAGCGGATAACAATTACGAGCTTCATGCACAGTGAAATCATGAAAAATTTATTTGCTTTGTGAGCGGATAACAATTATAATATGTGGAATTGTGAGCGCTCA
CAATTCCACAACG-3‟
5‟-TTTTTGCATTATATGCAAAAGCGTTTCTTATGAATACCCGCTTCTCTGTTGGCGACGCGGCGGCTACTCTGATTGCAGGTTGACGACGGGCTTCAGCGTCGCCGCATCCCGGCCGT

PbudAB

ATAGAGAGAAAACGCATAAACCTCGCGGCGTTTAGCACCAAATAGCAGATATTTTTCCCAGGCTGCGTCAGCCGCCTGTGGCGTTGATTGTCGCTCCAACACCAGATTAACCGTTC
AATTTGATATCCGACTCAACCTTAATGATTAGTGAGTCTTTACTTTCACTTATCTTCTTGTTGTTTCTGGATATCGGCCGGCCAGCCGTGCCGGTTTTTTTGTCGCCTCAGGCTGAATC
GTTCCAACTGATGAACGCGCCTGAGGGGCATCTTGGCCCGCCGTCGGCGGGTCTTTTGAACGCGTGGAACCGCAGTTCCGCGCTGGTGGAGGAGTCAGCA-3‟

PampR
PompA

5‟-TTCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATATTGAAAAAGGAAGAAT-3‟
5‟-GTAAATTTAGGATTTTTCCCATCATTTTCGCACCCCCTAAGCGGAACCTTTGCGTGGGAAGGCACAAAGCTAGTCCGGCTGCGGTTTGGCAAGCAAAAACGCTCGATGAATCGC
CGTTTTTTTAGGCAAAGAATGTTAGCAAATATGTACGATTCCGCGTTTTTTTTTAGAGCCTTATCACATCACACTTGTAACTTTCGCGCCACGTTGTAGACTTTACATCGCCAAGGTTG
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CTCTATAACGTCAGAAAAACTGGCGAGTAACAAACGAGGGCTTAAACCTTGGCGAAGGAATTTAACCAAGGGCTTAAACAGCTTTAAAGCTCA-3‟
5‟-TCGCACTTGCGATTATCGCTTTGACTTGGGGCCGAGATTTGTCTAGAATCTTATGCCCCAAGGTTTTGCTACTGGCTATGCCGTAGGCAAAACAAAGATTTTTCGGTTGGAGCCTG

PrplJ

GCCTATCCAGGCCTCCGTCCAAGACCGCAGGTGTATCGCAAGATACTTAATCCTTCCTGCGTAGACGGTGACAGAGCCTAAGAAAATTTTTCTTTTTTATAAAAGAATGTCTTTGCTG
GATTCTGCTCACCGTGTTAAGCCGCTCGGCGTGGCGTTTTACAAAGCGCCGAGTGAAGTGAGTTCCGGGGGATTTTCCCCGGCTAATCCAGGAGCAAAAAGCTA-3‟

PrpsG
PrpsL
PgpmA
PmetF
PcysP
PphlA
PSMDB11_4059

5‟-ATGGTTCTCCGTTAAGTAAGGCCAAACGTTTTAACTTTAATGTCAAAATAAACTCGTAGAGTTTTGGACAATCCTGAATTAACAACGGAGTATTTCC-3‟
5‟-ATGAGAGTGATGTTGTATATTTCTTGACACCCATACTGGTCAGCCCTAAAATTCTGCGTCCTCGTACTCTGCCAATAGTGCATACGAGGGGATTTATCACATGTTTACGAAGCTAGT
ACGAAGCAAAAACCAGGAGCTTTTTTA-3‟
5‟-ATTTCCCCCACGCCACGGCGCGCCCGGAGCGATTTCGGCGCGCCGTTTCCCCCTCACAGCGCCAGCCTGAACGATTCAGCTTTTTCCTTTCGCCAGCCCTTACTTTGCGGCAAGA
AATTGGCTATGGTTAGACACTATCGATTGCCGAGCCCCGGCCCGCGGCAATATAATGATTTTCGTTATCATTGAAATGTCAGATTATTAAGGAGTTAAGCT-3‟
5‟-TCCTCTGCGGGCGCGGGCTCACCGCGCCCCTTTGCTTTTCCTGCCATACTTATCTTTGCCGCGATCATGAAATTCCCTCGTTGAGCGGGTGAGGATTAATCATCTTATTCCCCTCAT
TTTCCTGTTGACTCTTTAGCCAACATGCGGCATTTTCTATCTAGACGTCTAAACGTATAGACGCTCATCAAGATGAAATAAAAACAGTGATCGATAAAGAGGTGAGCAGGGT-3‟
5‟-CGCCGTTGCCGAAGCCGGTGCGCCCGGCTTCGGCCCGTTTTTCCGTCCCGAAAACGCCTCGCATTCCCTGCCTTATAGCGTTTGATGCTTGTAAATCACCAAACGGTATATAAAA
GCGTTACAGCTCCGCACCGAGTTATAAATACACTGGTCGTCAATAAGGCGAAAGCCTGAAGGAATGACTCAGTGATAAGGTGCAGA-3‟
5‟-TTTGCGGCGCAGTCAATCAGGGAGCTTCGGCTCCCTTTTCTGCGTTTGGTGGCCGAAAACCGAACGCGGATCACATTCTGTACAAAGATAAGCATTTCTAATACAGAACTCATCC
GACCTGCCGATAGCTAAATCAGCACCTATTCAGGTGCTCAATAAAAAGTCTATCGACAAGGAGTCGGC-3‟
5‟-TTTGATGCCGGCCGGCGGCACTTTTTTAACCGCTGGCGGCCCCTGTGGGGCAACTGCTATACTATGCGGGCCGCTTCTGCGGCCCGATAGCTTCCCTTCTGGTTGTTATCGCTGCT
TTTTTTACTATGTACTACCCTTCCTCAAGAGCGCCGTCATCCCGTCGGCACGTATGGATAGATT-3‟
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Table S9 Primer sequences used for cloning and sequencing in this study.
Primers
Sequences
UNS7-F
5‟-CAAGACGCTGGCTCTGA-3‟
UNS7-R
5‟-CGAGTAGTTCAGTAGCGGA-3‟
UNS5-F
5‟-GAGCCAACTCCCTTTACAAC-3‟
UNS5-R
5‟-CTCTAACGGACTTGAGTGAGG-3‟
UNS3-F
5‟-GCACTGAAGGTCCTCAATC-3‟
UNS3-R
5‟-CGACCTTGATGTTTCCAGTG-3‟

Table S10 Primer sequences used for real-time PCR in this study.
Primers
Sequences
luxS-f
5‟-CCCTGAGCTGAACGAGTACC-3‟
luxS-r
5‟-ATCCAGAATGTGCTTGGCGA-3‟
slr1975-f
5‟-GGCCGAGATCAAGACGGTAA-3‟
slr1975-r
5‟-GGGCAATGGCTTTAGCTTCC-3‟
nanA-f
5‟-CTGCGATCACTATCGGGCAA-3‟
nanA-r
5‟-CACCTACGCCAGGCAATGTA-3‟
gfp-f
5‟-GGGTGAAGGTGACGCAACTA-3‟
gfp-r
5‟-CGAGCAAAGCACTGAACACC-3‟
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Table S11 Fermentation parameters of the S. marcescens recombinant strains on M9
medium with 0.1% yeast extract and 20 g/L GlcNAc at 30°C and 200 rpm.
Consumed
Biomass
S. marcescens strain

Neu5Ac

2,3-BD

Acetic acid

Lactic acid

(g/L)

(g/L)

(g/L)

(g/L)

GlcNAc
(g/L)
(g/L)

PT5-slr1975-PrplJ-nanA

1.35 ±0.12

18.4 ±0.58

0.30 ±0.03

0.81 ±0.06

0.34 ±0.02

0.53 ±0.09

PT5-AGE-PrplJ-neuB

1.34 ±0.10

19.4 ±0.32

0.45 ±0.05

0.75 ±0.07

0.21 ±0.03

0.45 ±0.10

PT5-AGE-PrplJ-nanA

1.72 ±0.10

18.4 ±0.37

0.21 ±0.04

0.92 ±0.24

0.31 ±0.02

0.62 ±0.10

PT5-slr1975-PrplJ-neuB

1.5 ±0.08

16.9 ±0.48

0.47 ±0.06

0.77 ±0.11

0.22 ±0.01

0.47 ±0.02

PrplJ-slr1975-PT5-nanA

1.44 ±0.11

19.0 ±0.60

0.1 ±0.02

1.12 ±0.56

0.67 ±0.02

1.03 ±0.33

PT5-slr1975-PT5-nanA

0.58 ±0.09

5.7 ±0.11

0.04 ±0.00

0.18 ±0.01

0.09 ±0.00

0.06 ±0.00

PrplJ-slr1975-PrplJ-nanA

1.85 ±0.10

19.3 ±0.78

0.10 ±0.02

1.15 ±0.22

0.68 ±0.02

1.3 ±0.23

PcysP-slr1975-PcysP-nanA

2.42 ±0.11

20.2 ±0.86

0.04 ±0.00

1.21 ±0.28

0.73 ±0.03

1.12 ±0.34

wild-type

2.41 ±0.12

20.0 ±0.99

0.00 ±0.00

3.38 ±0.52

0.84 ±0.03

0.84 ±0.03

Table S12 Number of genes excluded/included after the lower/upper bound cutoff.
Number of genes

M9 glucose

M9 N-acetylglucosamine

M9 glycerol

Lower bound 3.00
Upper bound 850.56

500
251

459
271

196
314
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Appendix B Figures

Fig S1A
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Fig S1B
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UNS5

chiR

PampR

pQY38

UNS8

(pUC19/chiR)
UNS7

3,773 bp
R

Amp

pMB1 ori

Fig S1C
Figure S1 (A) Overview of the strategy used for replacement of chiR in S.
marcescens. (B) PCR verification of the deletion mutants. PCR was conducted using
wild-type or chiR deletion strain genome as template and kan-f/kan-r as primers.
Lanes from left to right are 1 kb marker, wild-type (no band) and chiR deletion strain
(a single ~0.8 kb band). (C) Shuttle vector pQY38 map for overexpression chiR in S.
marcescens.
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Figure S2 Production of 2,3-BD in S. marcescens Db11. (A) Cell growth, (B) 2,3-BD
production and (C) sugar consumption was monitored using S. marcescens Db11
under M9 medium with 1% yeast extract and 20 g/L glucose (Glc, filled circle) or
N-acetylglucosamine (GlcNAc, unfilled circle) at 30°C and 100 rpm.
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Figure S3 Production of 2,3-BD from S. marcescens using untreated chitin. (A) Cell
growth using the S. marcescens Db11 (filled circle) and the S. marcescens chiROE
strain (unfilled circle); (B) endochtinase activity (circle), chitobiosidase activity
(triangle) and β-N-acetylglucosaminidase activity (square) using the S. marcescens
Db11 (filled) and the S. marcescens chiROE strain (unfilled) under M9 medium
supplemented with 1% yeast extract and 2% chitin at 30°C and 100 rpm.
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Figure S4 Raw data of fluorescence intensity of S. marcescens promoters using flow
cytometry.
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Figure S5 Characterization of (A) NanA and (B) NeuB enzymatic activities.
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Figure S6 Growth of S. marcescens recombinant strains on M9 medium with 0.1%
yeast extract and 20 g/L GlcNAc at 30°C and 200 rpm. (A) OD600; (B) GlcNAc
concentration.
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Figure S7 Representative figures of gene expression level distribution under M9 glucose medium
growth conditions.
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